URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Submission: On February 09 via manual from IN — Scanned from DE

Summary

This website contacted 90 IPs in 11 countries across 69 domains to perform 293 HTTP transactions. The main IP is 104.18.15.141, located in and belongs to CLOUDFLARENET, US. The main domain is www.fiercepharma.com. The Cisco Umbrella rank of the primary domain is 92179.
TLS certificate: Issued by Cloudflare Inc ECC CA-3 on July 14th 2021. Valid for: a year.
This is the only time www.fiercepharma.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
12 104.18.15.141 13335 (CLOUDFLAR...)
1 2a00:1450:400... 15169 (GOOGLE)
1 18.66.139.105 16509 (AMAZON-02)
1 104.16.93.165 13335 (CLOUDFLAR...)
7 45.133.44.4 39572 (ADVANCEDH...)
10 142.250.184.226 15169 (GOOGLE)
2 2a00:1450:400... 15169 (GOOGLE)
3 2606:4700:10:... 13335 (CLOUDFLAR...)
1 2a00:1450:400... 15169 (GOOGLE)
1 104.16.92.80 13335 (CLOUDFLAR...)
2 2a00:1450:400... 15169 (GOOGLE)
1 54.72.7.92 16509 (AMAZON-02)
2 4 66.155.71.150 13768 (COGECO-PEER1)
1 10 204.180.130.190 53866 (QTS-AS)
1 13.224.194.178 16509 (AMAZON-02)
5 2a00:1450:400... 15169 (GOOGLE)
4 2606:4700::68... 13335 (CLOUDFLAR...)
2 104.111.234.67 16625 (AKAMAI-AS)
1 13.32.99.71 16509 (AMAZON-02)
1 2606:4700::68... 13335 (CLOUDFLAR...)
13 204.180.130.159 53866 (QTS-AS)
1 18.66.100.58 16509 (AMAZON-02)
2 11 185.33.221.53 29990 (ASN-APPNEX)
3 3.226.203.17 14618 (AMAZON-AES)
1 2a00:1450:400... 15169 (GOOGLE)
1 54.144.144.142 14618 (AMAZON-AES)
2 52.208.138.90 16509 (AMAZON-02)
1 192.28.147.68 15224 (OMNITURE)
10 2a06:8640:799... 55081 (24SHELLS)
1 34.200.182.42 14618 (AMAZON-AES)
1 52.222.236.10 16509 (AMAZON-02)
1 18.66.122.57 16509 (AMAZON-02)
10 18.66.112.18 16509 (AMAZON-02)
5 205.162.42.5 53866 (QTS-AS)
1 34.249.212.247 16509 (AMAZON-02)
2 169.197.150.8 398989 (DEEPINTENT)
1 37.252.161.190 29990 (ASN-APPNEX)
11 51.89.9.254 16276 (OVH)
1 185.184.10.30 203690 (RTB-HOUSE...)
1 213.19.147.43 26120 (RHYTHMONE)
1 178.162.133.150 60781 (LEASEWEB-...)
1 72.251.249.14 29791 (VOXEL-DOT...)
2 147.75.61.140 54825 (PACKET)
2 185.64.189.112 62713 (AS-PUBMATIC)
1 5.178.65.246 50673 (SERVERIUS-AS)
1 146.0.227.110 29066 (VELIANET-...)
1 184.31.84.150 16625 (AKAMAI-AS)
1 96.46.186.59 7979 (SERVERS-COM)
2 34.98.64.218 15169 (GOOGLE)
8 2602:803:c004... 26667 (RUBICONPR...)
1 34.107.148.139 15169 (GOOGLE)
1 108.128.129.221 16509 (AMAZON-02)
1 34.246.73.139 16509 (AMAZON-02)
11 18.156.195.47 16509 (AMAZON-02)
1 8.2.111.126 46636 (NATCOWEB)
6 178.250.0.165 44788 (ASN-CRITE...)
1 198.148.27.134 19189 (PULSEPOINT)
1 2a00:1450:400... 15169 (GOOGLE)
3 2a00:1450:400... 15169 (GOOGLE)
1 2a00:1450:400... 15169 (GOOGLE)
5 185.184.8.65 204995 (RTB-HOUSE...)
1 44.238.59.174 16509 (AMAZON-02)
1 2606:4700:303... 13335 (CLOUDFLAR...)
2 204.180.130.165 53866 (QTS-AS)
11 2a00:1450:400... 15169 (GOOGLE)
3 4 142.250.181.226 15169 (GOOGLE)
1 35.244.174.68 15169 (GOOGLE)
7 3.215.243.168 14618 (AMAZON-AES)
1 1 62.149.0.72 15497 (COLOCALL ...)
1 193.200.65.5 6681 (GIVEME-CLOUD)
1 37.18.16.23 205675 (HYBRID-AS)
6 2a00:1450:400... 15169 (GOOGLE)
1 3 2606:4700:20:... 13335 (CLOUDFLAR...)
1 52.35.70.100 16509 (AMAZON-02)
1 44.236.205.19 16509 (AMAZON-02)
1 2 185.33.220.241 29990 (ASN-APPNEX)
1 8 52.43.149.174 16509 (AMAZON-02)
2 2 52.223.40.198 16509 (AMAZON-02)
2 2 204.237.133.120 62713 (AS-PUBMATIC)
2 2 34.240.134.29 16509 (AMAZON-02)
1 2 185.86.137.133 201081 (SMARTADSE...)
2 2 54.246.208.198 16509 (AMAZON-02)
1 54.245.167.10 16509 (AMAZON-02)
2 13.224.228.100 16509 (AMAZON-02)
1 2001:4de0:ac1... 20446 (HIGHWINDS3)
1 44.237.47.166 16509 (AMAZON-02)
2 2a02:2638:1::3 44788 (ASN-CRITE...)
4 142.250.185.130 15169 (GOOGLE)
17 2a00:1450:400... 15169 (GOOGLE)
8 2a00:1450:400... 15169 (GOOGLE)
1 2.21.141.148 16625 (AKAMAI-AS)
1 2 2a02:2638::1c 44788 (ASN-CRITE...)
2 178.250.2.146 44788 (ASN-CRITE...)
1 54.36.109.166 16276 (OVH)
293 90
Apex Domain
Subdomains
Transfer
22 fiercepharma.com
www.fiercepharma.com — Cisco Umbrella Rank: 92179
c405.fiercepharma.com — Cisco Umbrella Rank: 224117 Failed
137 KB
20 googlesyndication.com
73a3e8657f23645a3dbd8f1241c4efa7.safeframe.googlesyndication.com
pagead2.googlesyndication.com — Cisco Umbrella Rank: 92
tpc.googlesyndication.com — Cisco Umbrella Rank: 120
150 KB
19 doubleclick.net
securepubads.g.doubleclick.net — Cisco Umbrella Rank: 159
stats.g.doubleclick.net — Cisco Umbrella Rank: 67
cm.g.doubleclick.net — Cisco Umbrella Rank: 175
googleads4.g.doubleclick.net — Cisco Umbrella Rank: 276
208 KB
17 2mdn.net
s0.2mdn.net — Cisco Umbrella Rank: 246
460 KB
16 omeda.com
olytics.omeda.com — Cisco Umbrella Rank: 22440
cdn.omeda.com — Cisco Umbrella Rank: 37726
oqs.omeda.com — Cisco Umbrella Rank: 24584
165 KB
15 adnxs.com
ib.adnxs.com — Cisco Umbrella Rank: 210
prebid.adnxs.com — Cisco Umbrella Rank: 1384
secure.adnxs.com — Cisco Umbrella Rank: 350
acdn.adnxs.com — Cisco Umbrella Rank: 547
41 KB
14 dragonforms.com
sample.dragonforms.com — Cisco Umbrella Rank: 85056
hostedcontent.dragonforms.com — Cisco Umbrella Rank: 61705
90 KB
11 ad.gt
a.ad.gt — Cisco Umbrella Rank: 4375
p.ad.gt — Cisco Umbrella Rank: 4910
ids.ad.gt — Cisco Umbrella Rank: 3929
pixels.ad.gt — Cisco Umbrella Rank: 4858
17 KB
11 yahoo.com
c2shb.ssp.yahoo.com — Cisco Umbrella Rank: 654
1 KB
11 onetag-sys.com
onetag-sys.com — Cisco Umbrella Rank: 865
6 KB
10 criteo.com
bidder.criteo.com — Cisco Umbrella Rank: 736
gum.criteo.com — Cisco Umbrella Rank: 355
mug.criteo.com — Cisco Umbrella Rank: 3197
3 KB
9 spotible.com
ads.spotible.com Failed
creative.spotible.com — Cisco Umbrella Rank: 54388
cdn.spotible.com — Cisco Umbrella Rank: 57336
1 MB
8 rubiconproject.com
fastlane.rubiconproject.com — Cisco Umbrella Rank: 436
9 KB
8 mediafuse.com
player.mediafuse.com — Cisco Umbrella Rank: 41233
player.hbmp.mediafuse.com — Cisco Umbrella Rank: 30482
ghb.hbmp.mediafuse.com — Cisco Umbrella Rank: 39233
173 KB
7 adtelligent.com
player.adtelligent.com — Cisco Umbrella Rank: 5338
ghb.adtelligent.com — Cisco Umbrella Rank: 5603
sync.adtelligent.com — Cisco Umbrella Rank: 2421
6 KB
7 crazyegg.com
script.crazyegg.com — Cisco Umbrella Rank: 1701
pagestates-tracking.crazyegg.com — Cisco Umbrella Rank: 2981
assets-tracking.crazyegg.com — Cisco Umbrella Rank: 2973
tracking.crazyegg.com — Cisco Umbrella Rank: 2994
29 KB
6 googletagservices.com
www.googletagservices.com — Cisco Umbrella Rank: 146
151 KB
6 creativecdn.com
prebid-us.creativecdn.com — Cisco Umbrella Rank: 8725
prebid-eu.creativecdn.com — Cisco Umbrella Rank: 5927
1 KB
5 google-analytics.com
www.google-analytics.com — Cisco Umbrella Rank: 31
41 KB
4 b2c.com
api-54-245-167-10.b2c.com
v4-api-54-245-167-10.b2c.com
7 KB
4 pubmatic.com
hbopenbid.pubmatic.com — Cisco Umbrella Rank: 420
image2.pubmatic.com — Cisco Umbrella Rank: 752
808 B
4 dpmsrv.com
s.dpmsrv.com — Cisco Umbrella Rank: 19866
a.dpmsrv.com — Cisco Umbrella Rank: 17257
42 KB
3 ml314.com
ml314.com — Cisco Umbrella Rank: 1357
in.ml314.com — Cisco Umbrella Rank: 7281
13 KB
3 addtoany.com
static.addtoany.com — Cisco Umbrella Rank: 3662
60 KB
2 criteo.net
static.criteo.net — Cisco Umbrella Rank: 638
56 KB
2 360yield.com
ad.360yield.com — Cisco Umbrella Rank: 621
683 B
2 smartadserver.com
sync.smartadserver.com — Cisco Umbrella Rank: 1933
419 B
2 demdex.net
dpm.demdex.net — Cisco Umbrella Rank: 187
2 KB
2 adsrvr.org
match.adsrvr.org — Cisco Umbrella Rank: 295
961 B
2 google.com
adservice.google.com — Cisco Umbrella Rank: 59
671 B
2 google.de
adservice.google.de — Cisco Umbrella Rank: 9027
914 B
2 openx.net
adtelligent-d.openx.net — Cisco Umbrella Rank: 17514
u.openx.net — Cisco Umbrella Rank: 636
514 B
2 a-mo.net
prebid.a-mo.net — Cisco Umbrella Rank: 1014
554 B
2 deepintent.com
prebid.deepintent.com — Cisco Umbrella Rank: 5527
235 B
2 annocdn.com
p.annocdn.com — Cisco Umbrella Rank: 20622
14 KB
2 parsely.com
cdn.parsely.com — Cisco Umbrella Rank: 2498
p1.parsely.com — Cisco Umbrella Rank: 1996
18 KB
2 marketo.net
munchkin.marketo.net — Cisco Umbrella Rank: 2821
6 KB
2 sitescout.com
pixel.sitescout.com — Cisco Umbrella Rank: 2837
191 B
2 basis.net
pixel-a.basis.net — Cisco Umbrella Rank: 15273
132 B
2 gstatic.com
fonts.gstatic.com
54 KB
2 googletagmanager.com
www.googletagmanager.com — Cisco Umbrella Rank: 50
93 KB
2 blueconic.net
cdn.blueconic.net — Cisco Umbrella Rank: 6224
questex.blueconic.net — Cisco Umbrella Rank: 173879
42 KB
2 googleapis.com
fonts.googleapis.com — Cisco Umbrella Rank: 35
ajax.googleapis.com — Cisco Umbrella Rank: 250
7 KB
1 id5-sync.com
id5-sync.com — Cisco Umbrella Rank: 493
538 B
1 jquery.com
code.jquery.com — Cisco Umbrella Rank: 546
29 KB
1 aufp.io
aufp.io — Cisco Umbrella Rank: 5595
3 KB
1 hybrid.ai
dm.hybrid.ai — Cisco Umbrella Rank: 6079
238 B
1 trafmag.com
t.trafmag.com — Cisco Umbrella Rank: 6501
351 B
1 rlcdn.com
idsync.rlcdn.com — Cisco Umbrella Rank: 283
66 B
1 fouanalytics.com
api.fouanalytics.com — Cisco Umbrella Rank: 7573
933 B
1 medidexs.com
sync.medidexs.com — Cisco Umbrella Rank: 27342
21 KB
1 contextweb.com
bid.contextweb.com — Cisco Umbrella Rank: 2704
572 B
1 colossusssp.com
colossusssp.com — Cisco Umbrella Rank: 2141
247 B
1 servenobid.com
ads.servenobid.com — Cisco Umbrella Rank: 1489
641 B
1 yieldmo.com
ads.yieldmo.com — Cisco Umbrella Rank: 633
229 B
1 media.net
prebid.media.net — Cisco Umbrella Rank: 1112
874 B
1 betweendigital.com
ads.betweendigital.com — Cisco Umbrella Rank: 1448
916 B
1 casalemedia.com
htlb.casalemedia.com — Cisco Umbrella Rank: 427
335 B
1 admixer.net
inv-nets.admixer.net — Cisco Umbrella Rank: 2092
510 B
1 e-planning.net
pbjs.e-planning.net — Cisco Umbrella Rank: 6090
162 B
1 lijit.com
ap.lijit.com — Cisco Umbrella Rank: 598
526 B
1 sonobi.com
apex.go.sonobi.com — Cisco Umbrella Rank: 1414
881 B
1 1rx.io
tag.1rx.io — Cisco Umbrella Rank: 1196
176 B
1 mktoresp.com
294-mqf-056.mktoresp.com — Cisco Umbrella Rank: 109080
311 B
1 zoominfo.com
ws.zoominfo.com — Cisco Umbrella Rank: 7499
1 KB
1 cloudfront.net
d1z2jf7jlzjs58.cloudfront.net
1 KB
1 marketo.com
app-sj10.marketo.com — Cisco Umbrella Rank: 130268
68 KB
1 qtxasset.com
qtxasset.com — Cisco Umbrella Rank: 64013
135 KB
0 adxpremium.services Failed
rtb.adxpremium.services Failed
293 69
Domain Requested by
17 s0.2mdn.net www.fiercepharma.com
s0.2mdn.net
13 olytics.omeda.com www.fiercepharma.com
www.googletagmanager.com
olytics.omeda.com
sample.dragonforms.com
12 www.fiercepharma.com www.fiercepharma.com
11 pagead2.googlesyndication.com olytics.omeda.com
tpc.googlesyndication.com
www.fiercepharma.com
www.googletagservices.com
11 c2shb.ssp.yahoo.com player.mediafuse.com
11 onetag-sys.com player.mediafuse.com
p.annocdn.com
11 ib.adnxs.com 2 redirects player.mediafuse.com
p.annocdn.com
www.fiercepharma.com
10 c405.fiercepharma.com cdn.blueconic.net
10 sample.dragonforms.com 1 redirects www.fiercepharma.com
sample.dragonforms.com
code.jquery.com
10 securepubads.g.doubleclick.net www.fiercepharma.com
securepubads.g.doubleclick.net
www.googletagservices.com
8 tpc.googlesyndication.com www.fiercepharma.com
tpc.googlesyndication.com
8 ids.ad.gt 1 redirects www.fiercepharma.com
8 fastlane.rubiconproject.com player.mediafuse.com
7 creative.spotible.com securepubads.g.doubleclick.net
creative.spotible.com
www.fiercepharma.com
6 www.googletagservices.com olytics.omeda.com
securepubads.g.doubleclick.net
6 bidder.criteo.com player.mediafuse.com
p.annocdn.com
5 prebid-eu.creativecdn.com p.annocdn.com
5 ghb.adtelligent.com p.annocdn.com
player.mediafuse.com
5 ghb.hbmp.mediafuse.com player.hbmp.mediafuse.com
5 www.google-analytics.com www.googletagmanager.com
www.google-analytics.com
4 googleads4.g.doubleclick.net www.fiercepharma.com
4 hostedcontent.dragonforms.com sample.dragonforms.com
hostedcontent.dragonforms.com
4 cm.g.doubleclick.net 3 redirects www.fiercepharma.com
4 script.crazyegg.com www.googletagmanager.com
script.crazyegg.com
3 api-54-245-167-10.b2c.com 1 redirects www.fiercepharma.com
3 a.dpmsrv.com www.fiercepharma.com
s.dpmsrv.com
3 static.addtoany.com www.fiercepharma.com
static.addtoany.com
2 mug.criteo.com www.fiercepharma.com
2 gum.criteo.com 1 redirects
2 static.criteo.net player.mediafuse.com
static.criteo.net
2 cdn.spotible.com www.fiercepharma.com
2 ad.360yield.com 2 redirects
2 sync.smartadserver.com 1 redirects www.fiercepharma.com
2 dpm.demdex.net 2 redirects
2 image2.pubmatic.com 2 redirects
2 match.adsrvr.org 2 redirects
2 secure.adnxs.com 1 redirects acdn.adnxs.com
2 oqs.omeda.com olytics.omeda.com
2 adservice.google.com securepubads.g.doubleclick.net
2 adservice.google.de securepubads.g.doubleclick.net
2 hbopenbid.pubmatic.com player.mediafuse.com
2 prebid.a-mo.net player.mediafuse.com
2 prebid.deepintent.com player.mediafuse.com
2 p.annocdn.com player.mediafuse.com
p.annocdn.com
2 ml314.com www.fiercepharma.com
ml314.com
2 munchkin.marketo.net www.fiercepharma.com
munchkin.marketo.net
2 pixel.sitescout.com www.fiercepharma.com
2 pixel-a.basis.net 2 redirects
2 fonts.gstatic.com fonts.googleapis.com
2 www.googletagmanager.com www.fiercepharma.com
sample.dragonforms.com
2 player.mediafuse.com www.fiercepharma.com
1 id5-sync.com player.mediafuse.com
1 acdn.adnxs.com p.annocdn.com
1 u.openx.net www.fiercepharma.com
1 pixels.ad.gt p.ad.gt
1 code.jquery.com sample.dragonforms.com
1 v4-api-54-245-167-10.b2c.com www.fiercepharma.com
1 p.ad.gt a.ad.gt
1 aufp.io a.ad.gt
1 dm.hybrid.ai www.fiercepharma.com
1 t.trafmag.com www.fiercepharma.com
1 sync.adtelligent.com 1 redirects
1 idsync.rlcdn.com www.fiercepharma.com
1 api.fouanalytics.com player.hbmp.mediafuse.com
1 a.ad.gt player.hbmp.mediafuse.com
1 sync.medidexs.com player.hbmp.mediafuse.com
1 73a3e8657f23645a3dbd8f1241c4efa7.safeframe.googlesyndication.com securepubads.g.doubleclick.net
1 bid.contextweb.com player.mediafuse.com
1 colossusssp.com player.mediafuse.com
1 ads.servenobid.com player.mediafuse.com
1 ads.yieldmo.com player.mediafuse.com
1 prebid.media.net player.mediafuse.com
1 adtelligent-d.openx.net player.mediafuse.com
1 ads.betweendigital.com player.mediafuse.com
1 htlb.casalemedia.com player.mediafuse.com
1 inv-nets.admixer.net player.mediafuse.com
1 pbjs.e-planning.net player.mediafuse.com
1 ap.lijit.com player.mediafuse.com
1 apex.go.sonobi.com player.mediafuse.com
1 tag.1rx.io player.mediafuse.com
1 prebid-us.creativecdn.com player.mediafuse.com
1 prebid.adnxs.com player.mediafuse.com
1 tracking.crazyegg.com script.crazyegg.com
1 cdn.omeda.com sample.dragonforms.com
1 assets-tracking.crazyegg.com script.crazyegg.com
1 pagestates-tracking.crazyegg.com script.crazyegg.com
1 in.ml314.com ml314.com
1 player.adtelligent.com player.mediafuse.com
1 294-mqf-056.mktoresp.com munchkin.marketo.net
1 p1.parsely.com www.fiercepharma.com
1 stats.g.doubleclick.net www.google-analytics.com
1 player.hbmp.mediafuse.com player.mediafuse.com
1 cdn.parsely.com d1z2jf7jlzjs58.cloudfront.net
1 ws.zoominfo.com www.fiercepharma.com
1 s.dpmsrv.com www.fiercepharma.com
1 d1z2jf7jlzjs58.cloudfront.net www.fiercepharma.com
1 questex.blueconic.net cdn.blueconic.net
1 app-sj10.marketo.com www.fiercepharma.com
1 ajax.googleapis.com www.fiercepharma.com
1 qtxasset.com www.fiercepharma.com
1 cdn.blueconic.net www.fiercepharma.com
1 fonts.googleapis.com www.fiercepharma.com
0 ads.spotible.com Failed www.fiercepharma.com
0 rtb.adxpremium.services Failed p.annocdn.com
293 104
Subject Issuer Validity Valid
sni.cloudflaressl.com
Cloudflare Inc ECC CA-3
2021-07-14 -
2022-07-13
a year crt.sh
upload.video.google.com
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
*.blueconic.net
Amazon
2021-08-07 -
2022-09-05
a year crt.sh
player.mediafuse.com
R3
2022-01-15 -
2022-04-15
3 months crt.sh
*.g.doubleclick.net
GTS CA 1C3
2022-01-17 -
2022-04-11
3 months crt.sh
*.google-analytics.com
GTS CA 1C3
2022-01-17 -
2022-04-11
3 months crt.sh
app-sj10.marketo.com
Cloudflare Inc ECC CA-3
2021-06-08 -
2022-06-07
a year crt.sh
*.gstatic.com
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
*.sitescout.com
GeoTrust TLS DV RSA Mixed SHA256 2020 CA-1
2021-12-15 -
2023-01-15
a year crt.sh
*.omeda.com
SSL.com RSA SSL subCA
2021-07-16 -
2022-07-21
a year crt.sh
*.cloudfront.net
Amazon
2021-03-19 -
2022-03-17
a year crt.sh
*.marketo.net
DigiCert SHA2 Secure Server CA
2021-03-29 -
2022-04-06
a year crt.sh
*.dpmsrv.com
Amazon
2021-05-17 -
2022-06-15
a year crt.sh
zoominfo.com
Cloudflare Inc ECC CA-3
2021-06-04 -
2022-06-03
a year crt.sh
*.parsely.com
Amazon
2021-07-05 -
2022-08-03
a year crt.sh
player.hbmp.mediafuse.com
R3
2021-12-12 -
2022-03-12
3 months crt.sh
*.ml314.com
Amazon
2021-12-17 -
2023-01-14
a year crt.sh
*.mktoresp.com
DigiCert TLS RSA SHA256 2020 CA1
2021-11-30 -
2022-11-30
a year crt.sh
player.adtelligent.com
R3
2022-01-18 -
2022-04-18
3 months crt.sh
ghb.hbmp.mediafuse.com
ZeroSSL ECC Domain Secure Site CA
2022-02-06 -
2022-05-07
3 months crt.sh
p.annocdn.com
R3
2021-12-19 -
2022-03-19
3 months crt.sh
ghb.adtelligent.com
ZeroSSL ECC Domain Secure Site CA
2022-02-06 -
2022-05-07
3 months crt.sh
*.crazyegg.com
DigiCert SHA2 Secure Server CA
2020-07-26 -
2022-07-23
2 years crt.sh
s827.travelagentcentral.com
Amazon
2021-10-12 -
2022-11-10
a year crt.sh
*.deepintent.com
Go Daddy Secure Certificate Authority - G2
2020-04-09 -
2022-06-08
2 years crt.sh
prebid.adnxs.com
GeoTrust TLS RSA CA G1
2020-03-29 -
2022-03-29
2 years crt.sh
*.onetag-sys.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-01-10 -
2023-01-03
a year crt.sh
*.creativecdn.com
RapidSSL TLS DV RSA Mixed SHA256 2020 CA-1
2021-03-30 -
2022-04-12
a year crt.sh
*.1rx.io
Sectigo RSA Domain Validation Secure Server CA
2021-06-01 -
2022-07-02
a year crt.sh
*.go.sonobi.com
Go Daddy Secure Certificate Authority - G2
2021-12-08 -
2023-01-09
a year crt.sh
*.adnxs.com
GeoTrust ECC CA 2018
2021-03-05 -
2022-02-19
a year crt.sh
*.lijit.com
Go Daddy Secure Certificate Authority - G2
2021-03-11 -
2022-04-12
a year crt.sh
*.a-mo.net
R3
2021-12-20 -
2022-03-20
3 months crt.sh
*.pubmatic.com
DigiCert Baltimore TLS RSA SHA256 2020 CA1
2021-08-04 -
2022-09-04
a year crt.sh
*.e-planning.net
R3
2021-12-30 -
2022-03-30
3 months crt.sh
*.admixer.net
Sectigo ECC Domain Validation Secure Server CA
2021-11-16 -
2022-12-17
a year crt.sh
san.casalemedia.com
GeoTrust RSA CA 2018
2021-12-12 -
2022-12-13
a year crt.sh
*.ads.betweendigital.com
Sectigo RSA Domain Validation Secure Server CA
2021-12-15 -
2023-01-15
a year crt.sh
*.openx.net
GeoTrust RSA CA 2018
2021-07-08 -
2022-08-08
a year crt.sh
*.rubiconproject.com
DigiCert TLS RSA SHA256 2020 CA1
2021-03-30 -
2022-04-04
a year crt.sh
*.media.net
Sectigo RSA Domain Validation Secure Server CA
2021-04-12 -
2022-05-05
a year crt.sh
*.yieldmo.com
Amazon
2021-05-25 -
2022-06-23
a year crt.sh
ads.servenobid.com
Amazon
2021-06-28 -
2022-07-27
a year crt.sh
web.ssp.yahoo.com
DigiCert SHA2 High Assurance Server CA
2021-10-14 -
2022-04-06
6 months crt.sh
*.colossusssp.com
Go Daddy Secure Certificate Authority - G2
2021-11-07 -
2022-11-07
a year crt.sh
*.criteo.com
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-02-04 -
2022-05-03
3 months crt.sh
*.contextweb.com
DigiCert SHA2 Secure Server CA
2020-05-07 -
2022-05-12
2 years crt.sh
*.google.de
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
*.google.com
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
sync.medidexs.com
R3
2022-01-09 -
2022-04-09
3 months crt.sh
*.ad.gt
Amazon
2021-06-09 -
2022-07-08
a year crt.sh
*.rlcdn.com
Sectigo RSA Domain Validation Secure Server CA
2022-02-03 -
2023-02-25
a year crt.sh
*.spotible.com
Sectigo RSA Domain Validation Secure Server CA
2021-11-02 -
2022-12-03
a year crt.sh
*.hybrid.ai
Sectigo RSA Domain Validation Secure Server CA
2020-07-07 -
2022-10-05
2 years crt.sh
aufp.io
Amazon
2021-11-26 -
2022-12-24
a year crt.sh
*.jquery.com
Sectigo RSA Domain Validation Secure Server CA
2021-07-14 -
2022-08-14
a year crt.sh
*.criteo.net
DigiCert TLS Hybrid ECC SHA384 2020 CA1
2022-02-02 -
2022-05-03
3 months crt.sh
*.doubleclick.net
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
tpc.googlesyndication.com
GTS CA 1C3
2022-01-10 -
2022-04-04
3 months crt.sh
cdn.adnxs.com
GeoTrust RSA CA 2018
2021-12-10 -
2022-12-09
a year crt.sh
*.id5-sync.com
R3
2021-12-20 -
2022-03-20
3 months crt.sh

This page contains 27 frames:

Primary Page: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Frame ID: 497563EF47B0346109826B48D3FDE58A
Requests: 173 HTTP requests in this frame

Frame: https://pixel.sitescout.com/dmp/asyncPixelSync
Frame ID: F81D643993D698315E64B4A15C5419B4
Requests: 1 HTTP requests in this frame

Frame: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Frame ID: 4E7F42EEE073E81967081049E359EA26
Requests: 22 HTTP requests in this frame

Frame: https://static.addtoany.com/menu/sm.23.html
Frame ID: 675AC0853B2935603743984D97BAE65B
Requests: 1 HTTP requests in this frame

Frame: https://p.annocdn.com/prebidlink/19032/j.html?i=11594
Frame ID: D0E0EFF27AF3FD7567F331543A7C0805
Requests: 31 HTTP requests in this frame

Frame: https://73a3e8657f23645a3dbd8f1241c4efa7.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Frame ID: 73EE50F6720A2F7EF7D1ED7A88460DAB
Requests: 1 HTTP requests in this frame

Frame: https://ads.spotible.com/tag/universal-tag.js
Frame ID: 1CF7D769E9BE955BB23020EB49799B0C
Requests: 2 HTTP requests in this frame

Frame: https://creative.spotible.com/tag/allstream.js
Frame ID: BCD1283A0A3216DCC8A6987EF8CCCE63
Requests: 1 HTTP requests in this frame

Frame: https://creative.spotible.com/tag/storage-delegate.html
Frame ID: 392B5FE5F8DE5FD4556657833B028084
Requests: 1 HTTP requests in this frame

Frame: https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsu_yrtkTuUVd_P1Tf3ne8CTg-5KBEr5Hj3zfTtPnpSelqU2g23Rl2X-2rT9Nh75zq2wSQ4_bwVcmuaFE32DQwkNEzzdduD5yd24CU07T4iel1Q9bghuu3IwT7ZaKD-6AqHo2nKuzl7RM1PnZwimMQt2e29ujYcsjfT4XuVAsAKMsYjaEKGbvvjB1bBHN78TufgASCavLmQe4m15LdNoMkHjyRw-rWT_zrkmhfT9j4pWSO9ztv1NU5Q66MInglAfBGSvLfbX4dOdew08ThaTEyU-NtGQjyIrxQqbV8Ol87M9ezwELLfWoCK7WzN6MMJ_nICR7Thht4GuRhDcHMX9ej5fm9eQ8o7JMpGK4MgK_xrThyVGnk-LyzO7VWEa53Part-iZ95RRtKFSdzCeBuxRfq0w9f9XrItyxN6BRsodcQRhJFloqH7hEw&sig=Cg0ArKJSzGiGiWf2w6leEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Frame ID: D450155207FCDB68A968C192F784942A
Requests: 7 HTTP requests in this frame

Frame: https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsvh2xYAXKo_-cSjAqePtK6B1LmVo60ixq3moNu1TUcXWV6YE1m0iXNv0fSQ_2GcqW5eKhj287zNp4dlWmoM8GHgeiBVSSNLkgAQ-vamVYRFYrjSKg-71UECuYgh-WQyPYLMcUCpswnks1av2UZuvfnXQ_x7GtJ0vdMRnDpE8bYQIORy-66UJq3Cy0UZ-qwpsP7GMQ-iFUGcly6p7ZnsduQoV834NOT49Td7tl5PmZ2ZXuPn9W-BntI-JlL4g2PKe30nvyZwUUPCvN-XqWWuu3WL_13JEuBfBA0tEq1YT_uEk12-uguRNdXeRwjPjE1mhaljXVE7gp1S8kMMoguAXLkwQVAAO2-fvnvpEulzXovF-6_T6Z8b_C1UvfMiFoSEeXK7614IU6KsheUMaxcre6pZW1jAg2lycCHkEezhzJSH-oOdTGzrm1k&sig=Cg0ArKJSzDggyWbrN7kPEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Frame ID: 3A806A4B9750C0376FF28878F0ED4ECA
Requests: 6 HTTP requests in this frame

Frame: https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsuyka88gj6NucyuLVR67g2WmgakgrgaIRfmvA6JYqtq6yDX1t4Anjq-81dYNdT7ucqVGK5YXA9jgYD_s2DIKalkTdyGSjTshGmbAZ9zPb_v435YWDkpMbnMVKguI9OKeHx2u5rH_TuoRnWsTw2pjqBlFLDNz1bXwClVOKC0SsQ6P2gZhGVoZgl6MaDG0zCiMoo9Si77utGb3XIvoIEKnmaiN4HZDRv5q1YkwLQYBP68MOk834xVGHQm4TrTKb2g8pSyVH-kM4Tog91ehbk_AStwHyJZbWarJXpsO2EFuqauNPe5y3rvR5NTbAJGi6-XbXftk5E2FjYEugfDk1PbWeDBgLmYhCLRJmLObZKQJuFb1iRtbaaQK41ZDvawd1gwSJFc8wxf4GA7yojvNlMYFYfNN_IVpZ7hFTxb0R8K-nsVrksyMN1DFkg&sig=Cg0ArKJSzLLMlwM14EgAEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Frame ID: 74ECC5923B0659D39FB0C354F65CE793
Requests: 6 HTTP requests in this frame

Frame: https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsvPtJBBm-6EVfFY6rRe2ARM4CYVcKIFWtCjgBaD8jtWPBGxQvi7qKNlJJe6lfPDC_qCpUPn6-QMLFnaWRYloideb14aa55a67hNZv-2NdoxL3TndjnJlErcTBkhisbOuMJUvJkN8l_AzWlWMSCJX8OJhIJpqbz3BqS9ZZr7CnJhTYyiGnZtIbWn9oxJyf_4MVGgBywdQ0k2Z-Lm57q5etoYjZNSKY2WjxSqnawS1vnHUTLobhTNyljddA1QVpsSADVfSA8O0pg7m1mObt25cW7UfAuuHiqXs_RHJVtxtHWm2p8ijcNyvPeNnaShLNCpvB6451Md0ve8OH1cV1a4PIOqxyMR60LZ5cIOqDjP_MnoDdtLvBwvokkTJ_cwCxHq3cty0Sk96CMU7x9mAVC5a5WrFB7MTNhitSuf3OXpIVGQFNOOlHlqND0&sig=Cg0ArKJSzPklpWaX0Vn7EAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Frame ID: B9E9D2EEAF75C7A262D9F1B65B450E91
Requests: 6 HTTP requests in this frame

Frame: https://acdn.adnxs.com/ib/static/usersync/v3/async_usersync.html
Frame ID: 97C6364A79035FE4E745B3799F9AF5D8
Requests: 2 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644420977486
Frame ID: 05AD83F0930C809DAC94A678E7F3A3CE
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644420977488
Frame ID: D1446C1128B3CC9E4561C8B1FB129806
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644420977489
Frame ID: D84013D6A519ED5E27027A21EDCD375D
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644420977492
Frame ID: 42F9135069BAA6E33560150739E383BD
Requests: 1 HTTP requests in this frame

Frame: https://onetag-sys.com/usync/?cb=1644420977493
Frame ID: 7804B854A46CCBABA1E221D828B8E1AD
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Frame ID: 58AFD111302EEFB86F1C380D4A097C2F
Requests: 3 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Frame ID: F191E6F95605B724FE7A61D335C9EBE2
Requests: 3 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Frame ID: 03B788D6635407CD2B9263F63C6C87D9
Requests: 3 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Frame ID: 628714E5540F4ECEC0A72DCE8692D595
Requests: 3 HTTP requests in this frame

Frame: https://s0.2mdn.net/10583188/1640879425588/index.html
Frame ID: 71F7A5368DA17D79E90DEABA5C36437F
Requests: 4 HTTP requests in this frame

Frame: https://s0.2mdn.net/10583188/1640880401082/index.html
Frame ID: 9FE24CA97CC9DE5F46F8CFB5CBE34FF9
Requests: 3 HTTP requests in this frame

Frame: https://s0.2mdn.net/10583188/1640880401082/index.html
Frame ID: 602B69A92B4B4CD99FDF0E4B25D70701
Requests: 3 HTTP requests in this frame

Frame: https://s0.2mdn.net/10583188/1640880401082/index.html
Frame ID: BDF7A5ED11EE3A2C67DA085AEEC89F5C
Requests: 3 HTTP requests in this frame

Screenshot

Page Title

8. Mavacamten | FiercePharma

Detected technologies

Overall confidence: 100%
Detected patterns
  • addtoany\.com/menu/page\.js

Overall confidence: 100%
Detected patterns
  • adnxs\.(?:net|com)

Overall confidence: 100%
Detected patterns
  • script\.crazyegg\.com/pages/scripts/\d+/\d+\.js

Overall confidence: 100%
Detected patterns
  • 2mdn\.net

Overall confidence: 100%
Detected patterns
  • googletagservices\.com/tag/js/gpt(?:_mobile)?\.js

Overall confidence: 100%
Detected patterns
  • googlesyndication\.com/
  • 2mdn\.net

Overall confidence: 100%
Detected patterns
  • google-analytics\.com/(?:ga|urchin|analytics)\.js

Overall confidence: 100%
Detected patterns
  • googleapis\.com/.+webfont

Overall confidence: 100%
Detected patterns
  • googletagmanager\.com/gtm\.js

Overall confidence: 100%
Detected patterns
  • munchkin\.marketo\.\w+/(?:([\d.]+)/)?munchkin\.js

Overall confidence: 100%
Detected patterns
  • marketo\.\w+/js/forms(?:[\d.]+)/js/forms([\d.]+)\.min\.js

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.openx\.net

Overall confidence: 100%
Detected patterns
  • adnxs\.com/[^"]*(?:prebid|/pb\.js)

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.pubmatic\.com

Overall confidence: 100%
Detected patterns
  • https?://[^/]*\.rubiconproject\.com

Overall confidence: 100%
Detected patterns
  • jquery[.-]([\d.]*\d)[^/]*\.js
  • jquery.*\.js(?:\?ver(?:sion)?=([\d.]+))?

Page Statistics

293
Requests

91 %
HTTPS

24 %
IPv6

69
Domains

104
Subdomains

90
IPs

11
Countries

3897 kB
Transfer

7939 kB
Size

78
Cookies

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 23
  • https://pixel-a.basis.net/dmp/asyncPixelSync HTTP 301
  • https://pixel.sitescout.com/dmp/asyncPixelSync
Request Chain 24
  • https://pixel-a.basis.net/iap/7f1874304d399254 HTTP 301
  • https://pixel.sitescout.com/iap/7f1874304d399254
Request Chain 25
  • https://sample.dragonforms.com/FiercePharma_short HTTP 302
  • https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Request Chain 41
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D568688%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com%252Fspecial-report%252F10-most-anticipated-drug-launches-2022-8-mavacamten&_=1644420974554 HTTP 307
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D568688%2526tzOffset%253D0%2526url%253Dhttps%25253A%25252F%25252Fwww.fiercepharma.com%25252Fspecial-report%25252F10-most-anticipated-drug-launches-2022-8-mavacamten%26_%3D1644420974554 HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?id=1521003946560112395&q=xImp&v=1.x&cl=913&pixelIndex=0&r=568688&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&_=1644420974554
Request Chain 150
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=1521003946560112395&pixelIndex=0&_=1644420974555 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm=&ap_id=1521003946560112395&pixelIndex=0&_=1644420974555&google_tc= HTTP 302
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=1521003946560112395&pixelIndex=0&_=1644420974555&google_gid=CAESEH3UP3-ablTWNzH6x_PCjhM&google_cver=1
Request Chain 156
  • https://sync.adtelligent.com/csync?&redir=https%3A%2F%2Ft.trafmag.com%2Fimages%2Fimages%2F1px-matching-adtelligent.gif%3Fid%3D%7Buid%7D HTTP 302
  • https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=f4b0d7c034dd141c
Request Chain 165
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&adnxs_id=$UID HTTP 302
  • https://ids.ad.gt/api/v1/match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&adnxs_id=1521003946560112395
Request Chain 166
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49 HTTP 302
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49 HTTP 302
  • https://ids.ad.gt/api/v1/t_match?tdid=c11d1b10-ea13-4e77-a2d1-20ec64332d28&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
Request Chain 167
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49 HTTP 302
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49 HTTP 302
  • https://ids.ad.gt/api/v1/pbm_match?pbm=5FBA7F2A-C28D-4634-958B-689A4440E22D&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
Request Chain 168
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49 HTTP 302
  • https://ids.ad.gt/api/v1/g_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&google_gid=CAESEPpBdfmxhS_Ja7mAPsrE_W8&google_cver=1&google_ula=450542624,0
Request Chain 169
  • https://ids.ad.gt/api/v1/g_hosted?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49 HTTP 302
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=ZDhjMzA0NjEtYmQzZS00YWJmLTllZDYtM2U2YzNmMzVlZjQ5
Request Chain 170
  • https://dpm.demdex.net/ibs:dpid=348447&dpuuid=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&redir=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fadb_match%3Fadb%3D%24%7BDD_UUID%7D%26id%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49 HTTP 302
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=348447&dpuuid=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&redir=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fadb_match%3Fadb%3D%24%7BDD_UUID%7D%26id%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49 HTTP 302
  • https://ids.ad.gt/api/v1/adb_match?adb=62058959424908984673071064968801906464&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
Request Chain 171
  • https://sync.smartadserver.com/getuid?url=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fsmart_match%3Fid%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49%26sas_uid%3D%5bsas_uid%5d HTTP 302
  • https://sync.smartadserver.com/getuid?url=https://ids.ad.gt/api/v1/smart_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&sas_uid=[sas_uid]&cklb=1
Request Chain 172
  • https://ad.360yield.com/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49%26impr_uid%3D%7BPUB_USER_ID%7D HTTP 302
  • https://ad.360yield.com/ul_cb/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49%26impr_uid%3D%7BPUB_USER_ID%7D HTTP 302
  • https://ids.ad.gt/api/v1/impr_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&impr_uid=c9317cb7-bf2e-465e-b7ee-531af9130fae
Request Chain 174
  • https://api-54-245-167-10.b2c.com/api/x?UE7uFPxRDktV6qQ8$dXJsJDAkaHR0cHM6Ly93d3cuZmllcmNlcGhhcm1hLmNvbS9zcGVjaWFsLXJlcG9ydC8xMC1tb3N0LWFudGljaXBhdGVkLWRydWctbGF1bmNoZXMtMjAyMi04LW1hdmFjYW10ZW4iLCJyZWZlcnJlciQwJCIsImFuY2VzdG9yT3JpZ2lucyQwJCIsInZpZGVvJDAkMTYwMHgxMjAweDI0IiwiZnJhbWUkMCQwIiwiaGlkZGVuJDAkMCIsInZpc2liaWxpdHlTdGF0ZSQwJHZpc2libGUiLCJoYXNGb2N1cyQwJDEiLCJ3aW5kb3ckMCQxNjAweDEyMDAiLCJwaXhlbHJhdGlvJDAkMSIsImlubmVyJDAkMTYwMHgxMjAwIiwib3V0ZXIkMCQxNjAweDEyMDAiLCJsb2NhbFN0b3JhZ2UkMCQxIiwic2Vzc2lvblN0b3JhZ2UkMCQxIiwiYXBwQ29kZU5hbWUkMCRNb3ppbGxhIiwiYXBwTmFtZSQwJE5ldHNjYXBlIiwiYXBwVmVyc2lvbiQwJDUuMCAoV2luZG93cyBOVCAxMC4wOyBXaW42NDsgeDY0KSBBcHBsZVdlYktpdC81MzcuMzYgKEtIVE1MLCBsaWtlIEdlY2tvKSBDaHJvbWUvOTguMC40NzU4LjgwIFNhZmFyaS81MzcuMzYiLCJjb29raWVFbmFibGVkJDAkdHJ1ZSIsImRvTm90VHJhY2skMCQiLCJoYXJkd2FyZUNvbmN1cnJlbmN5JDAkNCIsImxhbmd1YWdlJDAkZW4tVVMiLCJwbGF0Zm9ybSQwJExpbnV4IHg4Nl82NCIsInByb2R1Y3QkMCRHZWNrbyIsInByb2R1Y3RTdWIkMCQyMDAzMDEwNyIsInNlbmRCZWFjb24kMCQxIiwidXNlckFnZW50JDAkTW96aWxsYS81LjAgKFdpbmRvd3MgTlQgMTAuMDsgV2luNjQ7IHg2NCkgQXBwbGVXZWJLaXQvNTM3LjM2IChLSFRNTCwgbGlrZSBHZWNrbykgQ2hyb21lLzk4LjAuNDc1OC44MCBTYWZhcmkvNTM3LjM2IiwidmVuZG9yJDAkR29vZ2xlIEluYy4iLCJ2ZW5kb3JTdWIkMCQiLCJmb250cmVuZGVyJDQkMSIsIndlYmdsJDExJDEiLCJ3ZWJnbDIkMTEkMSIsIndlYmdsLXZlbmRvciQxMSRJbnRlbCBJbmMuIiwid2ViZ2wtcmVuZGVyZXIkMTIkSW50ZWwgSXJpcyBPcGVuR0wgRW5naW5lIiwid2ViZ2wtZXh0ZW5zaW9ucyQxMiQ5ZGZkMjU1OSIsInRpbWUkMTIkMTY0NDQyMDk3NTg2MCIsInRpbWV6b25lJDEyJDAiLCJwbHVnaW5zLXRpbWUkMTIkMC4xIiwicGx1Z2lucyQxMiRiNmQwNTU1OCIsIm1lbS10b3RhbEpTSGVhcFNpemUkMTIkMjcuNiIsIm1lbS11c2VkSlNIZWFwU2l6ZSQxMiQyMS43IiwibWVtLWpzSGVhcFNpemVMaW1pdCQxMiQzNzYwIiwidGltZS1mZXRjaFN0YXJ0JDEyJDUiLCJ0aW1lLWRvbWFpbkxvb2t1cFN0YXJ0JDEyJDYiLCJ0aW1lLWRvbWFpbkxvb2t1cEVuZCQxMiQxOCIsInRpbWUtY29ubmVjdFN0YXJ0JDEyJDE4IiwidGltZS1jb25uZWN0RW5kJDEyJDU2IiwidGltZS1zZWN1cmVDb25uZWN0aW9uU3RhcnQkMTIkMzMiLCJ0aW1lLXJlcXVlc3RTdGFydCQxMiQ1NiIsInRpbWUtcmVzcG9uc2VTdGFydCQxMiQzMzciLCJ0aW1lLXJlc3BvbnNlRW5kJDEyJDMzOCIsInRpbWUtZG9tTG9hZGluZyQxMiQzNDAiLCJ0aW1lLWRvbUludGVyYWN0aXZlJDEyJDEwMzciLCJ0aW1lLWRvbUNvbnRlbnRMb2FkZWRFdmVudFN0YXJ0JDEyJDEwMzgiLCJ0aW1lLWRvbUNvbnRlbnRMb2FkZWRFdmVudEVuZCQxMiQxMDQ2IiwibmF2aWdhdGlvbi1yZWRpcmVjdENvdW50JDEzJDAiLCJuYXZpZ2F0aW9uLXR5cGUkMTMkbmF2aWdhdGUiLCJnbG9iYWxzLXRpbWUkMjIkMC40IiwiZ2xvYmFscyQyMiRhZTYzYzAzMCIsImRvY3VtZW50LXRpbWUkMzMkMiIsImRvY3VtZW50JDMzJDA2MDE0NDE3IiwiY29ubmVjdGlvbiQzMyQiLCJkb3dubGlua01heCQzMyQiLCJnZXRVc2VyTWVkaWEkMzMkMiIsInBhZ2UtZnJhbWUtY291bnQkMzQkNyIsInBhZ2UtZnJhbWUtbGlzdCQzNCQweDAjZ29vZ2xlIDF4MSNnb29nbGUgMzAweDQzMCNzYW1wbGUuZHJhZ29uZm9ybXMuY29tIDB4MCMgMHgwI3N0YXRpYy5hZGR0b2FueS5jb20gMHgwIzczYTNlODY1N2YyMzY0NWEzZGJkOGYxMjQxYzRlZmE3LnNhZmVmcmFtZS5nb29nbGVzeW5kaWNhdGlvbi5jb20gMHgwI3AuYW5ub2Nkbi5jb20iLCJwYWdlLWhhc2gtdGltZSQzNyQyLjkiLCJwYWdlLWhhc2gkMzckOTdiNThmMzQiLCJjbG9jayQ0MSQ1NjQ4IiwiYmF0dGVyeSQ0NyQxIDEgMCBJbmZpbml0eSIsInBlcm1pc3Npb24tZ2VvbG9jYXRpb24kNDgkcHJvbXB0IiwiYXVkaW9jb250ZXh0JDQ4JGY3ZTcxMmQ5IiwiaW50ZXJzZWN0aW9uLXNpemUkNDgkMTYwMHgxMjAwIiwiaW50ZXJzZWN0aW9uJDQ4JDQwIiwicGVybWlzc2lvbi1ub3RpZmljYXRpb25zJDQ4JHByb21wdCIsInBlcm1pc3Npb24tY2FtZXJhJDQ4JHByb21wdCIsInBlcm1pc3Npb24tbWljcm9waG9uZSQ0OSRwcm9tcHQiLCJwZXJtaXNzaW9uLXBlcnNpc3RlbnQtc3RvcmFnZSQ0OSRwcm9tcHQiLCJzb3J0JDc4JDE0LjYiLCJhZGJsb2NrJDc5JDAiLCJmcmFtZXJhdGUkMTQyJDgw HTTP 302
  • https://v4-api-54-245-167-10.b2c.com:444/api/4?UE7uFPxRDktV6qQ8
Request Chain 293
  • https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1 HTTP 302
  • https://mug.criteo.com/sid?cpp=zk4gtXx0WTJhVHhHSGh1Q0x1b3VLV0g2S05XM1JjRkZGUmlpMlRXUlQ0SmdJczBxOHhCK2cySnM0SHAyc2I0bzhBZWNtZS9DSzlmRS9CSlNjQi9qMmYvNUxlY21SeE9CM3JoSnZwd0xsZ3gxN3dNcERqVHh2YUVpb1dCb0pQUHcrSDVWTU9LU29PNVJuMmRwdUV4UHlRV1NIQUZBcndEMytGdUpjaFJxTU9sZUdtN0FoYnpBU3pEWFltR0RIWW9DcFd2ZUV2NVBhZGRmTXBEVHJZVFZKblRzbUV1L0tqM3JMalppK2RPbk5OUUJEQkJPOVJPT2dDT04yeTYxMXByUUlxWkU0fA&cppv=2

293 HTTP transactions

Resource
Path
Size
x-fer
Type
MIME-Type
Primary Request 10-most-anticipated-drug-launches-2022-8-mavacamten
www.fiercepharma.com/special-report/
67 KB
20 KB
Document
General
Full URL
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
059f885719ec13eb09369a367f259a96b7607af4e3d73a3a049b54b9b3e76627
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9

Response headers

date
Wed, 09 Feb 2022 15:36:13 GMT
content-type
text/html; charset=UTF-8
cache-control
max-age=16588800, public
x-drupal-dynamic-cache
MISS
link
<https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten>; rel="canonical" <https://www.fiercepharma.com/node/518311>; rel="shortlink" <https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten>; rel="revision"
x-ua-compatible
IE=edge
content-language
en
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
expires
Sun, 19 Nov 1978 05:00:00 GMT
last-modified
Wed, 09 Feb 2022 15:35:20 GMT
vary
Cookie,Accept-Encoding
x-generator
Drupal 8 (https://www.drupal.org)
x-drupal-cache
MISS
x-request-id
v-e3d90c2e-89bd-11ec-9128-e7ebf108f593
x-ah-environment
prod
via
varnish
x-cache
MISS
cf-cache-status
HIT
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
server
cloudflare
cf-ray
6dae2c0d5fcb3bbc-CDG
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
css2
fonts.googleapis.com/
7 KB
1 KB
Stylesheet
General
Full URL
https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:811::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
ESF /
Resource Hash
16bc5aa9539869018f77eb2a7edc3e56864ce7a05117202d044c7aed8caea080
Security Headers
Name Value
Strict-Transport-Security max-age=31536000
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

strict-transport-security
max-age=31536000
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
last-modified
Wed, 09 Feb 2022 15:36:13 GMT
server
ESF
cross-origin-opener-policy
same-origin-allow-popups
date
Wed, 09 Feb 2022 15:36:13 GMT
x-frame-options
SAMEORIGIN
content-type
text/css; charset=utf-8
access-control-allow-origin
*
cache-control
private, max-age=86400, stale-while-revalidate=604800
timing-allow-origin
*
link
<https://fonts.gstatic.com>; rel=preconnect; crossorigin
expires
Wed, 09 Feb 2022 15:36:13 GMT
css_2cUrMdLa05pOjEKh0y2Vv3GJVjJ1S9FlveDonq3CWE8.css
www.fiercepharma.com/sites/fiercepharma/files/css/
8 KB
2 KB
Stylesheet
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_2cUrMdLa05pOjEKh0y2Vv3GJVjJ1S9FlveDonq3CWE8.css
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2df8f7fcaa40376591e17d73d42fb68111d13f05c2feabbb9b89499d5a935ea0
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:13 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
123100
cf-polished
origSize=8029
x-cache
MISS
cf-bgj
minify
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-99d79262-855d-11ec-8dca-939d47ac7fda
x-robots-tag
noindex, nofollow
last-modified
Wed, 02 Feb 2022 17:29:01 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=1209600
cf-ray
6dae2c0f3cfd3bbc-CDG
expires
Fri, 18 Feb 2022 01:56:00 GMT
css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
www.fiercepharma.com/sites/fiercepharma/files/css/
605 KB
55 KB
Stylesheet
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
7533826884f96d6479ad16c923fb9ad6d9dad65930f9e3a4a5c82ebcdfd92f5c
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:13 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
136140
cf-polished
origSize=627000
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:55 GMT
x-cache-hits
67
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-ce82ec8e-77c3-11ec-82b5-bf6f4cf2aaa7
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/css
cache-control
max-age=1209600
cf-ray
6dae2c0f3d043bbc-CDG
expires
Mon, 14 Feb 2022 18:32:56 GMT
questex.js
cdn.blueconic.net/
141 KB
42 KB
Script
General
Full URL
https://cdn.blueconic.net/questex.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.139.105 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-139-105.fra60.r.cloudfront.net
Software
- /
Resource Hash
365bca218653492c7ccd4b2e285a3242b8f7d76fda1f62cd194eebf8f4a480a3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:28:08 GMT
content-encoding
gzip
x-content-type-options
nosniff
x-permitted-cross-domain-policies
master-only
age
488
x-cache
Hit from cloudfront
content-length
42354
x-xss-protection
1; mode=block
last-modified
Wed, 19 Jan 2022 14:47:53 GMT
server
-
etag
"233e2-5d5f0787c7150-gzip"
vary
Accept-Encoding
content-type
text/javascript; charset=utf-8
via
1.1 b1c64361268fcbad3c03abbe37eb5cfa.cloudfront.net (CloudFront)
cache-control
public, max-age=600, s-maxage=500
x-amz-cf-pop
FRA60-P4
accept-ranges
none
x-robots-tag
noindex, nofollow
x-amz-cf-id
4YRWa_j_EKDP9KnRu4rGIPgB1tePeWDgSolKjvPazEhZUe2RzgBK5w==
logo-pharma.svg
www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/
4 KB
2 KB
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite_fierce/assets/images/logo/logo-pharma.svg?v=1.03
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
5f18dc38e84dbadb36b6e7d6da27e45e6fdf4c41ddac6a53452503922e96a73a
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
107447
x-cache
HIT
x-cache-hits
1
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-0a9452a2-1947-11ec-986b-8bfed097753d
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:57:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=1209600
cf-ray
6dae2c0feade90e8-FRA
expires
Tue, 01 Feb 2022 12:27:41 GMT
BMS%20Street%20Sign.jpg
qtxasset.com/styles/breakpoint_xl_880px_w/s3/fiercepharma/1642682924/BMS%20Street%20Sign.jpg/
135 KB
135 KB
Image
General
Full URL
https://qtxasset.com/styles/breakpoint_xl_880px_w/s3/fiercepharma/1642682924/BMS%20Street%20Sign.jpg/BMS%20Street%20Sign.jpg?VersionId=H2ehD_mpPAzs70pjEdnCEIjp85s_yHD7&itok=fyKl5g5J
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
104.16.93.165 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
76083563a02d416657845ba812ab432d12d95c64d829b970e6448e12ed8138b9

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
cf-cache-status
HIT
age
198023
cf-polished
degrade=85, origSize=713900, status=webp_bigger
cf-ray
6dae2c104ec2926d-FRA
x-amz-replication-status
COMPLETED
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length
138008
x-amz-id-2
/iI+LoNSypQiyJXkTEByrqOrkDuj9Nn8FVQTk3HR9UYxVNz3WI5ZF4R/ECys+N1Wg5RYvmzmXUg=
last-modified
Mon, 24 Jan 2022 07:38:11 GMT
server
cloudflare
etag
"32878bbd739f46eb4af800a4e3a54f88"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
x-amz-request-id
P7PK0F17CA5MWKM1
cache-control
public, max-age=604800
x-amz-version-id
H2ehD_mpPAzs70pjEdnCEIjp85s_yHD7
accept-ranges
bytes
content-type
image/jpeg
cf-bgj
imgq:85,h2pri
questex-logo-white.svg
www.fiercepharma.com/themes/custom/tektite/assets/images/
4 KB
2 KB
Image
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite/assets/images/questex-logo-white.svg?v=0.1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
680030a41d9b8dcd5edc79e159a420da353dd6638a041a6db69eb0df8b5073b2
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
107447
x-cache
HIT
x-cache-hits
3
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-3fa602e8-23aa-11ec-8f9e-075ba2d22459
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:57:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
image/svg+xml
cache-control
max-age=1209600
cf-ray
6dae2c0feae090e8-FRA
expires
Tue, 01 Feb 2022 12:27:41 GMT
hb_302826_6936.js
player.mediafuse.com/prebidlink/456783/
467 KB
140 KB
Script
General
Full URL
https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
cfe7744f8ac2b57c06c2b660fca24158c1856b663b0644355ddef5b32e3d1b63

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
last-modified
Tue, 08 Feb 2022 02:12:46 GMT
server
nginx
etag
W/"6201d19e-74a4d"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Wed, 09 Feb 2022 16:36:14 GMT
gpt.js
securepubads.g.doubleclick.net/tag/js/
79 KB
27 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/tag/js/gpt.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
sffe /
Resource Hash
05c212f90103f69a4500957f49c6a92f82f755e0c08188eb4ecbe243d03bd7fb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27136
x-xss-protection
0
server
sffe
etag
"1126 / 752 of 1000 / last-modified: 1644408561"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Wed, 09 Feb 2022 15:36:14 GMT
wrapper_hb_302826_6936.js
player.mediafuse.com/prebidlink/456783/
1 KB
841 B
Script
General
Full URL
https://player.mediafuse.com/prebidlink/456783/wrapper_hb_302826_6936.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
6325f7a25c4403ed680a95172069a4571086cbcbf4aac2ea1f028e8ced4818d8

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
last-modified
Wed, 09 Feb 2022 14:57:32 GMT
server
nginx
etag
W/"6203d65c-421"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Wed, 09 Feb 2022 16:36:14 GMT
gtm.js
www.googletagmanager.com/
161 KB
55 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:831::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
2eefadee5974001527a83d9dd3a32b074f3ed8f7ced99987e6796d1ef5b76e09
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
56318
x-xss-protection
0
last-modified
Wed, 09 Feb 2022 15:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Wed, 09 Feb 2022 15:36:14 GMT
js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js
www.fiercepharma.com/sites/fiercepharma/files/js/
87 KB
32 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_c8LbWbHV1txem3q8oAzuadnL-HiBShaQH_WRviNqT_g.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
b541d631712bc34f7472aabf9cdeaf0fcb2257fd2436ffced1530f5d4f5a0383
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
107447
cf-polished
origSize=89478
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
41
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-d25ab1a8-7164-11ec-9e34-1b558f64b334
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6dae2c0f9a1790e8-FRA
expires
Tue, 01 Feb 2022 13:57:21 GMT
js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js
www.fiercepharma.com/sites/fiercepharma/files/js/
16 KB
7 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_hQSXU_zbJqof3y12MhPI7Ysd2kGl33cJXGVpYtnDbf0.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8111f22e56354c8880315afdd87fe63c7d82284596f7288969247a118accc642
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
107447
cf-polished
origSize=16281
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
17
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-874103aa-7215-11ec-a44a-83c705574550
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6dae2c0fba6090e8-FRA
expires
Mon, 31 Jan 2022 09:15:07 GMT
page.js
static.addtoany.com/menu/
72 KB
26 KB
Script
General
Full URL
https://static.addtoany.com/menu/page.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:10::6816:46c5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
f22120d1591b5397235fec8a01ffcc7d45fa6bd0b4cd6f93b8999c9365b359f1
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
e1s
x-content-type-options
nosniff
cf-cache-status
HIT
age
45473
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified
Wed, 01 Dec 2021 08:23:25 GMT
server
cloudflare
etag
W/"11ee2-5d2116348919c"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/javascript; charset=utf-8
vary
Accept-Encoding
cache-control
public, max-age=172800
cf-ray
6dae2c106ddd59d1-MXP
cf-bgj
minify
js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
www.fiercepharma.com/sites/fiercepharma/files/js/
21 KB
8 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
9b17ed6f201a539d617120eb2b829a3a32a661daf2f04893c5978b25dd781034
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
107447
cf-polished
origSize=21128
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
16
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-94fea102-6e2b-11ec-8e41-3325e2a98abd
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6dae2c0fead590e8-FRA
expires
Fri, 04 Feb 2022 10:23:45 GMT
webfont.js
ajax.googleapis.com/ajax/libs/webfont/1.6.26/
13 KB
6 KB
Script
General
Full URL
https://ajax.googleapis.com/ajax/libs/webfont/1.6.26/webfont.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:800::200a Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
81016ac6be850b72df5d4faa0c3cec8e2c1b0ba0045712144a6766adfad40bee
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Sat, 05 Feb 2022 11:49:56 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
359178
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/hosted-libraries-pushers
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
5437
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 19:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="hosted-libraries-pushers"
vary
Accept-Encoding
report-to
{"group":"hosted-libraries-pushers","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/hosted-libraries-pushers"}]}
content-type
text/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
public, max-age=31536000, stale-while-revalidate=2592000
accept-ranges
bytes
timing-allow-origin
*
expires
Sun, 05 Feb 2023 11:49:56 GMT
js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js
www.fiercepharma.com/sites/fiercepharma/files/js/
762 B
723 B
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_6txShFh2kqJNyQ8zIiSXaxbK3dpMeRh5Z0PsEAh7qp8.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
19d8552b92ae03e066893a9d818a5336bd0d107812dff3c05daef636d8750d38
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
107447
cf-polished
origSize=763
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:57 GMT
x-cache-hits
12
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-99d5f14a-72bc-11ec-9c36-17d9743aa17f
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6dae2c0ffaf190e8-FRA
expires
Fri, 04 Feb 2022 10:12:35 GMT
forms2.min.js
app-sj10.marketo.com/js/forms2/js/
205 KB
68 KB
Script
General
Full URL
https://app-sj10.marketo.com/js/forms2/js/forms2.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
104.16.92.80 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
2689a0237a95cfd8135f8da3ac79c430e903f3c542f8b862f68141c84c348c43
Security Headers
Name Value
Strict-Transport-Security max-age=63113904
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
HIT
last-modified
Wed, 12 Jan 2022 18:47:30 GMT
server
cloudflare
age
4304
etag
"a40c6f-33210-5d567007b9480"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=63113904
content-type
application/x-javascript; charset=utf-8
cache-control
public, max-age=14400
cf-ray
6dae2c12c806ee27-CDG
vary
Accept-Encoding
expires
Wed, 09 Feb 2022 19:36:14 GMT
js_7D5NINMm97AVjKhvsRV_XgPiqQeouLiSNcG1CZ8eWQM.js
www.fiercepharma.com/sites/fiercepharma/files/js/
5 KB
2 KB
Script
General
Full URL
https://www.fiercepharma.com/sites/fiercepharma/files/js/js_7D5NINMm97AVjKhvsRV_XgPiqQeouLiSNcG1CZ8eWQM.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
8f00fec474ffe65144177c5c92038cc7ce0695fc9975ebf2130d3bc393a3e645
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
107447
cf-polished
origSize=4669
x-cache
HIT
last-modified
Thu, 30 Dec 2021 18:15:58 GMT
x-cache-hits
1
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-f4329574-6f1c-11ec-ae90-033872d0c646
x-robots-tag
noindex, nofollow
cf-bgj
minify
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
cache-control
max-age=1209600
cf-ray
6dae2c0feadb90e8-FRA
expires
Thu, 03 Feb 2022 21:43:55 GMT
qFdH35WCmI96Ajtm81GlU9s.woff2
fonts.gstatic.com/s/overpass/v10/
38 KB
38 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v10/qFdH35WCmI96Ajtm81GlU9s.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82f::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
995dfb0c839090c9461662fca31b3d886f80dd9e881db8ea224374866eade55f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 21:13:11 GMT
x-content-type-options
nosniff
age
66183
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38496
x-xss-protection
0
last-modified
Thu, 03 Feb 2022 00:25:12 GMT
server
sffe
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="apps-themes"
expires
Wed, 08 Feb 2023 21:13:11 GMT
cs
questex.blueconic.net/DG/DEFAULT/
0
0
Script
General
Full URL
https://questex.blueconic.net/DG/DEFAULT/cs?&callback=bc_json573
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.72.7.92 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-72-7-92.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

qFdU35WCmI96Ajtm81GgSdXCNs-VMF0vNLADeqqIncM.woff2
fonts.gstatic.com/s/overpass/v10/
16 KB
16 KB
Font
General
Full URL
https://fonts.gstatic.com/s/overpass/v10/qFdU35WCmI96Ajtm81GgSdXCNs-VMF0vNLADeqqIncM.woff2
Requested by
Host: fonts.googleapis.com
URL: https://fonts.googleapis.com/css2?family=Overpass:ital,wght@0,400;0,700;0,900;1,400&display=swap
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82f::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
94e5daea972ac93120f8535bff5a2bd57f1dc36dd36e5dbfe70639b75f1f8e33
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://fonts.googleapis.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 18:53:30 GMT
x-content-type-options
nosniff
age
74564
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/apps-themes
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
16324
x-xss-protection
0
last-modified
Thu, 03 Feb 2022 00:25:41 GMT
server
sffe
report-to
{"group":"apps-themes","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/apps-themes"}]}
content-type
font/woff2
access-control-allow-origin
*
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="apps-themes"
expires
Wed, 08 Feb 2023 18:53:30 GMT
fontello.woff2
www.fiercepharma.com/themes/custom/tektite/assets/fonts/
6 KB
7 KB
Font
General
Full URL
https://www.fiercepharma.com/themes/custom/tektite/assets/fonts/fontello.woff2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1daf67a5a85e55210b5e212a8be8392f1f93c01ce54effd63eab78f0b80dfb44
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/sites/fiercepharma/files/css/css_OQCYQjGiXoYAdYeo0QfNaDBCZWYOPDNshs8IYXccnsY.css
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
107447
x-cache
HIT
x-cache-hits
231
x-ah-environment
prod
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
content-length
6644
x-request-id
v-6f862608-28e3-11ec-a436-bbed65516c8b
x-robots-tag
noindex, nofollow
last-modified
Tue, 31 Aug 2021 05:57:18 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
cache-control
max-age=1209600
accept-ranges
bytes
cf-ray
6dae2c0ffb0a90e8-FRA
expires
Sun, 30 Jan 2022 08:03:34 GMT
asyncPixelSync
pixel.sitescout.com/dmp/ Frame F81D
Redirect Chain
  • https://pixel-a.basis.net/dmp/asyncPixelSync
  • https://pixel.sitescout.com/dmp/asyncPixelSync
0
0
Document
General
Full URL
https://pixel.sitescout.com/dmp/asyncPixelSync
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, CHACHA20_POLY1305
Server
66.155.71.150 Portsmouth, United Kingdom, ASN13768 (COGECO-PEER1, CA),
Reverse DNS
Software
AC1.1 /
Resource Hash

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten

Response headers

cache-control
max-age=0,no-cache,no-store
pragma
no-cache
expires
Tue, 11 Oct 1977 12:34:56 GMT
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
date
Wed, 09 Feb 2022 15:36:14 GMT
server
AC1.1

Redirect headers

content-length
0
location
https://pixel.sitescout.com/dmp/asyncPixelSync
7f1874304d399254
pixel.sitescout.com/iap/
Redirect Chain
  • https://pixel-a.basis.net/iap/7f1874304d399254
  • https://pixel.sitescout.com/iap/7f1874304d399254
0
191 B
Image
General
Full URL
https://pixel.sitescout.com/iap/7f1874304d399254
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Server
66.155.71.150 Portsmouth, United Kingdom, ASN13768 (COGECO-PEER1, CA),
Reverse DNS
Software
AC1.1 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:14 GMT
cache-control
max-age=0,no-cache,no-store
server
AC1.1
p3p
CP="NON DEVa PSAa PSDa OUR NOR NAV",policyref="/w3c/p3p.xml"
expires
Tue, 11 Oct 1977 12:34:56 GMT

Redirect headers

location
https://pixel.sitescout.com/iap/7f1874304d399254
content-length
0
init.do
sample.dragonforms.com/ Frame 4E7F
Redirect Chain
  • https://sample.dragonforms.com/FiercePharma_short
  • https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
279 B
620 B
Document
General
Full URL
https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
82bf27f408e3d524f53a94492b845458ebb576e5873d57a452815f859953dff2
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
Access-Control-Allow-Origin
*
Content-Type
text/html;charset=ISO-8859-1
Date
Wed, 09 Feb 2022 15:36:14 GMT
Server
Apache
Vary
Accept-Encoding
Content-Encoding
gzip
Transfer-Encoding
chunked

Redirect headers

Location
init.do?omedasite=FiercePharma_short
Content-Length
0
Date
Wed, 09 Feb 2022 15:36:14 GMT
Server
Apache
p.js
d1z2jf7jlzjs58.cloudfront.net/
930 B
1 KB
Script
General
Full URL
https://d1z2jf7jlzjs58.cloudfront.net/p.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/sites/fiercepharma/files/js/js_K8WjWylJMuC9X7UPhFnx2PKpGfKXSmt2neJ09X-RgCQ.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
13.224.194.178 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-194-178.fra2.r.cloudfront.net
Software
nginx /
Resource Hash
62f586be8571b23584eb4a60a45a3157ff7c8388b1b1e3b4e8890e243b3e47de

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 04:21:59 GMT
Via
1.1 c2a926ef1bafe1ab239d4761594a8098.cloudfront.net (CloudFront)
Age
40455
X-Cache
Hit from cloudfront
Connection
keep-alive
Content-Length
930
Pragma
public
Last-Modified
Wed, 06 May 2020 20:19:48 GMT
Server
nginx
ETag
"5eb31be4-3a2"
Content-Type
application/javascript
Cache-Control
max-age=86400, public
X-Amz-Cf-Pop
FRA2-C1
Accept-Ranges
bytes
X-Amz-Cf-Id
8GA4uAICK_QDTzvXlljNArhmTveUcRtRKFB3yK8-yHxwQIc3pjAtZw==
Expires
Thu, 10 Feb 2022 04:21:59 GMT
pubads_impl_2022020301.js
securepubads.g.doubleclick.net/gpt/
351 KB
119 KB
Script
General
Full URL
https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
sffe /
Resource Hash
05ed7424c6f3c3d2aec5dfe7fa92e5f617afe58a01666c1c584d342a8b57a0e7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 12:32:23 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
11031
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
122037
x-xss-protection
0
last-modified
Thu, 03 Feb 2022 09:34:49 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
public, immutable, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Thu, 09 Feb 2023 12:32:23 GMT
ppub_config
securepubads.g.doubleclick.net/pagead/
39 B
79 B
XHR
General
Full URL
https://securepubads.g.doubleclick.net/pagead/ppub_config?ippd=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/tag/js/gpt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
2ad9341e45c5e7676ed8925d391b5a96802a29c898d1e4909c4537c0f5a6a2ce
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private, max-age=3600, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/json; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
55
x-xss-protection
0
expires
Wed, 09 Feb 2022 15:36:14 GMT
analytics.js
www.google-analytics.com/
49 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
a1925038db769477ab74b4df34350c35688a795bb718727b0f4292a4a78a6210
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 02 Nov 2021 17:39:06 GMT
server
Golfe2
age
5482
date
Wed, 09 Feb 2022 14:04:52 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20006
expires
Wed, 09 Feb 2022 16:04:52 GMT
4740.js
script.crazyegg.com/pages/scripts/0092/
5 KB
2 KB
Script
General
Full URL
https://script.crazyegg.com/pages/scripts/0092/4740.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
daaf47e176780239d864e64b1729d088b9e9a005e19b1bd39fda65dee2e26a6f

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
cf-cache-status
HIT
age
95813
cf-polished
origSize=4899
cf-ray
6dae2c12ce2a3760-MXP
ce-version
11.1.381
last-modified
Tue, 08 Feb 2022 12:59:21 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
timing-allow-origin
*
cf-bgj
minify
munchkin.js
munchkin.marketo.net/
1 KB
1 KB
Script
General
Full URL
https://munchkin.marketo.net/munchkin.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.111.234.67 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-234-67.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
4bf3aca933aa233702f890083af601fb16149ec8a17f8c1b90d30450562bde08

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:14 GMT
Content-Encoding
gzip
Last-Modified
Fri, 29 Oct 2021 01:24:07 GMT
Server
AkamaiNetStorage
ETag
"461ce1cffaadfebf2e7659745618ba8e:1635470647.434977"
Vary
Accept-Encoding
P3P
policyref="http://www.marketo.com/w3c/p3p.xml", CP="NOI DSP COR NID CURi OUR NOR"
Connection
keep-alive
Accept-Ranges
bytes
Content-Type
application/x-javascript
Content-Length
753
dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
s.dpmsrv.com/
128 KB
39 KB
Script
General
Full URL
https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
13.32.99.71 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-32-99-71.fra60.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
7807a225ec87fa7772a2bcdffe554886fe7cfb77fac2e65e4b6864c7005cbfeb

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 14:40:45 GMT
Content-Encoding
gzip
Last-Modified
Tue, 08 Feb 2022 14:40:10 GMT
Server
AmazonS3
Age
3338
ETag
"453ddb10b6f8cbe9f3ee7ed6d018410d"
X-Cache
Hit from cloudfront
Content-Type
application/x-javascript
Via
1.1 8b889e35789d2b97f2ba8771acc9a008.cloudfront.net (CloudFront)
Connection
keep-alive
X-Amz-Cf-Pop
FRA60-P3
Accept-Ranges
bytes
Content-Length
39772
X-Amz-Cf-Id
vMrJmeifIuUig_F24_6xdt_n3cokcZ5gkSzLlA3HBXk4bhzmVSyBOQ==
WgRbL7NLS90BFPSb6pBa
ws.zoominfo.com/pixel/
1 KB
1 KB
Script
General
Full URL
https://ws.zoominfo.com/pixel/WgRbL7NLS90BFPSb6pBa
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6810:a852 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare / Express
Resource Hash
ba8a68a79c27e3e5c5e617a1d99422de0ef3185b8937269e18c584ed86a6cb60
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
x-content-type-options
nosniff
cf-cache-status
DYNAMIC
server
cloudflare
x-powered-by
Express
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
access-control-allow-credentials
true
cf-ray
6dae2c12b9bb5b8c-FRA
access-control-allow-headers
Content-Type,cf-ipcountry,service-version,x-appengine-user-ip,x-forwarded-for
via
1.1 google
olytics.min.js
olytics.omeda.com/olytics/js/v3/p/
271 KB
73 KB
Script
General
Full URL
https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
d3db6456c45bfe697359d0c3c52564b0661ec8ad2f1b8de6e0c1926a90f44d8c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:14 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Tue, 18 Jan 2022 16:42:56 GMT
Server
Apache
ETag
W/"277838-1642524176000"
X-Frame-Options
SAMEORIGIN
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Wed, 09 Feb 2022 21:36:15 GMT
olytics.css
olytics.omeda.com/olytics/css/v3/p/
28 KB
3 KB
Stylesheet
General
Full URL
https://olytics.omeda.com/olytics/css/v3/p/olytics.css
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-KLQFWCZ
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
78057ff881c7ceb369c163fee7ab0d93ae4754f3a7503d5dbfd4a0b80e203a79
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:14 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Fri, 27 Aug 2021 04:05:28 GMT
Server
Apache
ETag
W/"28820-1630037128000"
X-Frame-Options
SAMEORIGIN
Content-Type
text/css
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Wed, 09 Feb 2022 21:36:14 GMT
sm.23.html
static.addtoany.com/menu/ Frame 675A
741 B
784 B
Document
General
Full URL
https://static.addtoany.com/menu/sm.23.html
Requested by
Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700:10::6816:46c5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4ca130786a2d2531241f8b8c7aaad6a4e27271f51b417b9c23f51bfb0c65c080
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-type
text/html; charset=utf-8
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
last-modified
Wed, 22 Sep 2021 23:42:51 GMT
etag
W/"2e5-5cc9e128a4c38"
cache-control
max-age=315360000, immutable
vary
Accept-Encoding
via
e4s
cf-cache-status
HIT
age
1326957
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
x-content-type-options
nosniff
server
cloudflare
cf-ray
6dae2c12bdaf68fe-FRA
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
truncated
/
34 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
1e85ec81b9800b4c443d39caca0d0926089a3ac201120db1ceb45b93789480b8

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Content-Type
image/gif
icons.30.svg.js
static.addtoany.com/menu/svg/
77 KB
33 KB
Script
General
Full URL
https://static.addtoany.com/menu/svg/icons.30.svg.js
Requested by
Host: static.addtoany.com
URL: https://static.addtoany.com/menu/page.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2606:4700:10::6816:46c5 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
7e6f3eacf6af919ace45f10e39eda3e72143e0f57aad29590a6d37d5ddd0292f
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
e3s
x-content-type-options
nosniff
cf-cache-status
HIT
age
1364758
p3p
CP="ALL DSP COR CURa ADMa DEVa TAIa PSAa PSDa OUR IND UNI COM NAV INT"
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
last-modified
Wed, 10 Nov 2021 01:49:04 GMT
server
cloudflare
etag
W/"132a9-5d0656e4a26b3"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
strict-transport-security
max-age=31536000; includeSubDomains; preload
content-type
application/javascript; charset=utf-8
vary
Accept-Encoding
cache-control
max-age=315360000, immutable
cf-ray
6dae2c12bdb168fe-FRA
cf-bgj
minify
p.js
cdn.parsely.com/keys/fiercepharma.com/
47 KB
18 KB
Script
General
Full URL
https://cdn.parsely.com/keys/fiercepharma.com/p.js
Requested by
Host: d1z2jf7jlzjs58.cloudfront.net
URL: https://d1z2jf7jlzjs58.cloudfront.net/p.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.100.58 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-100-58.fra56.r.cloudfront.net
Software
nginx /
Resource Hash
e1feaafecf95d6dfa9fd5dc4ade49fcb29c6a697c713e423940b83e00ae3ad35

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
public
date
Tue, 08 Feb 2022 20:27:40 GMT
content-encoding
gzip
last-modified
Fri, 02 Jul 2021 02:33:20 GMT
server
nginx
age
68988
etag
W/"60de7af0-bd27"
x-cache
Hit from cloudfront
content-type
application/javascript
via
1.1 666eddda46892ed48d8d771b6142ac24.cloudfront.net (CloudFront)
cache-control
max-age=86400, public
x-amz-cf-pop
FRA56-P2
x-amz-cf-id
SgXt_umlppn_rHuGag_1LTdY8P1cmcfzzR3Rxpfvqttk6ZX6fo72yw==
expires
Wed, 09 Feb 2022 20:26:26 GMT
collect
www.google-analytics.com/j/
2 B
22 B
XHR
General
Full URL
https://www.google-analytics.com/j/collect?v=1&_v=j96&a=1001435911&t=pageview&_s=1&dl=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&ul=en-us&de=UTF-8&dt=8.%20Mavacamten%20%7C%20FiercePharma&sd=24-bit&sr=1600x1200&vp=1600x1200&je=0&_u=YGBACAABBAAAAC~&jid=1515627617&gjid=602405764&cid=1143913336.1644420975&tid=UA-336524-28&_gid=1561711950.1644420975&_r=1&gtm=2wg270KLQFWCZ&z=1406331060
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
de3246094525b21a870fc7d2a67490d0132535c6fa5993755c549f1a9d1bd8af
Security Headers
Name Value
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:14 GMT
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
2
expires
Fri, 01 Jan 1990 00:00:00 GMT
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D913%26pixelIndex%3D0%26r%3D568688%26tzOffset%3D0%26url%3Dhttps%253A%252F%252Fwww.fiercepharma.com...
  • https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D913%2526pixelIndex%253D0%2526r%253D568688%2526tzOffset%25...
  • https://a.dpmsrv.com/dpmpxl/index.php?id=1521003946560112395&q=xImp&v=1.x&cl=913&pixelIndex=0&r=568688&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-...
249 B
995 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?id=1521003946560112395&q=xImp&v=1.x&cl=913&pixelIndex=0&r=568688&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&_=1644420974554
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Server
3.226.203.17 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-226-203-17.compute-1.amazonaws.com
Software
/
Resource Hash
56997b88ebe83283731da53337793cfcfb5c37772703173899bf910fd513935d

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
218
Expires
0

Redirect headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:14 GMT
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 718.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
31be8914-146e-488e-a7eb-25ca4b99262b
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://a.dpmsrv.com/dpmpxl/index.php?id=1521003946560112395&q=xImp&v=1.x&cl=913&pixelIndex=0&r=568688&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&_=1644420974554
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
572
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

munchkin.js
munchkin.marketo.net/161/
11 KB
5 KB
Script
General
Full URL
https://munchkin.marketo.net/161/munchkin.js
Requested by
Host: munchkin.marketo.net
URL: https://munchkin.marketo.net/munchkin.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
104.111.234.67 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a104-111-234-67.deploy.static.akamaitechnologies.com
Software
AkamaiNetStorage /
Resource Hash
c2aee78040b4ed46c2377e6825db12a9691a2eb584adf338e77312c8978d8537

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:14 GMT
Content-Encoding
gzip
Last-Modified
Wed, 08 Sep 2021 00:38:21 GMT
Server
AkamaiNetStorage
ETag
"0e0eefac8daf874e8b1aa34aeb160c52:1631061501.737429"
Vary
Accept-Encoding
P3P
policyref="http://www.marketo.com/w3c/p3p.xml", CP="NOI DSP COR NID CURi OUR NOR"
Cache-Control
max-age=8640000
Connection
keep-alive
Accept-Ranges
bytes
Content-Type
application/x-javascript
Content-Length
4681
Expires
Fri, 20 May 2022 15:36:14 GMT
hbw_master_302826_6936.js
player.hbmp.mediafuse.com/prebidlink/456783/
95 KB
30 KB
Script
General
Full URL
https://player.hbmp.mediafuse.com/prebidlink/456783/hbw_master_302826_6936.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/wrapper_hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
05af95d7439954d1e29bd9bfa143725f80057476a8e1b37fba7938f254787079

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
last-modified
Wed, 09 Feb 2022 14:57:32 GMT
server
nginx
etag
W/"6203d65c-17dcd"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Wed, 09 Feb 2022 16:36:14 GMT
collect
stats.g.doubleclick.net/j/
1 B
443 B
XHR
General
Full URL
https://stats.g.doubleclick.net/j/collect?t=dc&aip=1&_r=3&v=1&_v=j96&tid=UA-336524-28&cid=1143913336.1644420975&jid=1515627617&gjid=602405764&_gid=1561711950.1644420975&_u=YGBACAAABAAAAC~&z=1106333040
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:400c:c06::9b Brussels, Belgium, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
6b86b273ff34fce19d6b804eff5a3f5747ada4eaa22f1d49c01e52ddb7875b4b
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
strict-transport-security
max-age=10886400; includeSubDomains; preload
x-content-type-options
nosniff
last-modified
Sun, 17 May 1998 03:00:00 GMT
server
Golfe2
date
Wed, 09 Feb 2022 15:36:14 GMT
content-type
text/plain
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1
expires
Fri, 01 Jan 1990 00:00:00 GMT
/
p1.parsely.com/plogger/
43 B
260 B
Image
General
Full URL
https://p1.parsely.com/plogger/?rand=1644420974644&plid=46687759&idsite=fiercepharma.com&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&urlref=&screen=1600x1200%7C1600x1200%7C24&data=%7B%7D&sid=1&surl=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&sref=&sts=1644420974641&slts=0&title=8.+Mavacamten+%7C+FiercePharma&date=Wed+Feb+09+2022+15%3A36%3A14+GMT%2B0000+(GMT)&action=pageview&pvid=94349411&u=pid%3Dec1936911eda5a9ebc764a19a2b3d83e
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.144.144.142 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-54-144-144-142.compute-1.amazonaws.com
Software
nginx /
Resource Hash
cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:15 GMT
Cache-Control
no-cache
Last-Modified
Wednesday, 09-Feb-2022 15:36:15 GMT
Server
nginx
Connection
keep-alive
Content-Length
43
Content-Type
image/gif
tag.aspx
ml314.com/
27 KB
12 KB
Script
General
Full URL
https://ml314.com/tag.aspx?912022
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.208.138.90 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-208-138-90.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
e0eb74c400dded823098e4cdb9f71e9b360a3f33cad9b346879205851e70f887

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:13 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript
Cache-Control
public, max-age=86400
Connection
keep-alive
Content-Length
11617
lead
www.fiercepharma.com/api/v1/marketo/
34 B
563 B
Fetch
General
Full URL
https://www.fiercepharma.com/api/v1/marketo/lead?mkto=null&blueconicProfileId=null
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
104.18.15.141 -, , ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
336a2c6b0eaf929e5c5be1659be540dcc2cd6df5cc2971ecf4d65480f7505609
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
via
varnish
x-content-type-options
nosniff
cf-cache-status
HIT
age
1196600
x-cache
HIT
content-type
application/json
x-drupal-dynamic-cache
UNCACHEABLE
x-ah-environment
prod
content-encoding
br
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
x-request-id
v-e2047ce8-76c7-11ec-a3f1-a3c97edf9918
x-ua-compatible
IE=edge
last-modified
Sun, 16 Jan 2022 12:29:00 GMT
server
cloudflare
x-frame-options
SAMEORIGIN
etag
W/"1642336140"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Cookie,Accept-Encoding
content-language
en
x-generator
Drupal 8 (https://www.drupal.org)
expires
Sun, 19 Nov 1978 05:00:00 GMT
cache-control
max-age=16588800, public
cf-ray
6dae2c139c3b90e8-FRA
x-drupal-cache
MISS
x-cache-hits
54
4740.json
script.crazyegg.com/pages/data-scripts/0092/
18 KB
2 KB
XHR
General
Full URL
https://script.crazyegg.com/pages/data-scripts/0092/4740.json?t=1
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
ef6ef4428c03b60a54eb1fe17af5aa2f228be105dbb97fdef75c1a550bc81b0c

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
cf-cache-status
HIT
age
95813
ce-version
11.1.381
content-length
1899
timing-allow-origin
*
last-modified
Tue, 08 Feb 2022 12:59:21 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
accept-ranges
bytes
cf-ray
6dae2c145f305a1f-MXP
visitWebPage
294-mqf-056.mktoresp.com/webevents/
2 B
311 B
Ping
General
Full URL
https://294-mqf-056.mktoresp.com/webevents/visitWebPage?_mchNc=1644420974677&_mchCn=&_mchId=294-MQF-056&_mchTk=_mch-fiercepharma.com-1644420974676-46333&_mchHo=www.fiercepharma.com&_mchPo=&_mchRu=%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&_mchPc=https%3A&_mchVr=161&_mchEcid=&_mchHa=&_mchRe=&_mchQp=
Requested by
Host: munchkin.marketo.net
URL: https://munchkin.marketo.net/161/munchkin.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
192.28.147.68 , United States, ASN15224 (OMNITURE, US),
Reverse DNS
Software
nginx /
Resource Hash
565339bc4d33d72817b583024112eb7f5cdf3e5eef0252d6ec1b9c9a94e12bb3

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:15 GMT
Content-Encoding
gzip
Server
nginx
Transfer-Encoding
chunked
Content-Type
text/plain; charset=UTF-8
Access-Control-Allow-Origin
*
Connection
keep-alive
X-Request-Id
054303c4-b9d8-4e9b-88dd-6a6e579082e4
config.json
player.adtelligent.com/exchange_rates/279934/
9 KB
4 KB
XHR
General
Full URL
https://player.adtelligent.com/exchange_rates/279934/config.json?cb=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
00bb42904785daea4ce696afbbecd945d2e697df16a87a0e699445761b3eead6

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
last-modified
Wed, 09 Feb 2022 12:01:08 GMT
server
nginx
etag
W/"6203ad04-220f"
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
expires
Wed, 09 Feb 2022 16:36:14 GMT
cache-control
max-age=3600
x-proxy-cache
HIT
/
ghb.hbmp.mediafuse.com/geo/
141 B
397 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/geo/
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456783/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a06:8640:799:0:ec4:7aff:fe6e:a48e Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
728c49e796ecdeef583382526fbcf408d32d46bf8583550042f2260d6c0b07c6

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Wed, 09 Feb 2022 15:36:14 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
141
Content-Type
application/json
tracking
ghb.hbmp.mediafuse.com/adunit/
43 B
425 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/adunit/tracking?event=11&type=0&client_id=302826&site_id=6936&full_page_url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&adid=fpsgnq.zk&features=32&vpbv=N048&lifecycle_tte=1113
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456783/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a06:8640:799:0:ec4:7aff:fe6e:a48e Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Wed, 09 Feb 2022 15:36:14 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
43
Content-Type
image/gif
j.html
p.annocdn.com/prebidlink/19032/ Frame D0E0
1 KB
879 B
Document
General
Full URL
https://p.annocdn.com/prebidlink/19032/j.html?i=11594
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
cf35c9e8af47d8cd7233bebf1b785af16546782547f31501432cb7ad97d84714

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-type
text/html; charset=utf-8
server
nginx
last-modified
Wed, 16 Sep 2020 14:50:15 GMT
etag
W/"5f622627-434"
cache-control
max-age=3600
content-encoding
gzip
expires
Wed, 09 Feb 2022 16:36:14 GMT
access-control-allow-origin
*
pbm_307825_11594.js
p.annocdn.com/prebidlink/19032/ Frame D0E0
35 KB
13 KB
Script
General
Full URL
https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/j.html?i=11594
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
4dea6e60b9eca99255d720d81783560cfa6f8cf072109f104ae7e5150927ab9b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://p.annocdn.com/prebidlink/19032/j.html?i=11594
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
last-modified
Fri, 04 Feb 2022 15:02:42 GMT
server
nginx
etag
W/"61fd4012-8d82"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Wed, 09 Feb 2022 16:36:14 GMT
11.1.381.js
script.crazyegg.com/pages/versioned/common-scripts/
72 KB
23 KB
Script
General
Full URL
https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/scripts/0092/4740.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
dbd801aa2433b01869ff0b65be422a10ab7c59e680b8aff9a9f093615f37e2e0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
cf-cache-status
HIT
last-modified
Mon, 31 Jan 2022 14:08:13 GMT
server
cloudflare
age
95924
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=31536000, s-maxage=31536000
accept-ranges
bytes
cf-ray
6dae2c148b123760-MXP
content-length
23750
tracking
ghb.adtelligent.com/adunit/ Frame D0E0
43 B
415 B
XHR
General
Full URL
https://ghb.adtelligent.com/adunit/tracking?pubbid=0&event=11&full_page_url=https%3A%2F%2Fwww.fiercepharma.com&adid=108dbc5ddaf552&vpbv=M055&client_id=307825&site_id=11594&lifecycle_tte=99
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a06:8640:799:0:ec4:7aff:fe6e:a48e Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
2dfe28cbdb83f01c940de6a88ab86200154fd772d568035ac568664e52068363

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://p.annocdn.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://p.annocdn.com
Date
Wed, 09 Feb 2022 15:36:14 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
43
Content-Type
image/gif
/
ghb.adtelligent.com/geo/ Frame D0E0
141 B
390 B
XHR
General
Full URL
https://ghb.adtelligent.com/geo/
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a06:8640:799:0:ec4:7aff:fe6e:a48e Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
728c49e796ecdeef583382526fbcf408d32d46bf8583550042f2260d6c0b07c6

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://p.annocdn.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Access-Control-Allow-Origin
https://p.annocdn.com
Date
Wed, 09 Feb 2022 15:36:14 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
Content-Length
141
Content-Type
application/json
utsync.ashx
ml314.com/
62 B
572 B
Script
General
Full URL
https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=66459&ct=js&pi=&fp=GA1.2.1143913336.1644420975&clid=&if=0&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&pv=1644420974843_bhc882jig&bl=en-us&cb=4523786&return=&ht=&d=&dc=&si=1644420974843_bhc882jig&cid=&s=1600x1200&rp=
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?912022
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.208.138.90 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-208-138-90.eu-west-1.compute.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
5a1ba6ff6db12f791bbbfc4da3cb389e06f0cd53eede09ef3eb3ceb074089ef1

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:14 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
p3P
CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
application/javascript; charset=utf-8
Content-Length
147
Expires
0
ud.ashx
in.ml314.com/
20 B
482 B
Script
General
Full URL
https://in.ml314.com/ud.ashx?topiclimit=&cb=912022
Requested by
Host: ml314.com
URL: https://ml314.com/tag.aspx?912022
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.200.182.42 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-34-200-182-42.compute-1.amazonaws.com
Software
Microsoft-IIS/10.0 / ASP.NET
Resource Hash
d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:14 GMT
Content-Encoding
gzip
Server
Microsoft-IIS/10.0
X-AspNet-Version
4.0.30319
X-Powered-By
ASP.NET
Vary
Accept-Encoding
Content-Type
application/javascript; charset=utf-8
Cache-Control
public
Connection
keep-alive
Content-Length
138
Expires
Thu, 10 Feb 2022 15:36:15 GMT
4740.json
script.crazyegg.com/pages/sampling-data-scripts/0092/
1 KB
455 B
XHR
General
Full URL
https://script.crazyegg.com/pages/sampling-data-scripts/0092/4740.json?t=456783
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700::6813:9308 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
dab74169a9865e9ecf8d9a5f5f065488ae86f2b5336132a42d4945883e935d14

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
content-encoding
gzip
cf-cache-status
HIT
age
95813
ce-version
11.1.381
content-length
389
timing-allow-origin
*
last-modified
Tue, 08 Feb 2022 12:59:21 GMT
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
content-type
application/json
access-control-allow-origin
*
access-control-expose-headers
CE-Version
cache-control
public, max-age=300, s-maxage=1209600
accept-ranges
bytes
cf-ray
6dae2c14f8f55a1f-MXP
healthcheck
pagestates-tracking.crazyegg.com/
19 B
419 B
XHR
General
Full URL
https://pagestates-tracking.crazyegg.com/healthcheck
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
52.222.236.10 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-52-222-236-10.fra56.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
830e67bda2532cd5880ee86e3b33e69721082f8458bb0df0cd4edbb1577fd375

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Tue, 21 Dec 2021 13:52:43 GMT
via
1.1 3431ec594cac61983aae2d9ffaf23980.cloudfront.net (CloudFront)
last-modified
Tue, 05 Oct 2021 13:53:30 GMT
server
AmazonS3
age
4326213
etag
"d06f04fccf68d0b228a5923187ce1afd"
access-control-max-age
31536000
access-control-allow-methods
GET, HEAD
content-type
binary/octet-stream
access-control-allow-origin
*
x-cache
Hit from cloudfront
x-amz-cf-pop
FRA56-P4
accept-ranges
bytes
content-length
19
x-amz-cf-id
t91SLz0nkF0iz_cvjexBYIBDXn_YFC9aIlWYVw0SGGn5uQVhPJYhlQ==
healthcheck
assets-tracking.crazyegg.com/
19 B
420 B
XHR
General
Full URL
https://assets-tracking.crazyegg.com/healthcheck
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.122.57 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-122-57.fra60.r.cloudfront.net
Software
AmazonS3 /
Resource Hash
830e67bda2532cd5880ee86e3b33e69721082f8458bb0df0cd4edbb1577fd375

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Tue, 21 Dec 2021 13:24:28 GMT
via
1.1 1d087f24771eb6834b16162f1bb01660.cloudfront.net (CloudFront)
last-modified
Tue, 05 Oct 2021 13:53:30 GMT
server
AmazonS3
age
4327908
etag
"d06f04fccf68d0b228a5923187ce1afd"
access-control-max-age
31536000
access-control-allow-methods
GET, HEAD
content-type
binary/octet-stream
access-control-allow-origin
*
x-cache
Hit from cloudfront
x-amz-cf-pop
FRA60-P2
accept-ranges
bytes
content-length
19
x-amz-cf-id
wSykz1wnRy_5JnMYgue_gzTQe6390vZbDuxHknS0Q5UNdVDHvNSJaw==
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644420974057%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420974060%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420974061%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644420974062%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A15%2B00%3A00&callback=bc_json574
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.112.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-112-18.fra56.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

d293d0c8-d8e5-49b6-8130-e411db944267
https://www.fiercepharma.com/
53 B
0
Other
General
Full URL
blob:https://www.fiercepharma.com/d293d0c8-d8e5-49b6-8130-e411db944267
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
BLOB
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
8ff09cd0ee012fe06ed1b67dc914858cde819f21bb479f629994d9e49f3c0049

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Content-Length
53
Content-Type
text/javascript
spinner.gif
cdn.omeda.com/hosted/images/dragon/generic/ Frame 4E7F
9 KB
9 KB
Image
General
Full URL
https://cdn.omeda.com/hosted/images/dragon/generic/spinner.gif
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
056dd44aece96c67e45ba421d734f125e1497bbdb3b70194b7aadb8a68d10085
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 16:36:15 CET
X-Content-Type-Options
nosniff
Last-Modified
Mon, 10 Oct 2016 22:45:02 CEST
Server
Apache
ETag
W/"8851-1476132302920"
X-Frame-Options
SAMEORIGIN
Content-Type
image/gif
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
clock
tracking.crazyegg.com/
26 B
133 B
XHR
General
Full URL
https://tracking.crazyegg.com/clock?t=1644420975152
Requested by
Host: script.crazyegg.com
URL: https://script.crazyegg.com/pages/versioned/common-scripts/11.1.381.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.249.212.247 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-249-212-247.eu-west-1.compute.amazonaws.com
Software
awselb/2.0 /
Resource Hash
f0e368b3cabf58c02b169da98cfd0787b356b961babd0855919f91c7d08755fc

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

access-control-allow-origin
*
date
Wed, 09 Feb 2022 15:36:15 GMT
cache-control
no-store
server
awselb/2.0
content-length
26
content-type
text/plain
prebid
prebid.deepintent.com/ Frame
0
0
Preflight
General
Full URL
https://prebid.deepintent.com/prebid
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
169.197.150.8 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
g.deepintent.com
Software
b /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

access-control-allow-origin
https://www.fiercepharma.com
vary
Origin,Access-Control-Request-Method,Access-Control-Request-Headers
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
allow
GET, HEAD, POST, PUT, DELETE, OPTIONS, PATCH
content-length
0
date
Wed, 09 Feb 2022 15:36:15 GMT
server
b
auction
prebid.adnxs.com/pbs/v1/openrtb2/
88 B
481 B
XHR
General
Full URL
https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
37.252.161.190 , United States, ASN29990 (ASN-APPNEX, US),
Reverse DNS
prebid.ams1.adnexus.net
Software
nginx/1.19.0 /
Resource Hash
d1306870bdb1390bdd65f4db110c6837f6f9fd8f992950c5e257665720440bac

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
Server
nginx/1.19.0
X-Prebid
pbs-go/0.195.0
Vary
Origin
Content-Type
text/plain; charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Length
88
Expires
0
prebid-request
onetag-sys.com/
15 B
367 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-us.creativecdn.com/bidder/prebid/
0
182 B
XHR
General
Full URL
https://prebid-us.creativecdn.com/bidder/prebid/bids
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.10.30 , Poland, ASN203690 (RTB-HOUSE-ASH, PL),
Reverse DNS
ip-185-184-10-30.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Wed, 09 Feb 2022 15:36:15 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
mvo
tag.1rx.io/rmp/212473/0/
0
176 B
XHR
General
Full URL
https://tag.1rx.io/rmp/212473/0/mvo?z=1r&hbv=6.7.0-pre,2.1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
213.19.147.43 , United Kingdom, ASN26120 (RHYTHMONE, US),
Reverse DNS
Software
Tengine /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Wed, 09 Feb 2022 15:36:15 GMT
cache-control
private, max-age=0, no-cache, no-store
access-control-allow-credentials
true
server
Tengine
trinity.json
apex.go.sonobi.com/
179 B
881 B
XHR
General
Full URL
https://apex.go.sonobi.com/trinity.json?key_maker=%7B%2262588da6a0ae455%22%3A%226af9de6bbe34255426d7%7C970x90%2C970x250%2C970x415%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%2263c954b787eb7cd%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%226442922da696e8b%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%2265f74f24f913f65%22%3A%226af9de6bbe34255426d7%7C300x600%2C300x250%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%2C%226619965b589611a%22%3A%226af9de6bbe34255426d7%7C1600x1000%7Cgpid%3D%2F298443%2Fquestex.lifesciences%2Ffiercepharma%2Fspecialreports%22%7D&ref=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&s=e8647751-671b-492f-a1f8-5544babdd19e&pv=78c19a9d-81e9-4d73-b82b-aa7c8523f5f8&vp=desktop&lib_name=prebid&lib_v=6.7.0-pre&us=0&ius=1&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&userid=%7B%22pubcid%22%3A%2227248500-09db-46fe-83fe-d89b65c9ccbf%22%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%2227248500-09db-46fe-83fe-d89b65c9ccbf%22%2C%22atype%22%3A1%7D%5D%7D%5D&coppa=0
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
178.162.133.150 Rijswijk, Netherlands, ASN60781 (LEASEWEB-NL-AMS-01 Netherlands, NL),
Reverse DNS
ams-1-apex.go.sonobi.com
Software
sonobi-go /
Resource Hash
2f6aa416b8383287310ccb35e4a1177fe1be3c1c27a78d410c44141f700e767d
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
Content-Encoding
gzip
Server
sonobi-go
Vary
negotiate,Accept-Encoding
X-Go-Server
apex-ams-1-6-9
P3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, private
Access-Control-Allow-Credentials
true
Tcn
Choice
Content-Type
application/json
Content-Length
152
X-Xss-Protection
0
Expires
Sat, 26 Jul 1997 05:00:00 GMT
prebid
ib.adnxs.com/ut/v3/
13 KB
7 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.53 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
718.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
0b554d33c1382b0f9c6c48e1f666c578020caaa29d612df76ada3d418103a1a9
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Date
Wed, 09 Feb 2022 15:36:15 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Connection
keep-alive
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 718.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
X-XSS-Protection
0
Pragma
no-cache
AN-X-Request-Uuid
118b3356-a5ee-424b-97fd-86fad2558b90
Server
nginx/1.17.9
Vary
Accept-Encoding
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Expires
Sat, 15 Nov 2008 16:00:00 GMT
bid
ap.lijit.com/rtb/
25 B
526 B
XHR
General
Full URL
https://ap.lijit.com/rtb/bid?src=prebid_prebid_6.7.0-pre
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_256_GCM
Server
72.251.249.14 Amsterdam, Netherlands, ASN29791 (VOXEL-DOT-NET, US),
Reverse DNS
Software
/
Resource Hash
132922ccc9f248aa6dd05357904fd33283ca21bad16028aa861682bbfd5e7d6a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Date
Wed, 09 Feb 2022 15:36:15 GMT
Vary
Accept-Encoding, User-Agent
Access-Control-Allow-Methods
GET, POST, DELETE, PUT
Content-Type
application/json
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
X-Sovrn-Pod
ad_ap1ams1
Access-Control-Allow-Headers
X-Requested-With, Content-Type
Content-Length
25
c
prebid.a-mo.net/a/
0
202 B
XHR
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.75.61.140 Ashburn, United States, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Wed, 09 Feb 2022 15:36:15 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
server
envoy
x-envoy-upstream-service-time
222
vary
origin, Accept-Encoding
translator
hbopenbid.pubmatic.com/
0
120 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Wed, 09 Feb 2022 15:36:15 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
ROS
pbjs.e-planning.net/pbjs/1/2e43c/1/www.fiercepharma.com/
2 B
162 B
XHR
General
Full URL
https://pbjs.e-planning.net/pbjs/1/2e43c/1/www.fiercepharma.com/ROS?rnd=0.020298614248933866&e=970x250_0%3A970x250%2C970x90%2C970x415%2B300x250_0%3A300x250%2C300x600%2B300x250_1%3A300x250%2C300x600%2B300x250_2%3A300x250%2C300x600%2B1600x1000_0%3A1600x1000&ur=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&pbv=6.7.0-pre&ncb=1&vs=FFFFF&crs=UTF-8&fr=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&e_pubcid=27248500-09db-46fe-83fe-d89b65c9ccbf
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
5.178.65.246 Amersfoort, Netherlands, ASN50673 (SERVERIUS-AS, NL),
Reverse DNS
ads.us.e-planning.net
Software
openresty /
Resource Hash
44136fa355b3678a1146ad16f7e8649e94fb4fc21fe77e8310c060f61caaff8a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Wed, 09 Feb 2022 15:36:15 GMT
access-control-allow-credentials
true
server
openresty
content-type
text/plain
content-length
2
x-sid
AMS-602
prebid.1.2.aspx
inv-nets.admixer.net/
42 B
510 B
XHR
General
Full URL
https://inv-nets.admixer.net/prebid.1.2.aspx
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_256_GCM
Server
146.0.227.110 , Ascension Island, ASN29066 (VELIANET-AS velia.net Internetdienste GmbH, DE),
Reverse DNS
Software
nginx /
Resource Hash
c979ffd70003be58ccc574778b78d9303e8b5b3494a6cdeb01449d65a5a815e6
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Date
Wed, 09 Feb 2022 15:36:15 GMT
Server
nginx
P3p
CP="NID DSP ALL COR"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/javascript; charset=utf-8
Keep-Alive
timeout=25
Content-Length
42
X-Xss-Protection
0
cygnus
htlb.casalemedia.com/
38 B
335 B
XHR
General
Full URL
https://htlb.casalemedia.com/cygnus?s=356568&v=7.2&ac=j&sd=1&r=%7B%22id%22%3A%2214659d49e51b5bf6%22%2C%22site%22%3A%7B%22page%22%3A%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten%22%7D%2C%22ext%22%3A%7B%22source%22%3A%22prebid%22%2C%22ixdiag%22%3A%7B%22msd%22%3A4%2C%22msi%22%3A4%2C%22mfu%22%3A0%2C%22bu%22%3A4%2C%22iu%22%3A0%2C%22nu%22%3A0%2C%22ou%22%3A0%2C%22allu%22%3A4%2C%22ren%22%3Afalse%2C%22version%22%3A%226.7.0-pre%22%2C%22userIds%22%3A%5B%22pubcid%22%5D%7D%7D%2C%22imp%22%3A%5B%7B%22id%22%3A%2214718c9686b8f547%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A970%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22970x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%22149cdfe13a3292ee%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%22151503be55e9c217%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%2C%7B%22id%22%3A%2215350c22032596ad%22%2C%22banner%22%3A%7B%22topframe%22%3A1%2C%22format%22%3A%5B%7B%22w%22%3A300%2C%22h%22%3A250%2C%22ext%22%3A%7B%22siteID%22%3A%22356568%22%2C%22sid%22%3A%22300x250%22%7D%7D%5D%7D%7D%5D%2C%22at%22%3A1%2C%22user%22%3A%7B%22eids%22%3A%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%2227248500-09db-46fe-83fe-d89b65c9ccbf%22%7D%5D%7D%5D%7D%7D
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
184.31.84.150 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a184-31-84-150.deploy.static.akamaitechnologies.com
Software
Apache /
Resource Hash
c3d877191e310937831329c4187dcf007daed2da46c80d10a8a2daaddf944573

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:15 GMT
x-ak-initial-geo
CC:[DE], RC:[HE], CN:[EU], CIP:[193.27.14.42], XFF:[]
server
Apache
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
x-cs-client-geo
12
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
content-length
38
x-ak-client-geo
12
expires
Wed, 09 Feb 2022 15:36:15 GMT
prebid
ib.adnxs.com/ut/v3/
594 B
1 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.53 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
718.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
e68e18643fdd54d888095309459447a3f8133ff21542d927a1f706b28cd73103
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Date
Wed, 09 Feb 2022 15:36:16 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Connection
keep-alive
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 718.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
X-XSS-Protection
0
Pragma
no-cache
AN-X-Request-Uuid
a08999b0-ebd0-42f5-9a9a-0e192a476a3c
Server
nginx/1.17.9
Vary
Accept-Encoding
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Expires
Sat, 15 Nov 2008 16:00:00 GMT
adjson
ads.betweendigital.com/
2 B
916 B
XHR
General
Full URL
https://ads.betweendigital.com/adjson?t=prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
96.46.186.59 , United States, ASN7979 (SERVERS-COM, US),
Reverse DNS
Software
/
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, max-age=0, must-revalidate
access-control-allow-credentials
true
content-encoding
gzip
vary
Accept-Encoding
content-type
application/json
arj
adtelligent-d.openx.net/w/1.0/
73 B
383 B
XHR
General
Full URL
https://adtelligent-d.openx.net/w/1.0/arj?ju=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&ch=UTF-8&res=1600x1200x24&ifr=false&tz=0&tws=1600x1200&be=1&bc=hb_pb_3.0.3&dddid=ac65b260-d92a-43a0-b262-365b73b14360%2Cf74fbd14-dda1-4f94-bd20-2c5515d05bec%2C38e8fd5a-3973-4bf6-af40-e41ae10d59a6%2C331e7a35-d111-4b89-8fa6-01a4d09c2af9%2Ccb59144d-760d-45ea-a1e5-d1cb3a49ef35&nocache=1644420975350&pubcid=27248500-09db-46fe-83fe-d89b65c9ccbf&schain=1.0%2C1!adtelligent.com%2C283366%2C1%2C%2C%2C&aus=970x90%2C970x250%2C970x415%7C300x600%2C300x250%7C300x600%2C300x250%7C300x600%2C300x250%7C1600x1000&divids=header-ad%2Csidebar-ad%2Csidebar-ad2%2Csidebar-ad3%2Cwallpaper&aucs=%2C%2C%2C%2C&auid=541177132%2C541177132%2C541177132%2C541177132%2C541177132
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
218.64.98.34.bc.googleusercontent.com
Software
OXGW/17.1.0 /
Resource Hash
df6b1c27375c7efe3a718310dd6c4c1ddaf9c7d490676d1c45e63a8403046136

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
gzip
server
OXGW/17.1.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
access-control-allow-origin
https://www.fiercepharma.com
cache-control
private, max-age=0, no-cache
access-control-allow-credentials
true
content-type
application/json
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
79
via
1.1 google
expires
Mon, 26 Jul 1997 05:00:00 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=55&alt_size_ids=57&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=27248500-09db-46fe-83fe-d89b65c9ccbf%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=ac65b260-d92a-43a0-b262-365b73b14360&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.8117917916163797
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
2602:803:c004:200::140 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
214eb043836a368acf8ba599f8897635e22abc287eea8dcf1a604e94705f99af

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=27248500-09db-46fe-83fe-d89b65c9ccbf%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=f74fbd14-dda1-4f94-bd20-2c5515d05bec&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.8068087006856186
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
2602:803:c004:200::140 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
d7fe96e3d0d091c9247d31961fda1a8d6f3d38e36aefe8fac5522fe23ba0d980

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=27248500-09db-46fe-83fe-d89b65c9ccbf%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=38e8fd5a-3973-4bf6-af40-e41ae10d59a6&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.4102148303523139
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
2602:803:c004:200::140 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
8a87de3f76390638e4abd3c39bae456c0f07a21852d0766757027aa551029bf4

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
260 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=12398&site_id=48990&zone_id=1998744&size_id=15&alt_size_ids=10&rp_schain=1.0,1!luponmedia.com,1994122,1,,,&eid_pubcid.org=27248500-09db-46fe-83fe-d89b65c9ccbf%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=331e7a35-d111-4b89-8fa6-01a4d09c2af9&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.6090220494085701
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
2602:803:c004:200::140 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
2cd5a634b928f0bcac26a04ed4f614c3d175c2bca315931d0a0e34dba7d40022

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
260
Expires
Wed, 17 Sep 1975 21:32:10 GMT
prebid
prebid.media.net/rtb/
1 KB
874 B
XHR
General
Full URL
https://prebid.media.net/rtb/prebid?cid=8CUO2I9ST
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.107.148.139 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
139.148.107.34.bc.googleusercontent.com
Software
nginx /
Resource Hash
3a497793fee623b6972f91c3794cb3c2ec50863e5705197cf77f09d0a3f8700d

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
gzip
server
nginx
content-type
application/json;charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
via
1.1 google
prebid
ads.yieldmo.com/exchange/
0
229 B
XHR
General
Full URL
https://ads.yieldmo.com/exchange/prebid?pbav=6.7.0-pre&p=%5B%7B%22placement_id%22%3A%22header-ad%22%2C%22callback_id%22%3A%22191b274e21643985%22%2C%22sizes%22%3A%5B%5B970%2C90%5D%2C%5B970%2C250%5D%2C%5B970%2C415%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad%22%2C%22callback_id%22%3A%22192b0c7fea4e0823%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad2%22%2C%22callback_id%22%3A%2219371401ee7e6064%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22sidebar-ad3%22%2C%22callback_id%22%3A%22194ec5a665bbbcd8%22%2C%22sizes%22%3A%5B%5B300%2C600%5D%2C%5B300%2C250%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%2C%7B%22placement_id%22%3A%22wallpaper%22%2C%22callback_id%22%3A%221954468ddb2e5d77%22%2C%22sizes%22%3A%5B%5B1600%2C1000%5D%5D%2C%22ym_placement_id%22%3A%222926956988749259211%22%7D%5D&page_url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bust=1644420975369&dnt=false&description=Mavacamten%20could%20be%20BMS%27%20next%20big%20cardiovascular%20asset%20when%20Pfizer-shared%20blood%20thinner%20Eliquis%20falls%20off%20the%20patent%20cliff.&userConsent=%7B%22gdprApplies%22%3A%22%22%2C%22cmp%22%3A%22%22%7D&us_privacy=&pr=&scrd=1&title=8.%20Mavacamten%20%7C%20FiercePharma&w=1600&h=1200&pubcid=27248500-09db-46fe-83fe-d89b65c9ccbf&schain=%7B%22ver%22%3A%221.0%22%2C%22complete%22%3A1%2C%22nodes%22%3A%5B%7B%22asi%22%3A%22mediafuse.com%22%2C%22sid%22%3A%22358%22%2C%22hp%22%3A1%7D%5D%7D&eids=%5B%7B%22source%22%3A%22pubcid.org%22%2C%22uids%22%3A%5B%7B%22id%22%3A%2227248500-09db-46fe-83fe-d89b65c9ccbf%22%2C%22atype%22%3A1%7D%5D%7D%5D
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
108.128.129.221 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-108-128-129-221.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
pragma
no-cache
date
Wed, 09 Feb 2022 15:36:16 GMT
access-control-allow-credentials
true
x-robots-tag
none,NOINDEX,NOFOLLOW
access-control-allow-methods
POST, GET, OPTIONS
access-control-request-headers
Cache-Control, Pragma
translator
hbopenbid.pubmatic.com/
0
64 B
XHR
General
Full URL
https://hbopenbid.pubmatic.com/translator?source=prebid-client
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
185.64.189.112 , United Kingdom, ASN62713 (AS-PUBMATIC, US),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Wed, 09 Feb 2022 15:36:15 GMT
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
c
prebid.a-mo.net/a/
0
352 B
XHR
General
Full URL
https://prebid.a-mo.net/a/c
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
147.75.61.140 Ashburn, United States, ASN54825 (PACKET, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

access-control-allow-origin
https://www.fiercepharma.com
date
Wed, 09 Feb 2022 15:36:15 GMT
cache-control
max-age=0, private, must-revalidate
access-control-allow-credentials
true
server
envoy
x-envoy-upstream-service-time
222
vary
origin, Accept-Encoding
adreq
ads.servenobid.com/
728 B
641 B
XHR
General
Full URL
https://ads.servenobid.com/adreq?cb=554
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
34.246.73.139 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-34-246-73-139.eu-west-1.compute.amazonaws.com
Software
/
Resource Hash
31276869d30c774c8586d3b32d9b201305a54f20c5485989bcb7b4b5b325523e

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
gzip
amp-access-control-allow-source-origin
*
vary
accept-encoding
content-type
application/json
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
AMP-Access-Control-Allow-Source-Origin
cache-control
no-store, no-cache, must-revalidate, proxy-revalidate, max-age=0
access-control-allow-credentials
true
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44ae0500ac&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
11deb28a4524b9d4bd50c4d9b94517da3d65f5d48b97936a16601f249997256e

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
296 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44ad1a00b1&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
cc2e4a34af50586abe02130814d802cd780ad32aa3887a1ee45f8bb770c5a6f3

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
2599ef87d405215e58d5238192ad43c00a11d1d6573748e53d9d5e9cdd4fb69e

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
b14271ff449b856458b6129c9f84175133123ca8b791f7f5e62ac31ba01fdbd1

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
8d10f6ce316930cf45b84e2456df8968331e1ca4e38978429af08f7af2ca34cb

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
76ccc04c701c26cf4be119afb8c6d25de293a048b365d02ad13929896fe810f7

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
01068f9cba4d0d339f8ad59c1ae00fd52d78c2cf5364af716235f23fc6957dcd

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
ef2ec9bea4910625ea3a888ba7195c96c756b8bce42b354428687cbf3ab68a1c

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a9690f1017575bc3e53bd44a8a300aa&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
f3545469456497f0663f376c3e4b890e48978664b219726fe5bbc8e9d0c1ff55

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a96940d017575bc4351bd15f652001f&pos=8a969d82017575bc3922bd44aa6300b0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
a587a3034a09f0d6babe8eb21d7190520dbfe56dc145b8a60566717e998e19f8

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
bidRequest
c2shb.ssp.yahoo.com/
62 B
92 B
XHR
General
Full URL
https://c2shb.ssp.yahoo.com/bidRequest?dcn=8a9690f1017575bc3e53bd15f72c001b&pos=8a96940d017575bc4351bd44a97500c0&cmd=bid&secure=1
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
18.156.195.47 Frankfurt am Main, Germany, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-18-156-195-47.eu-central-1.compute.amazonaws.com
Software
ATS/9.1.0.33 /
Resource Hash
afd648ea748205a466639c1cd7040ff0e829aabbeb4ccd8400a885b31af1577b

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
ATS/9.1.0.33
age
0
vary
Origin, Access-Control-Request-Method, Access-Control-Request-Headers
access-control-allow-methods
POST,GET,HEAD,OPTIONS
content-type
application/json;charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
content-length
62
/
ghb.adtelligent.com/v2/auction/
1 KB
596 B
XHR
General
Full URL
https://ghb.adtelligent.com/v2/auction/
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a06:8640:799:0:ec4:7aff:fe6e:a48e Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
de5bf431b97e5c74638b8a316c20221bbeafa44163e1d2b42c6ad6272dab585a

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Date
Wed, 09 Feb 2022 15:36:14 GMT
Content-Encoding
gzip
Server
VertaMedia 1.0
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Content-Length
301
prebid
prebid.deepintent.com/
0
235 B
XHR
General
Full URL
https://prebid.deepintent.com/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
169.197.150.8 , United States, ASN398989 (DEEPINTENT, US),
Reverse DNS
g.deepintent.com
Software
c /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
application/json

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
c
vary
Origin
access-control-allow-methods
POST, GET, OPTIONS, DELETE
access-control-allow-origin
https://www.fiercepharma.com
access-control-max-age
3600
access-control-allow-credentials
true
access-control-allow-headers
Origin, X-Requested-With, Content-Type, Accept, X-CSRF-TOKEN
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=55&alt_size_ids=57&eid_pubcid.org=27248500-09db-46fe-83fe-d89b65c9ccbf%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=ac65b260-d92a-43a0-b262-365b73b14360&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.14895137454680718
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
2602:803:c004:200::140 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
3e815022c57c9cb286264b5ad269918b6bd033b6bd909097c6344858647dbd93

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=27248500-09db-46fe-83fe-d89b65c9ccbf%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=f74fbd14-dda1-4f94-bd20-2c5515d05bec&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.24568117602713246
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
2602:803:c004:200::140 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
6e2590037b7b53ca77ec81a22ba7b625faced087f59acf36fc16feacbde1b5a3

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=27248500-09db-46fe-83fe-d89b65c9ccbf%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=38e8fd5a-3973-4bf6-af40-e41ae10d59a6&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.3432077537747895
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
2602:803:c004:200::140 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
3f7baf3092e271a823162024f6caf312882415966256a96c9807ef4c7f44b90f

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
fastlane.json
fastlane.rubiconproject.com/a/api/
261 B
1 KB
XHR
General
Full URL
https://fastlane.rubiconproject.com/a/api/fastlane.json?account_id=17184&site_id=163630&zone_id=2126352&size_id=15&alt_size_ids=10&eid_pubcid.org=27248500-09db-46fe-83fe-d89b65c9ccbf%5E1&rf=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&tk_flint=pbjs_lite_v6.7.0-pre&x_source.tid=331e7a35-d111-4b89-8fa6-01a4d09c2af9&p_screen_res=1600x1200&rp_secure=1&rp_maxbids=1&slots=1&rand=0.8388036189196644
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_256_GCM
Server
2602:803:c004:200::140 Frankfurt am Main, Germany, ASN26667 (RUBICONPROJECT, US),
Reverse DNS
Software
nginx/1.16.0 /
Resource Hash
db4430945c6a32da0ecb792310d3d4c7f2fdf4207d59755bb91e3a55608ef380

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
Server
nginx/1.16.0
Vary
Accept-Encoding
P3P
CP="NOI CURa ADMa DEVa TAIa OUR BUS IND UNI COM NAV INT"
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-cache, no-store, max-age=0, must-revalidate
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json
Content-Length
261
Expires
Wed, 17 Sep 1975 21:32:10 GMT
/
colossusssp.com/
2 B
247 B
XHR
General
Full URL
https://colossusssp.com/?c=o&m=multi
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, RSA, AES_128_CBC
Server
8.2.111.126 , United States, ASN46636 (NATCOWEB, US),
Reverse DNS
Software
nginx /
Resource Hash
4f53cda18c2baa0c0354bb5f9a3ecbe5ed12ab4d8e11ba873c2f11161202b945

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Wed, 09 Feb 2022 15:36:15 GMT
Access-Control-Allow-Credentials
true
Server
nginx
Connection
keep-alive
Content-Length
2
Content-Type
application/json
prebid
ib.adnxs.com/ut/v3/
15 KB
8 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.53 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
718.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
55650a4d15e2975a2aee791f76d6655ee31fe38c7a7c1795379acf6280a27474
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Date
Wed, 09 Feb 2022 15:36:15 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Connection
keep-alive
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 718.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
X-XSS-Protection
0
Pragma
no-cache
AN-X-Request-Uuid
dc365ab1-35cb-40ff-96e8-fc245eb4266b
Server
nginx/1.17.9
Vary
Accept-Encoding
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/
18 B
317 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=34&wv=6.7.0-pre&cb=95571141959
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
ad6aa18e132c373e6a0be7543103d4e5dfde8680587cea250550686591419910
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
gzip
server
Finatra
vary
Origin
content-type
application/json; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
content-length
44
ortb
bid.contextweb.com/header/
0
572 B
XHR
General
Full URL
https://bid.contextweb.com/header/ortb?src=prebid
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
198.148.27.134 New York, United States, ASN19189 (PULSEPOINT, US),
Reverse DNS
Software
envoy /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
envoy
cwdl
22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148,22/148
access-control-allow-origin
https://www.fiercepharma.com
access-control-expose-headers
Access-Control-Allow-Origin
access-control-allow-credentials
true
x-envoy-upstream-service-time
6
cw-server
bid-deployment-66f4d6749f-jsmh4
integrator.js
adservice.google.de/adsid/
107 B
792 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:82a::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
549 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:811::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
11 KB
5 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2693454102022840&correlator=2162068562117899&output=ldjh&impl=fifs&eid=44752540&vrg=2022020301&ptt=17&sc=1&sfv=1-0-38&ecs=20220209&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cspecialreports&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=1x1%2C1x1%2C1x1%2C1x1&ists=15&prev_scp=pos%3D4%26hb_rfBid%3D0%7Cpos%3D7%26hb_rfBid%3D0%7Cpos%3D9%26hb_rfBid%3D0%7Cpos%3D8%26hb_rfBid%3D0&eri=1&cust_params=section%3DSpecial%2520Reports%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D518311%26fm-tester%3Dundefined%26topic%3Dcardiovascular%2520disease%252C%2520drug%2520launch%26keyword%3DBristol%2520Myers%2520Squibb%252C%2520mavacamten%26tag%3DBristol%2520Myers%2520Squibb%252C%2520mavacamten%252Ccardiovascular%2520disease%252C%2520drug%2520launch%252CSpecial%2520Reports%26path%3D%252Fspecial-report%252F10-most-anticipated-drug-launches-2022-8-mavacamten%26browserLargerThan1460%3D1&cookie_enabled=1&bc=31&abxe=1&dt=1644420975441&lmt=1644420920&dlt=1644420973930&idt=589&frm=20&biw=1600&bih=1200&oid=2&adxs=200%2C-12245933%2C800%2C262&adys=24%2C-12245933%2C2979%2C1155&adks=788811237%2C3513369560%2C376738169%2C326019841&ucis=1%7C2%7C3%7C4&ifi=1&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&dmc=8&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&vis=1&scr_x=0&scr_y=0&psz=1200x0%7C1200x0%7C1600x0%7C710x0&msz=1200x0%7C0x0%7C1600x0%7C710x0&ga_vid=1143913336.1644420975&ga_sid=1644420975&ga_hid=1001435911&ga_fc=true&fws=0%2C128%2C0%2C0&ohw=0%2C0%2C0%2C0&btvi=0%7C-1%7C1%7C0&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0.&nvt=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
921157a23adbe289a21edac175a6d0cb133718d2e72924615fe394b85d4384ad
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
4652
x-xss-protection
0
google-lineitem-id
4686405525,5884413056,-2,-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138234349545,138379391253,-2,-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
container.html
73a3e8657f23645a3dbd8f1241c4efa7.safeframe.googlesyndication.com/safeframe/1-0-38/html/ Frame 73EE
6 KB
4 KB
Document
General
Full URL
https://73a3e8657f23645a3dbd8f1241c4efa7.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:808::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a73730123a43c3040d889aaee11ec35094277ce5f778076b262c23a293870adb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
content-type
text/html
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
timing-allow-origin
*
content-length
3108
date
Wed, 09 Feb 2022 15:36:15 GMT
expires
Thu, 09 Feb 2023 15:36:15 GMT
cache-control
public, immutable, max-age=31536000
last-modified
Tue, 02 Mar 2021 20:17:03 GMT
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
prebid
ib.adnxs.com/ut/v3/ Frame D0E0
11 KB
6 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.53 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
718.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
09bb04d25407038888ef37f3c739b03c83ebf20160dc5fdc83b1df2140fa1cef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Date
Wed, 09 Feb 2022 15:36:15 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Connection
keep-alive
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 718.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
X-XSS-Protection
0
Pragma
no-cache
AN-X-Request-Uuid
eeceeadf-4525-4396-83f7-836e5926eb10
Server
nginx/1.17.9
Vary
Accept-Encoding
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://p.annocdn.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/ Frame D0E0
0
214 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=95126311114
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
Finatra
vary
Origin
access-control-allow-origin
https://p.annocdn.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
prebid-request
onetag-sys.com/ Frame D0E0
15 B
360 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://p.annocdn.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame D0E0
0
175 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS
ip-185-184-8-65.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://p.annocdn.com
date
Wed, 09 Feb 2022 15:36:15 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/ Frame D0E0
0
0

prebid
ib.adnxs.com/ut/v3/ Frame D0E0
11 KB
6 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.53 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
718.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
b8622074b16d1c3f1770d3de3b7b24dc55e82eaa19dbea85a75c87d593f6756c
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Date
Wed, 09 Feb 2022 15:36:15 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Connection
keep-alive
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 718.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
X-XSS-Protection
0
Pragma
no-cache
AN-X-Request-Uuid
496c2379-a6d1-4bc9-80d8-37abdc771ad1
Server
nginx/1.17.9
Vary
Accept-Encoding
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://p.annocdn.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/ Frame D0E0
0
214 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=42993221513
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
server
Finatra
vary
Origin
access-control-allow-origin
https://p.annocdn.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
prebid-request
onetag-sys.com/ Frame D0E0
15 B
360 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://p.annocdn.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame D0E0
0
175 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS
ip-185-184-8-65.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://p.annocdn.com
date
Wed, 09 Feb 2022 15:36:15 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/ Frame D0E0
0
0

prebid
ib.adnxs.com/ut/v3/ Frame D0E0
145 B
1 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.53 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
718.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
e01651b2b77e6ef647abec1936807ac6b6de4a69b732728c8d54c6155289ce15
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 718.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
765f2dd0-22d9-4a46-bba8-4129912ac5bd
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://p.annocdn.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
145
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/ Frame D0E0
0
214 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=36657345586
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
server
Finatra
vary
Origin
access-control-allow-origin
https://p.annocdn.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
prebid-request
onetag-sys.com/ Frame D0E0
15 B
360 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://p.annocdn.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame D0E0
0
175 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS
ip-185-184-8-65.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://p.annocdn.com
date
Wed, 09 Feb 2022 15:36:15 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/ Frame D0E0
0
0

prebid
ib.adnxs.com/ut/v3/ Frame D0E0
11 KB
6 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.53 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
718.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
ba87536ccdab0308e5d15de4386d265c36fe3b686770ebdc18de8562a14581c5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Date
Wed, 09 Feb 2022 15:36:15 GMT
Content-Encoding
gzip
Transfer-Encoding
chunked
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Connection
keep-alive
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 718.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
X-XSS-Protection
0
Pragma
no-cache
AN-X-Request-Uuid
05dd1056-7d02-42de-a5eb-fed859b0374e
Server
nginx/1.17.9
Vary
Accept-Encoding
Content-Type
application/json; charset=utf-8
Access-Control-Allow-Origin
https://p.annocdn.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/ Frame D0E0
0
214 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=8046419026
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
Finatra
vary
Origin
access-control-allow-origin
https://p.annocdn.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
prebid-request
onetag-sys.com/ Frame D0E0
15 B
360 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://p.annocdn.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame D0E0
0
175 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS
ip-185-184-8-65.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://p.annocdn.com
date
Wed, 09 Feb 2022 15:36:15 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/ Frame D0E0
0
0

prebid
ib.adnxs.com/ut/v3/ Frame D0E0
145 B
1 KB
XHR
General
Full URL
https://ib.adnxs.com/ut/v3/prebid
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.53 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
718.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
f8a6c46ad2f2902d926522538be15d918f7bd19f00059c60dea12c7d621a4c33
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:15 GMT
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 718.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
73f83910-583d-4cf9-ae06-01f0f0eb0baa
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
https://p.annocdn.com
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
application/json; charset=utf-8
Content-Length
145
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
cdb
bidder.criteo.com/ Frame D0E0
0
214 B
XHR
General
Full URL
https://bidder.criteo.com/cdb?profileId=207&av=31&wv=3.22&cb=13762410747
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.0.165 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
bidder.par.vip.prod.criteo.com
Software
Finatra /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Wed, 09 Feb 2022 15:36:14 GMT
server
Finatra
vary
Origin
access-control-allow-origin
https://p.annocdn.com
access-control-allow-credentials
true
cross-origin-resource-policy
cross-origin
strict-transport-security
max-age=31536000; preload;
timing-allow-origin
*
prebid-request
onetag-sys.com/ Frame D0E0
15 B
360 B
XHR
General
Full URL
https://onetag-sys.com/prebid-request
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
663dab1310a7e64c3bdd7dfdc81b7fc9a28884d4ee290b96077c7b32bbe84707
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

strict-transport-security
max-age=15552000
content-encoding
gzip
p3p
CP='CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR'
access-control-allow-origin
https://p.annocdn.com
cache-control
no-transform, no-cache
access-control-allow-credentials
true
content-type
application/json
access-control-allow-headers
content-type, origin, referer, user-agent
content-length
41
bids
prebid-eu.creativecdn.com/bidder/prebid/ Frame D0E0
0
175 B
XHR
General
Full URL
https://prebid-eu.creativecdn.com/bidder/prebid/bids
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
185.184.8.65 Amsterdam, Netherlands, ASN204995 (RTB-HOUSE-AMS, PL),
Reverse DNS
ip-185-184-8-65.rtbhouse.net
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

access-control-allow-origin
https://p.annocdn.com
date
Wed, 09 Feb 2022 15:36:15 GMT
access-control-allow-credentials
true
access-control-max-age
3600
vary
Origin
access-control-allow-methods
POST
auction
rtb.adxpremium.services/openrtb2/ Frame D0E0
0
0

csyncs
ghb.hbmp.mediafuse.com/
441 B
578 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/csyncs?aid1=535746&aid2=535749&aid3=undefined
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456783/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a06:8640:799:0:ec4:7aff:fe6e:a48e Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
8511f98206804fb8c0075966c6b5d03399d359e87c22aa0a4285ed906fdeffe0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:14 GMT
Content-Encoding
gzip
Server
VertaMedia 1.0
Content-Type
application/json; charset=UTF-8
Access-Control-Allow-Origin
https://www.fiercepharma.com
Access-Control-Allow-Credentials
true
Connection
Keep-Alive
Content-Length
283
7c3.js
sync.medidexs.com/ps/10/
57 KB
21 KB
Script
General
Full URL
https://sync.medidexs.com/ps/10/7c3.js
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456783/hbw_master_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
45.133.44.4 Philadelphia, United States, ASN39572 (ADVANCEDHOSTERS-AS, NL),
Reverse DNS
Software
nginx /
Resource Hash
baf0ab84c1595ad02bf60b1d84cb1f271fd13486fd76dc599ec425f0c91c65be

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
gzip
last-modified
Mon, 07 Feb 2022 10:35:22 GMT
server
nginx
etag
W/"6200f5ea-e3ef"
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=3600
expires
Wed, 09 Feb 2022 16:36:15 GMT
170
a.ad.gt/api/v1/u/matches/
3 KB
4 KB
Script
General
Full URL
https://a.ad.gt/api/v1/u/matches/170
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456783/hbw_master_302826_6936.js
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
44.238.59.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-44-238-59-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
89320af38c64416cbf3066639ebae44c899e8aa3c1eb9b5ce90cf1f6acca884d

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
server
nginx/1.18.0
content-length
3409
content-type
application/javascript
init-1016mnvd6jvjr44ajs9g.js
api.fouanalytics.com/api/
471 B
933 B
Script
General
Full URL
https://api.fouanalytics.com/api/init-1016mnvd6jvjr44ajs9g.js
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456783/hbw_master_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:3036::ac43:c834 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
1f30149084231d745a766c327b90836c15c312e5fef041ea855bc08c04d46845

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
br
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=92gX1MdLx19%2Fa6LXYbFyO%2BxdxFef8SCvEEgEBQZkcL%2FaCfmE089wyWBAchEW9IE7ldoYHHTqk40Y1MoBVI%2F0c%2BSVc%2F3Eqgh%2FdF7%2B56nU1YVMlytkgLjrCWK7yqmQcX7YUTsaor7odbAV0%2FRWxtTSni2BYg%3D%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript
cache-control
no-cache, no-store, must-revalidate
cf-ray
6dae2c190f8c5c50-FRA
alt-svc
h3=":443"; ma=86400, h3-29=":443"; ma=86400
expires
0
olytics
oqs.omeda.com/oqs/rest/ Frame
0
0
Preflight
General
Full URL
https://oqs.omeda.com/oqs/rest/olytics
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.165 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

X-Frame-Options
SAMEORIGIN
X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
Access-Control-Max-Age
600
Access-Control-Allow-Origin
*
Access-Control-Allow-Headers
Access-Control-Request-Headers, Content-Type, Origin, Accept, Accept-Encoding, Accept-Language, HOST, User-Agent, Access-Control-Request-Method, Access-Control-Max-Age
Content-Type
text/plain
Content-Length
0
Date
Wed, 09 Feb 2022 15:36:16 GMT
Server
Apache
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
etag
14069902871804803999
vary
Accept-Encoding, Origin
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
private, max-age=3600
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
text/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
expires
Wed, 09 Feb 2022 15:36:15 GMT
olytics
oqs.omeda.com/oqs/rest/
15 B
307 B
XHR
General
Full URL
https://oqs.omeda.com/oqs/rest/olytics
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.165 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
2edaa30d4700e9c64439fd90cba328cf7eeb1177cbf7b7e26520266bb75d724d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
application/json

Response headers

Date
Wed, 09 Feb 2022 15:36:15 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
index.php
a.dpmsrv.com/dpmpxl/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=1521003946560112395&pixelIndex=0&_=1644420974555
  • https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm=&ap_id=1521003946560112395&pixelIndex=0&_=1644420974555&google_tc=
  • https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=1521003946560112395&pixelIndex=0&_=1644420974555&google_gid=CAESEH3UP3-ablTWNzH6x_PCjhM&google_cver=1
0
597 B
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=1521003946560112395&pixelIndex=0&_=1644420974555&google_gid=CAESEH3UP3-ablTWNzH6x_PCjhM&google_cver=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Server
3.226.203.17 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-226-203-17.compute-1.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Pragma
no-cache
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
0
Expires
0

Redirect headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:15 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=1521003946560112395&pixelIndex=0&_=1644420974555&google_gid=CAESEH3UP3-ablTWNzH6x_PCjhM&google_cver=1
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
368
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
423396.gif
idsync.rlcdn.com/
0
66 B
Image
General
Full URL
https://idsync.rlcdn.com/423396.gif?partner_uid=1521003946560112395
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
35.244.174.68 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
68.174.244.35.bc.googleusercontent.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
via
1.1 google
alt-svc
clear
content-length
0
universal-tag.js
ads.spotible.com/tag/ Frame 1CF7
0
0

truncated
/ Frame 1CF7
213 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
ef761cea5f205e1db0fc0228f27c763264c3bd343f23ab89e9bb1b3d3c86494b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Content-Type
image/png
allstream.js
creative.spotible.com/tag/ Frame BCD1
4 KB
2 KB
Script
General
Full URL
https://creative.spotible.com/tag/allstream.js
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.215.243.168 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-215-243-168.compute-1.amazonaws.com
Software
/
Resource Hash
13b3e0ebce53b1bad544de9ab941325c97244335a255d701f964667fdcec7e12

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
cache-control
public, max-age=3600
content-encoding
gzip
etag
"13d60a009d7a4ed35e01731ee02c2db7"
vary
accept-encoding
content-type
application/javascript
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644420974057%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420974060%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420974061%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644420974062%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A15%2B00%3A00&callback=bc_json575
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.112.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-112-18.fra56.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

1px-matching-adtelligent.gif
t.trafmag.com/images/images/
Redirect Chain
  • https://sync.adtelligent.com/csync?&redir=https%3A%2F%2Ft.trafmag.com%2Fimages%2Fimages%2F1px-matching-adtelligent.gif%3Fid%3D%7Buid%7D
  • https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=f4b0d7c034dd141c
35 B
351 B
Image
General
Full URL
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=f4b0d7c034dd141c
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Server
193.200.65.5 Amsterdam, Netherlands, ASN6681 (GIVEME-CLOUD, PL),
Reverse DNS
t.trafmag.com
Software
nginx /
Resource Hash
6adc3d4c1056996e4e8b765a62604c78b1f867cceb3b15d0b9bedb7c4857f992

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:17 GMT
Server
nginx
Connection
keep-alive
Content-Type
image/gif
Content-Length
35
P3P
CP="NON DSP COR CURa TIA"

Redirect headers

Location
https://t.trafmag.com/images/images/1px-matching-adtelligent.gif?id=f4b0d7c034dd141c
Date
Wed, 09 Feb 2022 15:36:16 GMT
Server
VertaMedia 1.0
Etag
f4b0d7c034dd141c
Content-Length
0
match
dm.hybrid.ai/
0
238 B
Image
General
Full URL
https://dm.hybrid.ai/match?id=186&burl=https%3A%2F%2Fsync.adtelligent.com%2Fcsync%3Ft%3Da%26ep%3D324902%26extuid%3D%24%7BVID%7D
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
37.18.16.23 , Netherlands, ASN205675 (HYBRID-AS, RU),
Reverse DNS
Software
Hybrid Web Server /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:15 GMT
server
Hybrid Web Server
p3p
CP="NOI DSP COR CUR ADMa DEVo TAIo PSAo PSDo IVAo IVDo OUR IND COM NAV INT STA OTC"
access-control-allow-origin
*
cache-control
no-cache, no-store
x-mode
102
x-xss-protection
1; mode=block
expires
-1
gpt.js
www.googletagservices.com/tag/js/
0
0
Fetch
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
sffe
etag
"1126 / 521 of 1000 / last-modified: 1644408561"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
x-xss-protection
0
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Wed, 09 Feb 2022 15:36:15 GMT
pp.js
api-54-245-167-10.b2c.com/s/
13 KB
5 KB
Script
General
Full URL
https://api-54-245-167-10.b2c.com/s/pp.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:623 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
4f999f96da9bb7bd681b62c42ef5e5e2c9d80896b8aafa4a030279c0d05ea674

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
content-encoding
br
cf-cache-status
HIT
last-modified
Mon, 03 Jan 2022 15:12:15 GMT
server
cloudflare
age
3255
etag
W/"61d3124f-3346"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=sY1uDra0jvIlp4LC712uZcImUiISUylRBH%2B%2FCB%2FsoFzmBbU0kTXshAf913t7ycvXX%2FBuInlIKv%2FNFP1gTh3BkkNkBxz0X3MBPgasxDpay2j0hNhA0SWXOjPfLeJ6Gxl9N4ZFAKN212566udRX9RWRQwAupNPJYQ%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/javascript
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
cf-ray
6dae2c1acdb283be-MXP
ad.gif
api-54-245-167-10.b2c.com/s/
43 B
380 B
Image
General
Full URL
https://api-54-245-167-10.b2c.com/s/ad.gif
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2606:4700:20::681a:623 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software
cloudflare /
Resource Hash
dcecab1355b5c2b9ecef281322bf265ac5840b4688748586e9632b473a5fe56b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
cf-cache-status
HIT
last-modified
Mon, 03 Jan 2022 15:12:15 GMT
server
cloudflare
age
3251
etag
"61d3124f-2b"
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary
Accept-Encoding
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=zkrkQo%2FJBJ2LRmJYzuHFUqfpessSdbgfMN1FnXyUqPNMz1f4%2BcflRtUFLsFLt%2FYpAQjymxYmuBMYNwVYZEvMin8gCDfQoLquqBDZ1EKNb4VKuSa97A082hV0P5BJg1AwKwX6RcfGFdina7myxhVFd9U%2FbHCDOCk%3D"}],"group":"cf-nel","max_age":604800}
content-type
text/plain; charset=utf-8
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
accept-ranges
bytes
cf-ray
6dae2c1b5f3e83be-MXP
content-length
43
storage-delegate.html
creative.spotible.com/tag/ Frame 392B
581 B
498 B
Document
General
Full URL
https://creative.spotible.com/tag/storage-delegate.html
Requested by
Host: creative.spotible.com
URL: https://creative.spotible.com/tag/allstream.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.215.243.168 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-215-243-168.compute-1.amazonaws.com
Software
/
Resource Hash
3560bdf6b103e68c5e0aa13507ad74e7e2ced19d36257d4f7685e121fa4fa30d

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

etag
"60fdf8d946db5045a34df20232ae250b"
cache-control
public, max-age=3600
vary
accept-encoding
content-encoding
gzip
content-type
text/html
date
Wed, 09 Feb 2022 15:36:15 GMT
delivery.js
creative.spotible.com/creative/f4mq/
75 KB
25 KB
Script
General
Full URL
https://creative.spotible.com/creative/f4mq/delivery.js?referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten
Requested by
Host: creative.spotible.com
URL: https://creative.spotible.com/tag/allstream.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.215.243.168 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-215-243-168.compute-1.amazonaws.com
Software
/
Resource Hash
3b55576d98b685a677e2214f18b0c5942a91b6271ab4c1dd189a3e9968dcdfb3

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
cache-control
no-cache
content-encoding
gzip
etag
"9ffe3350db9d596ddb5afabfa2969d65"
vary
accept-encoding
content-type
application/javascript;charset=utf-8
haloid
aufp.io/api/v1/
6 KB
3 KB
Script
General
Full URL
https://aufp.io/api/v1/haloid
Requested by
Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.35.70.100 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-35-70-100.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
85e50082d7ce113bfa87dbade18dbf747d1bacfcffdbd628296dcffa98a08f94

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:16 GMT
content-encoding
gzip
last-modified
Wed, 02 Feb 2022 00:28:16 GMT
server
nginx/1.18.0
etag
W/"1643761696.0-6132-2958560116"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
access-control-allow-origin
*, *
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
cache-control
public, max-age=43200
origin-trial
A/KTxPuSXtwcggydvUxw5B4dXspsb2iweedc7KDi2xv9M89MtnOpULTs7DQJVHBxGDV5wj5a3LW9S4ev3WfQkwIAAAB+eyJvcmlnaW4iOiJodHRwczovL2hhbG9mbG9jLmNvbTo0NDMiLCJmZWF0dXJlIjoiSW50ZXJlc3RDb2hvcnRBUEkiLCJleHBpcnkiOjE2MjYyMjA3OTksImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
expires
Thu, 10 Feb 2022 03:36:16 GMT
170
p.ad.gt/api/v1/p/
26 KB
8 KB
Script
General
Full URL
https://p.ad.gt/api/v1/p/170
Requested by
Host: a.ad.gt
URL: https://a.ad.gt/api/v1/u/matches/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
44.236.205.19 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-44-236-205-19.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
e6974b62b821dafba979149e0d3dd2d2942c2f49be62d2d2c581c1e2899a9027

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:16 GMT
content-encoding
gzip
last-modified
Wed, 02 Feb 2022 00:25:44 GMT
server
nginx/1.18.0
etag
W/"1643761544.0-26279-2710964840"
access-control-allow-methods
GET, POST, OPTIONS
content-type
application/javascript
access-control-allow-origin
*
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
cache-control
public, max-age=43200
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
expires
Thu, 10 Feb 2022 03:36:16 GMT
match
ids.ad.gt/api/v1/
Redirect Chain
  • https://secure.adnxs.com/getuid?https://ids.ad.gt/api/v1/match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&adnxs_id=$UID
  • https://ids.ad.gt/api/v1/match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&adnxs_id=1521003946560112395
43 B
565 B
Image
General
Full URL
https://ids.ad.gt/api/v1/match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&adnxs_id=1521003946560112395
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:16 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Thu, 10 Feb 2022 03:36:16 GMT

Redirect headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:16 GMT
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 732.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
9c1284ac-ce41-4e8e-9e3b-061512148096
Server
nginx/1.17.9
Access-Control-Allow-Origin
*
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location
https://ids.ad.gt/api/v1/match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&adnxs_id=1521003946560112395
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
t_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://match.adsrvr.org/track/cmf/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
  • https://match.adsrvr.org/track/cmb/generic?ttd_pid=8gkxb6n&ttd_tpi=1&gpdr=0&ttd_puid=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
  • https://ids.ad.gt/api/v1/t_match?tdid=c11d1b10-ea13-4e77-a2d1-20ec64332d28&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
43 B
569 B
Image
General
Full URL
https://ids.ad.gt/api/v1/t_match?tdid=c11d1b10-ea13-4e77-a2d1-20ec64332d28&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:16 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Thu, 10 Feb 2022 03:36:16 GMT

Redirect headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:16 GMT
x-aspnet-version
4.0.30319
p3p
CP="NOI DSP COR CUR ADMo DEVo PSAo PSDo OUR SAMo BUS UNI NAV"
location
https://ids.ad.gt/api/v1/t_match?tdid=c11d1b10-ea13-4e77-a2d1-20ec64332d28&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
cache-control
private,no-cache, must-revalidate
content-type
text/html
content-length
259
pbm_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
  • https://image2.pubmatic.com/AdServer/UCookieSetPug?ird=1&rd=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fpbm_match%3Fpbm%3D%23PM_USER_ID%26id%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
  • https://ids.ad.gt/api/v1/pbm_match?pbm=5FBA7F2A-C28D-4634-958B-689A4440E22D&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
43 B
572 B
Image
General
Full URL
https://ids.ad.gt/api/v1/pbm_match?pbm=5FBA7F2A-C28D-4634-958B-689A4440E22D&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:16 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Thu, 10 Feb 2022 03:36:16 GMT

Redirect headers

location
https://ids.ad.gt/api/v1/pbm_match?pbm=5FBA7F2A-C28D-4634-958B-689A4440E22D&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
date
Wed, 09 Feb 2022 15:36:16 GMT
cache-control
no-store, no-cache, private
server
nginx
p3p
CP="NOI DSP COR LAW CUR ADMo DEVo TAIo PSAo PSDo IVAo IVDo HISo OTPo OUR SAMo BUS UNI COM NAV INT DEM CNT STA PRE LOC"
g_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_cm&google_sc&google_ula=450542624&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
  • https://ids.ad.gt/api/v1/g_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&google_gid=CAESEPpBdfmxhS_Ja7mAPsrE_W8&google_cver=1&google_ula=450542624,0
43 B
571 B
Image
General
Full URL
https://ids.ad.gt/api/v1/g_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&google_gid=CAESEPpBdfmxhS_Ja7mAPsrE_W8&google_cver=1&google_ula=450542624,0
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:16 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Thu, 10 Feb 2022 03:36:16 GMT

Redirect headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:16 GMT
server
HTTP server (unknown)
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location
https://ids.ad.gt/api/v1/g_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&google_gid=CAESEPpBdfmxhS_Ja7mAPsrE_W8&google_cver=1&google_ula=450542624,0
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
text/html; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
357
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
pixel
cm.g.doubleclick.net/
Redirect Chain
  • https://ids.ad.gt/api/v1/g_hosted?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
  • https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=ZDhjMzA0NjEtYmQzZS00YWJmLTllZDYtM2U2YzNmMzVlZjQ5
170 B
188 B
Image
General
Full URL
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=ZDhjMzA0NjEtYmQzZS00YWJmLTllZDYtM2U2YzNmMzVlZjQ5
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Server
142.250.181.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s56-in-f2.1e100.net
Software
HTTP server (unknown) /
Resource Hash
0b8a20373c6dd04e091902226d922b3688143a8938afb9d283d889de7b55ceb5
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:16 GMT
server
HTTP server (unknown)
content-type
image/png
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
170
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT

Redirect headers

location
https://cm.g.doubleclick.net/pixel?google_nid=audigent_w_appnexus_3985&google_hm=ZDhjMzA0NjEtYmQzZS00YWJmLTllZDYtM2U2YzNmMzVlZjQ5
date
Wed, 09 Feb 2022 15:36:16 GMT
server
nginx/1.18.0
content-length
473
content-type
text/html; charset=utf-8
adb_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://dpm.demdex.net/ibs:dpid=348447&dpuuid=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&redir=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fadb_match%3Fadb%3D%24%7BDD_UUID%7D%26id%3Dd8c30461-bd3e-4abf-9ed6-3e6c3...
  • https://dpm.demdex.net/demconf.jpg?et:ibs%7cdata:dpid=348447&dpuuid=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&redir=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fadb_match%3Fadb%3D%24%7BDD_UUID%7D%26id%3Dd8c3046...
  • https://ids.ad.gt/api/v1/adb_match?adb=62058959424908984673071064968801906464&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
43 B
479 B
Image
General
Full URL
https://ids.ad.gt/api/v1/adb_match?adb=62058959424908984673071064968801906464&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:16 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Thu, 10 Feb 2022 03:36:16 GMT

Redirect headers

DCS
dcs-prod-irl1-1-v027-0a1cb48e8.edge-irl1.demdex.com UNKNOWN
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains
X-TID
Kk7ITk34RpM=
P3P
policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Location
https://ids.ad.gt/api/v1/adb_match?adb=62058959424908984673071064968801906464&id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
Cache-Control
no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection
keep-alive
Content-Length
0
Expires
Thu, 01 Jan 1970 00:00:00 UTC
getuid
sync.smartadserver.com/
Redirect Chain
  • https://sync.smartadserver.com/getuid?url=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fsmart_match%3Fid%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49%26sas_uid%3D%5bsas_uid%5d
  • https://sync.smartadserver.com/getuid?url=https://ids.ad.gt/api/v1/smart_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&sas_uid=[sas_uid]&cklb=1
0
75 B
Image
General
Full URL
https://sync.smartadserver.com/getuid?url=https://ids.ad.gt/api/v1/smart_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&sas_uid=[sas_uid]&cklb=1
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Server
185.86.137.133 , France, ASN201081 (SMARTADSERVER, FR),
Reverse DNS
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:15 GMT
content-length
0

Redirect headers

location
https://sync.smartadserver.com:443/getuid?url=https://ids.ad.gt/api/v1/smart_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&sas_uid=[sas_uid]&cklb=1
pragma
no-cache
date
Wed, 09 Feb 2022 15:36:15 GMT
cache-control
no-cache,no-store
content-length
0
p3p
CP="BUS CUR CONo FIN IVDo ONL OUR PHY SAMo TELo"
impr_match
ids.ad.gt/api/v1/
Redirect Chain
  • https://ad.360yield.com/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49%26impr_uid%3D%7BPUB_USER_ID%7D
  • https://ad.360yield.com/ul_cb/ux?&publisher_dmp_id=15&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fimpr_match%3Fid%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49%26impr_uid%3D%7BPUB_USER_ID%7D
  • https://ids.ad.gt/api/v1/impr_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&impr_uid=c9317cb7-bf2e-465e-b7ee-531af9130fae
43 B
484 B
Image
General
Full URL
https://ids.ad.gt/api/v1/impr_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&impr_uid=c9317cb7-bf2e-465e-b7ee-531af9130fae
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:16 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Thu, 10 Feb 2022 03:36:16 GMT

Redirect headers

location
https://ids.ad.gt/api/v1/impr_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&impr_uid=c9317cb7-bf2e-465e-b7ee-531af9130fae
date
Wed, 09 Feb 2022 15:36:16 GMT
access-control-allow-origin
*
content-type
text/plain
content-length
0
p3p
CP="NOI DSP COR NID CURa ADMa DEVa PSAa PSDa OUR BUS COM INT OTC PUR STA"
loading.do
sample.dragonforms.com/ Frame 4E7F
21 KB
6 KB
Document
General
Full URL
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
8908b491dd85cc1882749fa3a8437b09798d2c99ffa145db4f833cfe8d05dc71
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/init.do?omedasite=FiercePharma_short

Response headers

X-Content-Type-Options
nosniff
X-XSS-Protection
1; mode=block
Access-Control-Allow-Origin
*
Content-Type
text/html;charset=ISO-8859-1
Date
Wed, 09 Feb 2022 15:36:16 GMT
Server
Apache
Vary
Accept-Encoding
Content-Encoding
gzip
Transfer-Encoding
chunked
4
v4-api-54-245-167-10.b2c.com/api/
Redirect Chain
  • https://api-54-245-167-10.b2c.com/api/x?UE7uFPxRDktV6qQ8$dXJsJDAkaHR0cHM6Ly93d3cuZmllcmNlcGhhcm1hLmNvbS9zcGVjaWFsLXJlcG9ydC8xMC1tb3N0LWFudGljaXBhdGVkLWRydWctbGF1bmNoZXMtMjAyMi04LW1hdmFjYW10ZW4iLCJy...
  • https://v4-api-54-245-167-10.b2c.com:444/api/4?UE7uFPxRDktV6qQ8
0
141 B
XHR
General
Full URL
https://v4-api-54-245-167-10.b2c.com:444/api/4?UE7uFPxRDktV6qQ8
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Server
54.245.167.10 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-54-245-167-10.us-west-2.compute.amazonaws.com
Software
/
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Access-Control-Allow-Origin
*
Connection
keep-alive
Transfer-Encoding
chunked
Access-Control-Allow-Methods
*

Redirect headers

date
Wed, 09 Feb 2022 15:36:16 GMT
cf-cache-status
DYNAMIC
nel
{"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server
cloudflare
expect-ct
max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
location
https://v4-api-54-245-167-10.b2c.com:444/api/4?UE7uFPxRDktV6qQ8
access-control-allow-methods
*
content-type
text/html
access-control-allow-origin
*
report-to
{"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=xXuMrNwcCE4i1oLTD8kXpQ3vkoXd12MgrL2hiSKED96PlpxSdS8MPmVQ5zq6Xny0sU3%2F194JVEuNX%2Bvu%2F9NGPARGdS1A7BSefxxGPUFo0FE6MzlWrSVsFtZas7w0xSeQCUvRpavs%2F%2BmXOY5VeTY4Rx8IEGRxGqk%3D"}],"group":"cf-nel","max_age":604800}
cf-ray
6dae2c1d1b45375f-MXP
Background%20Fierce-Pharma-DMPK-1920px-x-1080px%20(2)%20(1).png
cdn.spotible.com/creative/f4mq/hashed/ef77ca59cea4edcfcbaa1f13f798bce5/
1 MB
1 MB
Image
General
Full URL
https://cdn.spotible.com/creative/f4mq/hashed/ef77ca59cea4edcfcbaa1f13f798bce5/Background%20Fierce-Pharma-DMPK-1920px-x-1080px%20(2)%20(1).png
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
13.224.228.100 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-228-100.lhr61.r.cloudfront.net
Software
/
Resource Hash
007c0f4a3db37c258bee2fda5e948c3b026b8a078b9758ec1e207ede10362689

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 01:53:55 GMT
via
1.1 74e2a59e06d5b7556eb510403eacd42e.cloudfront.net (CloudFront)
age
49340
etag
"ef77ca59cea4edcfcbaa1f13f798bce5"
x-cache
Hit from cloudfront
content-type
image/png
cache-control
public, max-age=604800
x-amz-cf-pop
LHR61-C2
accept-ranges
bytes
content-length
1495548
x-amz-cf-id
UFZNLUnKsvcRXw8gNGHViAyImnySucJSBQqrdhF0zeZG2Msa22goXw==
Foreground--Fierce-Pharma-DMPK-720px-x-900px%20(2)%20(1).png
cdn.spotible.com/creative/f4mq/hashed/f153bdfb5501ff4c3fa0f84baeedc496/
40 KB
41 KB
Image
General
Full URL
https://cdn.spotible.com/creative/f4mq/hashed/f153bdfb5501ff4c3fa0f84baeedc496/Foreground--Fierce-Pharma-DMPK-720px-x-900px%20(2)%20(1).png
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
13.224.228.100 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-13-224-228-100.lhr61.r.cloudfront.net
Software
/
Resource Hash
0ad339532ae4c77495d2f687f82a50e70d8678eab0afcd60e20135375e77fe2f

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 01:53:55 GMT
via
1.1 74e2a59e06d5b7556eb510403eacd42e.cloudfront.net (CloudFront)
age
49340
etag
"f153bdfb5501ff4c3fa0f84baeedc496"
x-cache
Hit from cloudfront
content-type
image/png
cache-control
public, max-age=604800
x-amz-cf-pop
LHR61-C2
accept-ranges
bytes
content-length
41132
x-amz-cf-id
agfA5lPPnL6gHpv9RBgEn0g-9vic1cpGUp3RX2KcX8lbO51eHFk3PQ==
entity_313b.css
hostedcontent.dragonforms.com/hosted/images/dragon/generic/313/ Frame 4E7F
19 KB
19 KB
Stylesheet
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/generic/313/entity_313b.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
a33614a196d3854d7d068b3d73dca4806956c548d1ae3163bcd8e0b7664a2ed6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 16:36:16 CET
X-Content-Type-Options
nosniff
Last-Modified
Fri, 22 Nov 2019 15:51:34 CET
Server
Apache
ETag
W/"19161-1574434294969"
X-Frame-Options
SAMEORIGIN
Content-Type
text/css
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
jquery-2.2.4.min.js
code.jquery.com/ Frame 4E7F
84 KB
29 KB
Script
General
Full URL
https://code.jquery.com/jquery-2.2.4.min.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2001:4de0:ac18::1:a:3a , Netherlands, ASN20446 (HIGHWINDS3, US),
Reverse DNS
Software
nginx /
Resource Hash
05b85d96f41fff14d8f608dad03ab71e2c1017c2da0914d7c59291bad7a54f8e

Request headers

Referer
https://sample.dragonforms.com/
Origin
https://sample.dragonforms.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:16 GMT
content-encoding
gzip
last-modified
Fri, 20 Aug 2021 17:47:53 GMT
server
nginx
etag
W/"611feac9-14e4a"
vary
Accept-Encoding
x-hw
1644420976.dop212.ml1.t,1644420976.cds221.ml1.hn,1644420976.cds220.ml1.c
content-type
application/javascript; charset=utf-8
access-control-allow-origin
*
cache-control
max-age=315360000, public
accept-ranges
bytes
content-length
29811
conditional.js
sample.dragonforms.com/js/ Frame 4E7F
31 KB
32 KB
Script
General
Full URL
https://sample.dragonforms.com/js/conditional.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
d7993cf613408050b47ca5417eac7f90986d57213211a6b27f7579894e306389
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:16 GMT
X-Content-Type-Options
nosniff
Last-Modified
Fri, 03 Sep 2021 16:11:38 GMT
Server
Apache
ETag
W/"31881-1630685498000"
Transfer-Encoding
chunked
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
dragonCampaign.js
sample.dragonforms.com/js/ Frame 4E7F
13 KB
13 KB
Script
General
Full URL
https://sample.dragonforms.com/js/dragonCampaign.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
0dbc0190864fe5c6e0bd63e7b5233f94265ee535dc3c3e2031f27a251bbb2f60
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:16 GMT
X-Content-Type-Options
nosniff
Last-Modified
Mon, 30 Aug 2021 17:56:04 GMT
Server
Apache
ETag
W/"13235-1630346164000"
Transfer-Encoding
chunked
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
generic.css
sample.dragonforms.com/style/ Frame 4E7F
2 KB
1 KB
Stylesheet
General
Full URL
https://sample.dragonforms.com/style/generic.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
a75268aabd3efca2333dda30048a44d566fca0fa0c70f87249784d6c4dbaaa50
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:16 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Thu, 10 Jun 2021 15:35:48 GMT
Server
Apache
ETag
W/"2478-1623339348000"
Vary
Accept-Encoding
Content-Type
text/css;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
962.css
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 4E7F
3 KB
3 KB
Stylesheet
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
9b7e5dca586aec7050576b4dad559ab2688067149e60467be5ca505970455229
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 16:36:16 CET
X-Content-Type-Options
nosniff
Last-Modified
Mon, 04 Oct 2021 19:31:31 CEST
Server
Apache
ETag
W/"2856-1633368691632"
X-Frame-Options
SAMEORIGIN
Content-Type
text/css
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
363.js
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 4E7F
5 KB
6 KB
Script
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/363.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
3f680ec1d9f173ca064c4fc16850d78e3b0bd291f4e0908f203245011861567d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 16:36:16 CET
X-Content-Type-Options
nosniff
Last-Modified
Fri, 28 May 2021 16:35:55 CEST
Server
Apache
ETag
W/"5462-1622212555614"
X-Frame-Options
SAMEORIGIN
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
olyticsLinkAssistance.js
sample.dragonforms.com/js/ Frame 4E7F
4 KB
4 KB
Script
General
Full URL
https://sample.dragonforms.com/js/olyticsLinkAssistance.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
f88e771cd7aeeb1241c61b165090b9d197534d937e2bd53a62631a738439a2e6
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:16 GMT
X-Content-Type-Options
nosniff
Last-Modified
Fri, 16 Nov 2018 20:46:06 GMT
Server
Apache
ETag
W/"3961-1542401166000"
Transfer-Encoding
chunked
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
multitracking
ghb.hbmp.mediafuse.com/adunit/
0
211 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/adunit/multitracking
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456783/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a06:8640:799:0:ec4:7aff:fe6e:a48e Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Wed, 09 Feb 2022 15:36:17 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
mut
ghb.adtelligent.com/adunit/ Frame D0E0
0
204 B
XHR
General
Full URL
https://ghb.adtelligent.com/adunit/mut
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a06:8640:799:0:ec4:7aff:fe6e:a48e Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://p.annocdn.com
Date
Wed, 09 Feb 2022 15:36:17 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
getpixels
pixels.ad.gt/api/v1/
0
344 B
Script
General
Full URL
https://pixels.ad.gt/api/v1/getpixels?tagger_id=e0fc5aa47bed062e265fc29d169e5770&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&code=%27none%27
Requested by
Host: p.ad.gt
URL: https://p.ad.gt/api/v1/p/170
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
44.237.47.166 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-44-237-47-166.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

access-control-allow-origin
*
date
Wed, 09 Feb 2022 15:36:16 GMT
server
nginx/1.18.0
access-control-allow-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
access-control-allow-methods
GET, POST, OPTIONS
access-control-expose-headers
DNT,X-CustomHeader,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Content-Range,Range
ecommerce.js
www.google-analytics.com/plugins/ua/
1 KB
763 B
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ecommerce.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
8e1b84265e633c043720dd0921476c16bc9f75e393e855c9116ca7c3a847b5c7
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:14:52 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1284
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
738
x-xss-protection
0
last-modified
Tue, 22 Oct 2019 18:15:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Wed, 09 Feb 2022 16:14:52 GMT
ec.js
www.google-analytics.com/plugins/ua/
3 KB
1 KB
Script
General
Full URL
https://www.google-analytics.com/plugins/ua/ec.js
Requested by
Host: www.google-analytics.com
URL: https://www.google-analytics.com/analytics.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
058ed961bfe422af7bfc65865f4c08531ec8ace995f8a1ec560a46581cb7712c
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 14:57:14 GMT
content-encoding
br
x-content-type-options
nosniff
age
2342
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
1129
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 12:48:00 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"static-on-bigtable","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/static-on-bigtable"}]}
content-type
text/javascript
cache-control
public, max-age=3600
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="static-on-bigtable"
expires
Wed, 09 Feb 2022 15:57:14 GMT
p
olytics.omeda.com/olytics/segments/
4 KB
4 KB
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
918982ba15ff28997e16dc269e28fe3cca85b92dd3852ac0114cbaf959a03b0b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
application/json

Response headers

Date
Wed, 09 Feb 2022 15:36:19 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
/
olytics.omeda.com/olytics/segments/form/check/
20 B
313 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/form/check/
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
dd0103b71a9f800bf8509fb3f34f29a1af4b26a10ceef71cea5bb29ae4ea106d
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
application/json

Response headers

Date
Wed, 09 Feb 2022 15:36:16 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
cswitch
olytics.omeda.com/olytics/segments/
88 B
381 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
6a035d9c29943e99874c663ecd6c2db2930b5001f488f710bd314165cdbee906
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
application/json

Response headers

Date
Wed, 09 Feb 2022 15:36:16 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
p
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Wed, 09 Feb 2022 15:36:16 GMT
Server
Apache
/
olytics.omeda.com/olytics/segments/form/check/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/form/check/
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Wed, 09 Feb 2022 15:36:16 GMT
Server
Apache
cswitch
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Wed, 09 Feb 2022 15:36:16 GMT
Server
Apache
cm
u.openx.net/w/1.0/
43 B
131 B
Image
General
Full URL
https://u.openx.net/w/1.0/cm?id=998eaf06-9905-4eae-9e26-9fac75960c53&r=https%3A%2F%2Fids.ad.gt%2Fapi%2Fv1%2Fopenx%3Fopenx_id%3D%7BOPENX_ID%7D%26id%3D0200j2q9gt07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl%26auid%3Dd8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
34.98.64.218 Kansas City, United States, ASN15169 (GOOGLE, US),
Reverse DNS
218.64.98.34.bc.googleusercontent.com
Software
OXGW/17.1.0 /
Resource Hash
4e0705327480ad2323cb03d9c450ffcae4a98bf3a5382fa0c7882145ed620e49

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:16 GMT
content-encoding
gzip
server
OXGW/17.1.0
vary
Accept, Accept-Encoding
p3p
CP="CUR ADM OUR NOR STA NID"
via
1.1 google
cache-control
private, max-age=0, no-cache
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000
content-length
56
expires
Mon, 26 Jul 1997 05:00:00 GMT
halo_match
ids.ad.gt/api/v1/
43 B
652 B
Image
General
Full URL
https://ids.ad.gt/api/v1/halo_match?id=d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49&halo_id=0200j2q9gt07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
52.43.149.174 Boardman, United States, ASN16509 (AMAZON-02, US),
Reverse DNS
ec2-52-43-149-174.us-west-2.compute.amazonaws.com
Software
nginx/1.18.0 /
Resource Hash
afe0dcfca292a0fae8bce08a48c14d3e59c9d82c6052ab6d48a22ecc6c48f277

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:16 GMT
cache-control
public, max-age=43200
server
nginx/1.18.0
content-type
image/gif
expires
Thu, 10 Feb 2022 03:36:16 GMT
index.php
a.dpmsrv.com/dpmpxl/
5 B
1 KB
Script
General
Full URL
https://a.dpmsrv.com/dpmpxl/index.php?q=xSeg&v=1.x&ep%5Bids%5D=29315642%2C29315652%2C29028703%2C29430809%2C16013439%2C16671093&cl=913&pixelIndex=0&r=343710&tzOffset=0&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&id=1521003946560112395&_=1644420974556
Requested by
Host: s.dpmsrv.com
URL: https://s.dpmsrv.com/dpm_fa5b7e293127b3837c39f7fbd05598f32c8ce1c9.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
3.226.203.17 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-226-203-17.compute-1.amazonaws.com
Software
/
Resource Hash
fbc45fe018830de401f0cf801177a57d0039bc72d922b8ff2c82af7af05dd32b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Pragma
no-cache
content-encoding
gzip
Access-Control-Max-Age
10
Access-Control-Allow-Methods
GET, POST, PUT, DELETE, OPTIONS
P3P
CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin
*
Cache-Control
no-cache, no-store, must-revalidate
Connection
keep-alive
Content-Type
text/javascript
Access-Control-Allow-Headers
content-type, accept
Content-Length
31
Expires
0
seg
ib.adnxs.com/
43 B
1019 B
Image
General
Full URL
https://ib.adnxs.com/seg?member=827&add=29315642,29315652,29028703,29430809,16013439,16671093
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.221.53 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
718.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
4b5b6b15c6255109e06720cce42a06d3aead8b7874423d9c52cb0303212c25ef
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:16 GMT
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 718.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
56dcfd38-2ebf-4322-8a3e-860fac653fc4
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Access-Control-Allow-Origin
*
Cache-Control
no-store, no-cache, private
Access-Control-Allow-Credentials
true
Connection
keep-alive
Content-Type
image/gif
Content-Length
43
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
gtm.js
www.googletagmanager.com/ Frame 4E7F
95 KB
37 KB
Script
General
Full URL
https://www.googletagmanager.com/gtm.js?id=GTM-MV5SCJ
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:831::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Google Tag Manager /
Resource Hash
3bd41c747404de999a2f21b9b2dab5f250aab40d6557c6c992eb90ba5fc3e237
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; includeSubDomains
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
br
vary
Accept-Encoding
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38004
x-xss-protection
0
last-modified
Wed, 09 Feb 2022 15:00:00 GMT
server
Google Tag Manager
strict-transport-security
max-age=31536000; includeSubDomains
content-type
application/javascript; charset=UTF-8
access-control-allow-origin
*
cache-control
private, max-age=900
access-control-allow-credentials
true
access-control-allow-headers
Cache-Control
expires
Wed, 09 Feb 2022 15:36:17 GMT
olytics.min.js
olytics.omeda.com/olytics/js/v3/p/ Frame 4E7F
271 KB
73 KB
Script
General
Full URL
https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Requested by
Host: sample.dragonforms.com
URL: https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
a054aa97d11e81c0b049b5eeb2bda656aece2bf407995fd19e4a459ce60cec28
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:16 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Last-Modified
Tue, 18 Jan 2022 16:42:56 GMT
Server
Apache
ETag
W/"277838-1642524176000"
X-Frame-Options
SAMEORIGIN
Content-Type
application/javascript
Access-Control-Allow-Origin
*
Cache-Control
max-age=21600
Transfer-Encoding
chunked
Accept-Ranges
bytes
vary
accept-encoding
X-XSS-Protection
1; mode=block
Expires
Wed, 09 Feb 2022 21:36:17 GMT
956.svg
hostedcontent.dragonforms.com/hosted/images/dragon/12247/ Frame 4E7F
2 KB
2 KB
Image
General
Full URL
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/956.svg
Requested by
Host: hostedcontent.dragonforms.com
URL: https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
205.162.42.5 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
cdn.omeda.com
Software
Apache /
Resource Hash
576f1c20a3f2469e8fc92810450d9d4f25642aa38c0777307cc47ce8c59c6cef
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://hostedcontent.dragonforms.com/hosted/images/dragon/12247/962.css
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 16:36:16 CET
X-Content-Type-Options
nosniff
Last-Modified
Mon, 04 Oct 2021 19:02:01 CEST
Server
Apache
ETag
W/"1609-1633366921496"
X-Frame-Options
SAMEORIGIN
Content-Type
image/svg+xml
Access-Control-Allow-Origin
*
Access-Control-Expose-Headers
Access-Control-Allow-Origin,Access-Control-Allow-Credentials
Transfer-Encoding
chunked
Accept-Ranges
bytes
X-XSS-Protection
1; mode=block
evaluateConditionalContent.do;jsessionid=7A96E48C4BC732B16292C5D4DE636B21
sample.dragonforms.com/ Frame 4E7F
277 B
468 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=7A96E48C4BC732B16292C5D4DE636B21?demo147906=short&demo147907=&demo147908=&opt147912=1&demo147915=LS-FP-FORM-NSL-FPShort&dragon_pagenumber=1&jsessionid=7A96E48C4BC732B16292C5D4DE636B21&timestemp=1644420977093
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
de7fb728cb39a5400c73eba1a03035da14f877e20e474fc60c7c6bd68a735acb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With
XMLHttpRequest
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:17 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
evaluateConditionalContent.do;jsessionid=7A96E48C4BC732B16292C5D4DE636B21
sample.dragonforms.com/ Frame 4E7F
277 B
468 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=7A96E48C4BC732B16292C5D4DE636B21?demo147906=short&demo147907=&demo147908=&opt147912=1&demo147915=LS-FP-FORM-NSL-FPShort&dragon_pagenumber=1&jsessionid=7A96E48C4BC732B16292C5D4DE636B21&timestemp=1644420977099
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
de7fb728cb39a5400c73eba1a03035da14f877e20e474fc60c7c6bd68a735acb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With
XMLHttpRequest
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:17 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
analytics.js
www.google-analytics.com/ Frame 4E7F
49 KB
20 KB
Script
General
Full URL
https://www.google-analytics.com/analytics.js
Requested by
Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtm.js?id=GTM-MV5SCJ
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:808::200e Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
Golfe2 /
Resource Hash
a1925038db769477ab74b4df34350c35688a795bb718727b0f4292a4a78a6210
Security Headers
Name Value
Strict-Transport-Security max-age=10886400; includeSubDomains; preload
X-Content-Type-Options nosniff

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

strict-transport-security
max-age=10886400; includeSubDomains; preload
content-encoding
gzip
x-content-type-options
nosniff
last-modified
Tue, 02 Nov 2021 17:39:06 GMT
server
Golfe2
age
5485
date
Wed, 09 Feb 2022 14:04:52 GMT
vary
Accept-Encoding
content-type
text/javascript
cache-control
public, max-age=7200
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
20006
expires
Wed, 09 Feb 2022 16:04:52 GMT
report
creative.spotible.com/creative/f4mq/
43 B
113 B
Image
General
Full URL
https://creative.spotible.com/creative/f4mq/report?,1644420976,444001;UNIQUE_USER_GLOBAL!0,1,0;UNIQUE_USER_DAILY!0,1,0;UNIQUE_USER_HOURLY!0,1,0;IMPRESSION!0,1,0!18,1,0!55,1,0!69,1,0!113,1,0!120,1,0;IN_VIEW!0,1,1!18,1,1!55,1,1!69,1,1!113,1,1!120,1,1&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.215.243.168 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-215-243-168.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
cache-control
no-store
content-length
43
content-type
image/gif
view
securepubads.g.doubleclick.net/pcs/
0
23 B
Image
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuDsfTVmmet_I0jNkBTMA8d40_u1gcGMBeq4cxitPG5-7DK7kidXzHlp-A0ajecEcg825dr58qYaGBC3N9N0tc8AGVw7OTvwy6ixTpZJdOaGYMVnVa7x7neCFe5JoWQJzw1KVkz42r8-OAGyHlPeMQl_68P2LNNMTxbunoFwVlyXG6G6KjF4PjBdudqcdEZfjlOR4xoz4n7OuVp3E1NZuJFGapvqs2hhnAKyKN0K0KOraU3pXLJbHSTw-hKRXswDJn42fv3NMVCsche5NPxqae14z5u469SfLacQwAGPnoQh0PVlViT8xJMkKpJUbZaLzqs6BEZRXvjYDfTwGmn1wZ2fiPgOZbJ8PzPu9zehtfQjVb17c2mGNlY2gkydfw1B98n2_y7JcMzPt_GZbmZKQ&sai=AMfl-YRkDDz6bn4Iap-Y6byjEhqUb-SIyI8o2dA6XiUE_OUZ_pWIpt3HF_jnBzJGi0vsw8VVDzGPiUUC6Y53oKiP_azfi4RjT9NdiJ8OkMrgVZ01XolMMcgYJT3ow64FVz4&sig=Cg0ArKJSzATmYDtFfGsvEAE&uach_m=[UACH]&urlfix=1&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
integrator.js
adservice.google.de/adsid/
107 B
122 B
Script
General
Full URL
https://adservice.google.de/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3="googleads.g.doubleclick.net:443"; ma=2592000,h3=":443"; ma=2592000,h3-29="googleads.g.doubleclick.net:443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
integrator.js
adservice.google.com/adsid/
107 B
122 B
Script
General
Full URL
https://adservice.google.com/adsid/integrator.js?domain=www.fiercepharma.com
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:811::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
a4a1824defec1084ca81d496ee77891684c26196924bdc4fc21dd3482ce15e14
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
server
cafe
p3p
CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
cache-control
private, no-cache, no-store
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
content-type
application/javascript; charset=UTF-8
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
100
x-xss-protection
0
ads
securepubads.g.doubleclick.net/gampad/
184 KB
56 KB
XHR
General
Full URL
https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=2693454102022840&correlator=1424608655510411&output=ldjh&impl=fifs&eid=44752540&vrg=2022020301&ptt=17&sc=1&sfv=1-0-38&ecs=20220209&iu_parts=298443%2Cquestex.lifesciences%2Cfiercepharma%2Cspecialreports&enc_prev_ius=%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3%2C%2F0%2F1%2F2%2F3&prev_iu_szs=970x90%7C970x250%7C970x415%2C300x600%7C300x250%2C300x600%7C300x250%2C300x600%7C300x250%2C1600x1000&prev_scp=pos%3D0%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D1%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D2%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D3%26hb_rfBid%3D0%26excl_cat%3DPREPOST%7Cpos%3D5%26hb_rfBid%3D0%26excl_cat%3DPREPOST&eri=1&cust_params=section%3DSpecial%2520Reports%26homefront%3D0%26sectionfront%3D0%26article%3D1%26nodeid%3D518311%26fm-tester%3Dundefined%26topic%3Dcardiovascular%2520disease%252C%2520drug%2520launch%26keyword%3DBristol%2520Myers%2520Squibb%252C%2520mavacamten%26tag%3DBristol%2520Myers%2520Squibb%252C%2520mavacamten%252Ccardiovascular%2520disease%252C%2520drug%2520launch%252CSpecial%2520Reports%26path%3D%252Fspecial-report%252F10-most-anticipated-drug-launches-2022-8-mavacamten%26browserLargerThan1460%3D1&cookie=ID%3D383af4d7f074109a-22e3b0e03acd003a%3AT%3D1644420975%3AS%3DALNI_MZtufNDoiusQljtgqOp_ZN14Gkwhw&bc=31&abxe=1&dt=1644420977324&lmt=1644420920&dlt=1644420973930&idt=589&frm=20&biw=1600&bih=1200&oid=2&adxs=200%2C1100%2C1100%2C1100%2C-12245933&adys=988%2C1196%2C1658%2C1658%2C-12245933&adks=313090359%2C2965285993%2C3032192005%2C3032192004%2C3031910803&ucis=5%7C6%7C7%7C8%7C9&ifi=5&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&dmc=8&url=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&vis=1&scr_x=0&scr_y=0&psz=1200x0%7C300x0%7C300x0%7C300x0%7C1200x0&msz=1200x0%7C300x0%7C300x0%7C300x0%7C1600x0&psts=AGkb-H_8YFBVafa3v0WOwBEb0zKNT36qqJbX67MjPI1kpyVCpKZT9uRK-hG3u19nNlNlYWrkIxwZA7Ph4DcEcSG9%2CAGkb-H9j4ekpTwJAcAdpZaojkDbBhBdNxlzzDocPR1NeOae-aOJsB7PejS5II_xrC8RFGVBcQ5Egn33fTg24QA8b%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=1143913336.1644420975&ga_sid=1644420975&ga_hid=1001435911&ga_fc=true&fws=4%2C4%2C4%2C4%2C132&ohw=1600%2C1600%2C1600%2C1600%2C1600&btvi=0%7C0%7C2%7C3%7C-1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0.&nvt=1
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
f881b78e34fb3c79f7b881d3549a8c8ce45cc076163e0deaba9ee82335084e39
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
br
x-content-type-options
nosniff
google-mediationgroup-id
-2,-2,-2,-2,-2
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
57389
x-xss-protection
0
google-lineitem-id
5773092226,5773092226,5773092226,5773092226,-2
pragma
no-cache
server
cafe
google-mediationtag-id
-2
google-creative-id
138379479778,138379479787,138379479781,138379479784,-2
content-type
text/plain; charset=UTF-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, must-revalidate
access-control-allow-credentials
true
timing-allow-origin
*
expires
Fri, 01 Jan 1990 00:00:00 GMT
evaluateConditionalContent.do;jsessionid=7A96E48C4BC732B16292C5D4DE636B21
sample.dragonforms.com/ Frame 4E7F
277 B
468 B
XHR
General
Full URL
https://sample.dragonforms.com/evaluateConditionalContent.do;jsessionid=7A96E48C4BC732B16292C5D4DE636B21?demo147906=short&demo147907=&demo147908=&opt147912=1&demo147915=LS-FP-FORM-NSL-FPShort&dragon_pagenumber=1&jsessionid=7A96E48C4BC732B16292C5D4DE636B21&timestemp=1644420977335
Requested by
Host: code.jquery.com
URL: https://code.jquery.com/jquery-2.2.4.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.190 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
Software
Apache /
Resource Hash
de7fb728cb39a5400c73eba1a03035da14f877e20e474fc60c7c6bd68a735acb
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 1; mode=block

Request headers

Accept
application/json, text/javascript, */*; q=0.01
Referer
https://sample.dragonforms.com/loading.do?omedasite=FiercePharma_short
X-Requested-With
XMLHttpRequest
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Date
Wed, 09 Feb 2022 15:36:17 GMT
Content-Encoding
gzip
X-Content-Type-Options
nosniff
Server
Apache
Vary
Accept-Encoding
Content-Type
text/x-json;charset=UTF-8
Access-Control-Allow-Origin
*
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
adsbygoogle.js
pagead2.googlesyndication.com/pagead/js/ Frame 4E7F
0
0
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cross-origin-resource-policy
cross-origin
content-disposition
attachment; filename="f.txt"
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
53873
x-xss-protection
0
server
cafe
etag
3953002362039415623
vary
Accept-Encoding, Origin
content-type
text/javascript; charset=UTF-8
cache-control
private, max-age=3600
timing-allow-origin
*
expires
Wed, 09 Feb 2022 15:36:17 GMT
gpt.js
www.googletagservices.com/tag/js/ Frame 4E7F
0
0
Fetch
General
Full URL
https://www.googletagservices.com/tag/js/gpt.js
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://sample.dragonforms.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27247
x-xss-protection
0
server
sffe
etag
"1126 / 115 of 1000 / last-modified: 1644408663"
vary
Accept-Encoding
report-to
{"group":"ads-gpt-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-gpt-scs"}]}
content-type
text/javascript
cache-control
private, max-age=900, stale-while-revalidate=3600
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-gpt-scs"
expires
Wed, 09 Feb 2022 15:36:17 GMT
publishertag.prebid.117.js
static.criteo.net/js/ld/
87 KB
28 KB
Script
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.117.js
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638:1::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
90c9017a8a6447588520f38cd94ba14cdb9839c92626aa06bb8a4a1052c2ab7e
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
gzip
last-modified
Wed, 29 Dec 2021 12:30:46 GMT
server
nginx
etag
W/"61cc54f6-15c19"
strict-transport-security
max-age=31536000; preload;
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Thu, 10 Feb 2022 15:36:17 GMT
view
googleads4.g.doubleclick.net/pcs/ Frame D450
0
0
Fetch
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsu_yrtkTuUVd_P1Tf3ne8CTg-5KBEr5Hj3zfTtPnpSelqU2g23Rl2X-2rT9Nh75zq2wSQ4_bwVcmuaFE32DQwkNEzzdduD5yd24CU07T4iel1Q9bghuu3IwT7ZaKD-6AqHo2nKuzl7RM1PnZwimMQt2e29ujYcsjfT4XuVAsAKMsYjaEKGbvvjB1bBHN78TufgASCavLmQe4m15LdNoMkHjyRw-rWT_zrkmhfT9j4pWSO9ztv1NU5Q66MInglAfBGSvLfbX4dOdew08ThaTEyU-NtGQjyIrxQqbV8Ol87M9ezwELLfWoCK7WzN6MMJ_nICR7Thht4GuRhDcHMX9ej5fm9eQ8o7JMpGK4MgK_xrThyVGnk-LyzO7VWEa53Part-iZ95RRtKFSdzCeBuxRfq0w9f9XrItyxN6BRsodcQRhJFloqH7hEw&sig=Cg0ArKJSzGiGiWf2w6leEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
express_html_inpage_rendering_lib_200_275.js
s0.2mdn.net/879366/ Frame D450
106 KB
38 KB
Script
General
Full URL
https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a23e44d9d02a2a9641a9bd3b47693656054c00b71890aed2fa7fc90151750f73
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 06:12:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33813
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37892
x-xss-protection
0
last-modified
Mon, 27 Sep 2021 18:44:52 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Thu, 10 Feb 2022 06:12:44 GMT
UFYwWwmt.js
tpc.googlesyndication.com/sodar/ Frame D450
41 KB
15 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5056305b09ad6474ea540f796c79be51d6b8e96043cb3d7bc4ef774e56765f4f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:11:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1468
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15207
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 09 Feb 2023 15:11:49 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame D450
124 KB
38 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cecd27ce9737114e23fa8dda3be3041f7c36cdafd31822d2e5bae793669bd13f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38562
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1644237382599929"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Wed, 09 Feb 2022 15:36:17 GMT
view
googleads4.g.doubleclick.net/pcs/ Frame 3A80
0
0
Fetch
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsvh2xYAXKo_-cSjAqePtK6B1LmVo60ixq3moNu1TUcXWV6YE1m0iXNv0fSQ_2GcqW5eKhj287zNp4dlWmoM8GHgeiBVSSNLkgAQ-vamVYRFYrjSKg-71UECuYgh-WQyPYLMcUCpswnks1av2UZuvfnXQ_x7GtJ0vdMRnDpE8bYQIORy-66UJq3Cy0UZ-qwpsP7GMQ-iFUGcly6p7ZnsduQoV834NOT49Td7tl5PmZ2ZXuPn9W-BntI-JlL4g2PKe30nvyZwUUPCvN-XqWWuu3WL_13JEuBfBA0tEq1YT_uEk12-uguRNdXeRwjPjE1mhaljXVE7gp1S8kMMoguAXLkwQVAAO2-fvnvpEulzXovF-6_T6Z8b_C1UvfMiFoSEeXK7614IU6KsheUMaxcre6pZW1jAg2lycCHkEezhzJSH-oOdTGzrm1k&sig=Cg0ArKJSzDggyWbrN7kPEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
express_html_inpage_rendering_lib_200_275.js
s0.2mdn.net/879366/ Frame 3A80
106 KB
37 KB
Script
General
Full URL
https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a23e44d9d02a2a9641a9bd3b47693656054c00b71890aed2fa7fc90151750f73
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 06:12:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33813
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37892
x-xss-protection
0
last-modified
Mon, 27 Sep 2021 18:44:52 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Thu, 10 Feb 2022 06:12:44 GMT
UFYwWwmt.js
tpc.googlesyndication.com/sodar/ Frame 3A80
41 KB
15 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5056305b09ad6474ea540f796c79be51d6b8e96043cb3d7bc4ef774e56765f4f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:11:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1468
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15207
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 09 Feb 2023 15:11:49 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 3A80
124 KB
38 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cecd27ce9737114e23fa8dda3be3041f7c36cdafd31822d2e5bae793669bd13f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38562
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1644237382599929"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Wed, 09 Feb 2022 15:36:17 GMT
view
googleads4.g.doubleclick.net/pcs/ Frame 74EC
0
0
Fetch
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsuyka88gj6NucyuLVR67g2WmgakgrgaIRfmvA6JYqtq6yDX1t4Anjq-81dYNdT7ucqVGK5YXA9jgYD_s2DIKalkTdyGSjTshGmbAZ9zPb_v435YWDkpMbnMVKguI9OKeHx2u5rH_TuoRnWsTw2pjqBlFLDNz1bXwClVOKC0SsQ6P2gZhGVoZgl6MaDG0zCiMoo9Si77utGb3XIvoIEKnmaiN4HZDRv5q1YkwLQYBP68MOk834xVGHQm4TrTKb2g8pSyVH-kM4Tog91ehbk_AStwHyJZbWarJXpsO2EFuqauNPe5y3rvR5NTbAJGi6-XbXftk5E2FjYEugfDk1PbWeDBgLmYhCLRJmLObZKQJuFb1iRtbaaQK41ZDvawd1gwSJFc8wxf4GA7yojvNlMYFYfNN_IVpZ7hFTxb0R8K-nsVrksyMN1DFkg&sig=Cg0ArKJSzLLMlwM14EgAEAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
express_html_inpage_rendering_lib_200_275.js
s0.2mdn.net/879366/ Frame 74EC
106 KB
37 KB
Script
General
Full URL
https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a23e44d9d02a2a9641a9bd3b47693656054c00b71890aed2fa7fc90151750f73
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 06:12:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33813
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37892
x-xss-protection
0
last-modified
Mon, 27 Sep 2021 18:44:52 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Thu, 10 Feb 2022 06:12:44 GMT
UFYwWwmt.js
tpc.googlesyndication.com/sodar/ Frame 74EC
41 KB
15 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5056305b09ad6474ea540f796c79be51d6b8e96043cb3d7bc4ef774e56765f4f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:11:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1468
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15207
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 09 Feb 2023 15:11:49 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame 74EC
124 KB
38 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cecd27ce9737114e23fa8dda3be3041f7c36cdafd31822d2e5bae793669bd13f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38562
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1644237382599929"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Wed, 09 Feb 2022 15:36:17 GMT
view
googleads4.g.doubleclick.net/pcs/ Frame B9E9
0
0
Fetch
General
Full URL
https://googleads4.g.doubleclick.net/pcs/view?xai=AKAOjsvPtJBBm-6EVfFY6rRe2ARM4CYVcKIFWtCjgBaD8jtWPBGxQvi7qKNlJJe6lfPDC_qCpUPn6-QMLFnaWRYloideb14aa55a67hNZv-2NdoxL3TndjnJlErcTBkhisbOuMJUvJkN8l_AzWlWMSCJX8OJhIJpqbz3BqS9ZZr7CnJhTYyiGnZtIbWn9oxJyf_4MVGgBywdQ0k2Z-Lm57q5etoYjZNSKY2WjxSqnawS1vnHUTLobhTNyljddA1QVpsSADVfSA8O0pg7m1mObt25cW7UfAuuHiqXs_RHJVtxtHWm2p8ijcNyvPeNnaShLNCpvB6451Md0ve8OH1cV1a4PIOqxyMR60LZ5cIOqDjP_MnoDdtLvBwvokkTJ_cwCxHq3cty0Sk96CMU7x9mAVC5a5WrFB7MTNhitSuf3OXpIVGQFNOOlHlqND0&sig=Cg0ArKJSzPklpWaX0Vn7EAE&uach_m=[UACH]&fbs_aeid=[gw_fbsaeid]&urlfix=1&adurl=
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
142.250.185.130 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra16s50-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:17 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
express_html_inpage_rendering_lib_200_275.js
s0.2mdn.net/879366/ Frame B9E9
106 KB
37 KB
Script
General
Full URL
https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
a23e44d9d02a2a9641a9bd3b47693656054c00b71890aed2fa7fc90151750f73
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Referer
https://www.fiercepharma.com/
Origin
https://www.fiercepharma.com
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 06:12:44 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
33813
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
37892
x-xss-protection
0
last-modified
Mon, 27 Sep 2021 18:44:52 GMT
server
sffe
vary
Accept-Encoding
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
text/javascript
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
timing-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Thu, 10 Feb 2022 06:12:44 GMT
UFYwWwmt.js
tpc.googlesyndication.com/sodar/ Frame B9E9
41 KB
15 KB
Script
General
Full URL
https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a00:1450:4001:828::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
5056305b09ad6474ea540f796c79be51d6b8e96043cb3d7bc4ef774e56765f4f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:11:49 GMT
content-encoding
gzip
x-content-type-options
nosniff
age
1468
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
15207
x-xss-protection
0
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
vary
Accept-Encoding
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
timing-allow-origin
*
expires
Thu, 09 Feb 2023 15:11:49 GMT
rx_lidar.js
www.googletagservices.com/activeview/js/current/ Frame B9E9
124 KB
38 KB
Script
General
Full URL
https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Requested by
Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2022020301.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
cecd27ce9737114e23fa8dda3be3041f7c36cdafd31822d2e5bae793669bd13f
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
gzip
x-content-type-options
nosniff
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/active-view-scs-read-write-acl
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
38562
x-xss-protection
0
server
sffe
cross-origin-opener-policy
same-origin; report-to="active-view-scs-read-write-acl"
etag
"1644237382599929"
vary
Accept-Encoding
report-to
{"group":"active-view-scs-read-write-acl","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/active-view-scs-read-write-acl"}]}
content-type
text/javascript
cache-control
private, max-age=3000
accept-ranges
bytes
expires
Wed, 09 Feb 2022 15:36:17 GMT
async_usersync.html
acdn.adnxs.com/ib/static/usersync/v3/ Frame 97C6
995 B
875 B
Document
General
Full URL
https://acdn.adnxs.com/ib/static/usersync/v3/async_usersync.html
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
2.21.141.148 Frankfurt am Main, Germany, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a2-21-141-148.deploy.static.akamaitechnologies.com
Software
nginx/1.13.10 /
Resource Hash
8730c26defc411dd8a51f1da47e5ae3804fab6868f7914a26b09d8e0791bbe39

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.annocdn.com/

Response headers

Last-Modified
Fri, 20 May 2016 02:07:09 GMT
ETag
"573e714d-3e3"
Server
nginx/1.13.10
Content-Type
text/html
Access-Control-Allow-Origin
*
Content-Encoding
gzip
Content-Length
506
Cache-Control
max-age=31536000
Expires
Thu, 09 Feb 2023 15:36:17 GMT
Date
Wed, 09 Feb 2022 15:36:17 GMT
Connection
keep-alive
Vary
Accept-Encoding
/
onetag-sys.com/usync/ Frame 05AD
2 KB
814 B
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1644420977486
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.annocdn.com/

Response headers

content-type
text/html
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
strict-transport-security
max-age=15552000
/
onetag-sys.com/usync/ Frame D144
2 KB
814 B
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1644420977488
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.annocdn.com/

Response headers

content-type
text/html
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
strict-transport-security
max-age=15552000
/
onetag-sys.com/usync/ Frame D840
2 KB
814 B
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1644420977489
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.annocdn.com/

Response headers

content-type
text/html
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
strict-transport-security
max-age=15552000
/
onetag-sys.com/usync/ Frame 42F9
2 KB
814 B
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1644420977492
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.annocdn.com/

Response headers

content-type
text/html
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
strict-transport-security
max-age=15552000
/
onetag-sys.com/usync/ Frame 7804
2 KB
814 B
Document
General
Full URL
https://onetag-sys.com/usync/?cb=1644420977493
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
51.89.9.254 London, United Kingdom, ASN16276 (OVH, FR),
Reverse DNS
ip254.ip-51-89-9.eu
Software
/
Resource Hash
37a31642af0a7fe695ed0fd68a06a55af44e854d083dc7f5d0e70535f0189ae0
Security Headers
Name Value
Strict-Transport-Security max-age=15552000

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://p.annocdn.com/

Response headers

content-type
text/html
cache-control
no-transform, no-cache
content-encoding
gzip
content-length
731
strict-transport-security
max-age=15552000
publishertag.prebid.js
static.criteo.net/js/ld/
90 KB
28 KB
XHR
General
Full URL
https://static.criteo.net/js/ld/publishertag.prebid.js
Requested by
Host: static.criteo.net
URL: https://static.criteo.net/js/ld/publishertag.prebid.117.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638:1::3 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
nginx /
Resource Hash
2c8ae0c883c62c03c5800ca91a31d1f0e00088683fb5f4131667c0504ce99e64
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:17 GMT
content-encoding
gzip
last-modified
Mon, 31 Jan 2022 09:04:35 GMT
server
nginx
etag
W/"61f7a623-16685"
strict-transport-security
max-age=31536000; preload;
content-type
text/javascript
access-control-allow-origin
*
cache-control
max-age=86400, public
cross-origin-resource-policy
cross-origin
timing-allow-origin
*
expires
Thu, 10 Feb 2022 15:36:17 GMT
Enqz_20U.html
tpc.googlesyndication.com/sodar/ Frame 58AF
22 KB
8 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
127ab3ff6d14112ae6aa40b68d9d3144748eda08efbc60a48a5be0555cf8622b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
timing-allow-origin
*
content-length
8395
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Wed, 09 Feb 2022 15:11:50 GMT
expires
Thu, 09 Feb 2023 15:11:50 GMT
cache-control
public, max-age=31536000
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
content-type
text/html
age
1467
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
Enqz_20U.html
tpc.googlesyndication.com/sodar/ Frame F191
22 KB
8 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
127ab3ff6d14112ae6aa40b68d9d3144748eda08efbc60a48a5be0555cf8622b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
timing-allow-origin
*
content-length
8395
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Wed, 09 Feb 2022 15:11:50 GMT
expires
Thu, 09 Feb 2023 15:11:50 GMT
cache-control
public, max-age=31536000
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
content-type
text/html
age
1467
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
572
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

truncated
/ Frame 3A80
211 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
6b0903ae98a81f40bacd5e0e5dbc0e33b830079fe40df02fd40d5d8f791aff86

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Content-Type
image/png
Enqz_20U.html
tpc.googlesyndication.com/sodar/ Frame 03B7
22 KB
8 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
127ab3ff6d14112ae6aa40b68d9d3144748eda08efbc60a48a5be0555cf8622b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
timing-allow-origin
*
content-length
8395
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Wed, 09 Feb 2022 15:11:50 GMT
expires
Thu, 09 Feb 2023 15:11:50 GMT
cache-control
public, max-age=31536000
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
content-type
text/html
age
1467
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
Enqz_20U.html
tpc.googlesyndication.com/sodar/ Frame 6287
22 KB
8 KB
Document
General
Full URL
https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/UFYwWwmt.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
127ab3ff6d14112ae6aa40b68d9d3144748eda08efbc60a48a5be0555cf8622b
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy
same-origin; report-to="adspam-signals-scs"
report-to
{"group":"adspam-signals-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/adspam-signals-scs"}]}
timing-allow-origin
*
content-length
8395
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Wed, 09 Feb 2022 15:11:50 GMT
expires
Thu, 09 Feb 2023 15:11:50 GMT
cache-control
public, max-age=31536000
last-modified
Tue, 03 Mar 2020 20:15:00 GMT
content-type
text/html
age
1467
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
572
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

truncated
/ Frame B9E9
214 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
24b34d90a16cb0adafa8cf6de512ad0fac45ba4fd62547fdd9ceafe383f567b5

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Content-Type
image/png
572
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

truncated
/ Frame D450
210 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
16eb02e1542368559c4dd628afd142bb5dc5ea0e78bd1ef081a183088f152608

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Content-Type
image/png
572
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0

truncated
/ Frame 74EC
211 B
0
Image
General
Full URL
data:truncated
Protocol
DATA
Server
-, , ASN (),
Reverse DNS
Software
/
Resource Hash
53e8023edd65f48bd9337401db420273f7b1c36fae561b86e153e7fc3a0a90bc

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Content-Type
image/png
index.html
s0.2mdn.net/10583188/1640879425588/ Frame 71F7
70 KB
27 KB
Document
General
Full URL
https://s0.2mdn.net/10583188/1640879425588/index.html
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
f9c75a25ae34756467b4fac1f89d36e961fcbe2356c39b920eac51c781c1a1d3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

cross-origin-resource-policy
cross-origin
accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
access-control-allow-origin
*
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-length
27448
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Wed, 09 Feb 2022 12:12:56 GMT
expires
Thu, 10 Feb 2022 12:12:56 GMT
cache-control
public, max-age=86400
age
12201
last-modified
Thu, 30 Dec 2021 15:50:25 GMT
content-type
text/html
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
index.html
s0.2mdn.net/10583188/1640880401082/ Frame 9FE2
69 KB
27 KB
Document
General
Full URL
https://s0.2mdn.net/10583188/1640880401082/index.html
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
88cb192c297b3124473944d01d906d80e14580d33f5252eff6f537967d174e58
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
access-control-allow-origin
*
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-length
27310
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Tue, 08 Feb 2022 19:55:38 GMT
expires
Wed, 09 Feb 2022 19:55:38 GMT
cache-control
public, max-age=86400
age
70839
last-modified
Thu, 30 Dec 2021 16:06:41 GMT
content-type
text/html
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
index.html
s0.2mdn.net/10583188/1640880401082/ Frame 602B
69 KB
27 KB
Document
General
Full URL
https://s0.2mdn.net/10583188/1640880401082/index.html
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
88cb192c297b3124473944d01d906d80e14580d33f5252eff6f537967d174e58
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
access-control-allow-origin
*
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-length
27310
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Tue, 08 Feb 2022 19:55:38 GMT
expires
Wed, 09 Feb 2022 19:55:38 GMT
cache-control
public, max-age=86400
age
70839
last-modified
Thu, 30 Dec 2021 16:06:41 GMT
content-type
text/html
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
index.html
s0.2mdn.net/10583188/1640880401082/ Frame BDF7
69 KB
27 KB
Document
General
Full URL
https://s0.2mdn.net/10583188/1640880401082/index.html
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_275.js
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
88cb192c297b3124473944d01d906d80e14580d33f5252eff6f537967d174e58
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/

Response headers

accept-ranges
bytes
vary
Accept-Encoding
content-encoding
gzip
access-control-allow-origin
*
cross-origin-resource-policy
cross-origin
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-length
27310
x-content-type-options
nosniff
server
sffe
x-xss-protection
0
date
Tue, 08 Feb 2022 19:55:38 GMT
expires
Wed, 09 Feb 2022 19:55:38 GMT
cache-control
public, max-age=86400
age
70839
last-modified
Thu, 30 Dec 2021 16:06:41 GMT
content-type
text/html
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
async_usersync
secure.adnxs.com/ Frame 97C6
0
729 B
Script
General
Full URL
https://secure.adnxs.com/async_usersync?cbfn=AN_async_load
Requested by
Host: acdn.adnxs.com
URL: https://acdn.adnxs.com/ib/static/usersync/v3/async_usersync.html
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_ECDSA, AES_128_GCM
Server
185.33.220.241 Amsterdam, Netherlands, ASN29990 (ASN-APPNEX, US),
Reverse DNS
732.bm-nginx-loadbalancer.mgmt.ams1.adnexus.net
Software
nginx/1.17.9 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://acdn.adnxs.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

Pragma
no-cache
Date
Wed, 09 Feb 2022 15:36:17 GMT
X-Proxy-Origin
193.27.14.42; 193.27.14.42; 732.bm-nginx-loadbalancer.mgmt.ams1; adnxs.com
AN-X-Request-Uuid
3013d985-da23-42fd-951a-98ccd2eecdc3
Server
nginx/1.17.9
P3P
policyref="http://cdn.adnxs-simple.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Cache-Control
no-store, no-cache, private
Connection
keep-alive
Content-Type
text/html; charset=utf-8
Content-Length
0
X-XSS-Protection
0
Expires
Sat, 15 Nov 2008 16:00:00 GMT
OJsPeSlINeJyzOQXpTvtD9cMgHq4K4YXI50fjA0xvQc.js
pagead2.googlesyndication.com/bg/ Frame F191
35 KB
13 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/OJsPeSlINeJyzOQXpTvtD9cMgHq4K4YXI50fjA0xvQc.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
389b0f79294835e272cce417a53bed0fd70c807ab82b8617239d1f8c0d31bd07
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 14:50:51 GMT
content-encoding
br
x-content-type-options
nosniff
age
2726
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13596
x-xss-protection
0
last-modified
Wed, 02 Feb 2022 12:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 09 Feb 2023 14:50:51 GMT
OJsPeSlINeJyzOQXpTvtD9cMgHq4K4YXI50fjA0xvQc.js
pagead2.googlesyndication.com/bg/ Frame 58AF
35 KB
13 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/OJsPeSlINeJyzOQXpTvtD9cMgHq4K4YXI50fjA0xvQc.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
389b0f79294835e272cce417a53bed0fd70c807ab82b8617239d1f8c0d31bd07
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 14:50:51 GMT
content-encoding
br
x-content-type-options
nosniff
age
2726
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13596
x-xss-protection
0
last-modified
Wed, 02 Feb 2022 12:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 09 Feb 2023 14:50:51 GMT
OJsPeSlINeJyzOQXpTvtD9cMgHq4K4YXI50fjA0xvQc.js
pagead2.googlesyndication.com/bg/ Frame 03B7
35 KB
13 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/OJsPeSlINeJyzOQXpTvtD9cMgHq4K4YXI50fjA0xvQc.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
389b0f79294835e272cce417a53bed0fd70c807ab82b8617239d1f8c0d31bd07
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 14:50:51 GMT
content-encoding
br
x-content-type-options
nosniff
age
2726
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13596
x-xss-protection
0
last-modified
Wed, 02 Feb 2022 12:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 09 Feb 2023 14:50:51 GMT
OJsPeSlINeJyzOQXpTvtD9cMgHq4K4YXI50fjA0xvQc.js
pagead2.googlesyndication.com/bg/ Frame 6287
35 KB
13 KB
Script
General
Full URL
https://pagead2.googlesyndication.com/bg/OJsPeSlINeJyzOQXpTvtD9cMgHq4K4YXI50fjA0xvQc.js
Requested by
Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/Enqz_20U.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
389b0f79294835e272cce417a53bed0fd70c807ab82b8617239d1f8c0d31bd07
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 14:50:51 GMT
content-encoding
br
x-content-type-options
nosniff
age
2726
content-security-policy-report-only
require-trusted-types-for 'script'; report-uri https://csp.withgoogle.com/csp/botguard-scs
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
13596
x-xss-protection
0
last-modified
Wed, 02 Feb 2022 12:48:00 GMT
server
sffe
cross-origin-opener-policy
same-origin; report-to="botguard-scs"
vary
Accept-Encoding
report-to
{"group":"botguard-scs","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/botguard-scs"}]}
content-type
text/javascript
cache-control
public, max-age=31536000
accept-ranges
bytes
expires
Thu, 09 Feb 2023 14:50:51 GMT
bg.jpg
s0.2mdn.net/10583188/1640880401082/ Frame 9FE2
22 KB
22 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640880401082/bg.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640880401082/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
1b493e86f8cb98c5ca527ca125ab7244265e9b0c1e826826920d724acadb4472
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640880401082/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 19:55:38 GMT
x-content-type-options
nosniff
age
70839
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
22253
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 16:06:41 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Wed, 09 Feb 2022 19:55:38 GMT
spriteSheet.png
s0.2mdn.net/10583188/1640880401082/ Frame 9FE2
27 KB
27 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640880401082/spriteSheet.png
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640880401082/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
54559f223845f9b716943aeaeb18ac90264ffbfc3573ceee0c155396013059f4
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640880401082/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 19:55:38 GMT
x-content-type-options
nosniff
age
70839
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27679
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 16:06:41 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Wed, 09 Feb 2022 19:55:38 GMT
spriteSheet.png
s0.2mdn.net/10583188/1640880401082/ Frame 602B
27 KB
27 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640880401082/spriteSheet.png
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640880401082/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
54559f223845f9b716943aeaeb18ac90264ffbfc3573ceee0c155396013059f4
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640880401082/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 19:55:38 GMT
x-content-type-options
nosniff
age
70839
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27679
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 16:06:41 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Wed, 09 Feb 2022 19:55:38 GMT
bg.jpg
s0.2mdn.net/10583188/1640880401082/ Frame 602B
22 KB
22 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640880401082/bg.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640880401082/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
1b493e86f8cb98c5ca527ca125ab7244265e9b0c1e826826920d724acadb4472
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640880401082/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 19:55:38 GMT
x-content-type-options
nosniff
age
70839
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
22253
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 16:06:41 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Wed, 09 Feb 2022 19:55:38 GMT
spriteSheet.png
s0.2mdn.net/10583188/1640880401082/ Frame BDF7
27 KB
27 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640880401082/spriteSheet.png
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640880401082/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
54559f223845f9b716943aeaeb18ac90264ffbfc3573ceee0c155396013059f4
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640880401082/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 19:55:38 GMT
x-content-type-options
nosniff
age
70839
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
27679
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 16:06:41 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Wed, 09 Feb 2022 19:55:38 GMT
bg.jpg
s0.2mdn.net/10583188/1640880401082/ Frame BDF7
22 KB
22 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640880401082/bg.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640880401082/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
1b493e86f8cb98c5ca527ca125ab7244265e9b0c1e826826920d724acadb4472
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640880401082/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Tue, 08 Feb 2022 19:55:38 GMT
x-content-type-options
nosniff
age
70839
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
22253
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 16:06:41 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Wed, 09 Feb 2022 19:55:38 GMT
bg.jpg
s0.2mdn.net/10583188/1640879425588/ Frame 71F7
23 KB
23 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879425588/bg.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879425588/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
302f7648b1edc744ef010060096e2e0f105e32d5929a72dd68bcf14adbf49df1
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879425588/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 12:12:56 GMT
x-content-type-options
nosniff
age
12202
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
23776
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:25 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Thu, 10 Feb 2022 12:12:56 GMT
spriteSheet.png
s0.2mdn.net/10583188/1640879425588/ Frame 71F7
22 KB
23 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879425588/spriteSheet.png
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879425588/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
abd1acfb2adbbc6e057cc4529bf673baf3c9b633fda9188ef1513cb7411845b5
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879425588/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 12:12:56 GMT
x-content-type-options
nosniff
age
12202
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
23019
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:25 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/png
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Thu, 10 Feb 2022 12:12:56 GMT
bg2.jpg
s0.2mdn.net/10583188/1640879425588/ Frame 71F7
12 KB
12 KB
Image
General
Full URL
https://s0.2mdn.net/10583188/1640879425588/bg2.jpg
Requested by
Host: s0.2mdn.net
URL: https://s0.2mdn.net/10583188/1640879425588/index.html
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:828::2006 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
sffe /
Resource Hash
0bf8c87a7e2bf32d7565d1e77afabfe67534a17132dd1c4f190aff574b613f21
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://s0.2mdn.net/10583188/1640879425588/index.html
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 12:12:56 GMT
x-content-type-options
nosniff
age
12202
cross-origin-resource-policy
cross-origin
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
12727
x-xss-protection
0
last-modified
Thu, 30 Dec 2021 15:50:25 GMT
server
sffe
report-to
{"group":"ads-doubleclick-media","max_age":2592000,"endpoints":[{"url":"https://csp.withgoogle.com/csp/report-to/ads-doubleclick-media"}]}
content-type
image/jpeg
access-control-allow-origin
*
cache-control
public, max-age=86400
accept-ranges
bytes
cross-origin-opener-policy-report-only
same-origin; report-to="ads-doubleclick-media"
expires
Thu, 10 Feb 2022 12:12:56 GMT
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977623%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977628%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977623%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_all_%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_all_%5C%22%3A%5B%5C%222898354882%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977629%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json576
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.112.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-112-18.fra56.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

view
securepubads.g.doubleclick.net/pcs/ Frame 3A80
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstJ9RJIhU41i65hKaxE_-4G6P6N0XK_IwFFwfqprDbVsup96q-65BDDkPuyA0x2nSrbeN2wQ_I8D0TNBWHaKth-dYT0sOU7rMl6Wq3m9lhWECe3KBZTxnpubYVeJ2jWYn4vhxez-Qh2OSo7XtSHYQmnDg0N2rzPF5GI6XgbXvhqxshYzIh7MLfLoA8lx0YL7bZkZTmisv4dJ3uiZHVs4FfhtgMnxIuF37gE6xfiDsEFu2o2mKt0E6Mw-KX9gbBm-tH6uylhyD6g7Y7cYstxBdquamczpnZDHidVM7yePLqmCvOvZeWWXXgYUtcORAVU3nn50KQ4Rtbdb9rD8U23T3W6ouWV6FlZ4Xic6cwradzfozQ&sig=Cg0ArKJSzNQb0mx7FkkOEAE&uach_m=[UACH]&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:18 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Wed, 09 Feb 2022 15:36:18 GMT
view
securepubads.g.doubleclick.net/pcs/ Frame B9E9
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsuu9iS8IcE_GxMtYkgnKdpVUwct8-PR7rrMDy8Xe-w4j9QR3NrLuP2KXfuOt01n6Qf_DppXYXrvkyo0EYpUvdCwY3j7snj2naeMVBHUSnaNFGm2VwBTVW3BKJjo7K0--G2QevCpxTM9th-P4ZtFKjr04-U29S3v0d6mbi1XG3-Jn3VtFGJTMPiw_B94MLARPaoamtcvZ7TSsb1HcVQieyqvUUVkk1mFoDcQIOgvimv7qPg9rvd0NGl20XF1ZAl8Q0cdW6AejpSLxupRd6MTCBJFsszdJJpM0nbDdZHhNx2DvEK1_Ohz70eeAc9HreHZV_3XDZJVLNYz3IorjGq59kWTg05UdhqngKMQc0bhnOB5RYU&sig=Cg0ArKJSzEOGkuFvebxLEAE&uach_m=[UACH]&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:18 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Wed, 09 Feb 2022 15:36:18 GMT
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977643%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977650%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977643%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977651%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json577
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.112.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-112-18.fra56.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

view
securepubads.g.doubleclick.net/pcs/ Frame 74EC
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssv1MDITvfxPqlU8qMLzdg6PFn-FDTVID8wm3ErveQpITTpFRRrEHOVQkN1xt74gQ2Lg7tuP8j0QUYv9W7S1vKOUS1-v6x0U88sXOYZBIVJ-WOyNE9ccYp78mKllxNb3PzcewEOU-ibjoMruWwl4TaMxiKfIVoFt4P0rvzLPDKgfH2Ct8TQmumN3r5VrUxfGlej78zJo8vOO_sRUVRoU6LR8LvDo2Kc7590z0kkrqtYYOZufV3Ci8Sxh6JHhidhDQ8jW6rkNp1mNUJIidMvm6tSCIyMU30k3DOzVOlzKuDkHj2F93xELXjKkjBPiFexDaCWlWsSe9gpnOwn83Vq1niu_VK3i-EUfl47MpwaY-9h7jk&sig=Cg0ArKJSzCWS1i4cLItGEAE&uach_m=[UACH]&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:18 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Wed, 09 Feb 2022 15:36:18 GMT
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977660%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977669%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977660%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977671%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json578
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.112.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-112-18.fra56.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

view
securepubads.g.doubleclick.net/pcs/ Frame D450
0
0
Fetch
General
Full URL
https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjstokn5q0P1VEHbuiB_t4Gv8xMfhw2Xu0xB1fBP7txhqeeAE_ZzpmmoFQ8yJ8HnC8IhP7yksnJlgUCdNylIdKqUYfl0hmahYOtR0Zsi5WPf0H_z4I0HxBm6TiGXenKq7P59vJzAz8k3hbZnE_--7NOlh-8MMILzwpNG6OvAInvb7UkLnBUWr4e8wMKxXC-mbTp7F6g8JrpThXoliyACBhDd3tuZL9UhcS6yGIyJ9aUjJ0GVW5BLaRw23MzkxpsNqgbozzp9ziIe-dkcQA-b2apWVlLaDCYSoplNyAQeyLZ5pIl74pKOm7s4qDi0BOeY005Iih6q6AbEetakoUyyzMtFVe0ScepjQe4nCUAY3WDsfVCg&sig=Cg0ArKJSzPRKw7u_2n4eEAE&uach_m=[UACH]&urlfix=1&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0%3D&adurl=
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
142.250.184.226 , United States, ASN15169 (GOOGLE, US),
Reverse DNS
fra24s12-in-f2.1e100.net
Software
cafe /
Resource Hash
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

timing-allow-origin
*
date
Wed, 09 Feb 2022 15:36:18 GMT
x-content-type-options
nosniff
accept-ch
Sec-CH-UA-Platform, Sec-CH-UA-Platform-Version, Sec-CH-UA-Arch, Sec-CH-UA-Model, Sec-CH-UA-Full-Version
p3p
policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin
*
cache-control
private
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
server
cafe
expires
Wed, 09 Feb 2022 15:36:18 GMT
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977679%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977690%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977679%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977691%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json579
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.112.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-112-18.fra56.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977623%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977628%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977623%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_all_%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_all_%5C%22%3A%5B%5C%222898354882%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977629%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json580
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.112.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-112-18.fra56.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

gen_204
pagead2.googlesyndication.com/pagead/ Frame 6287
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar&v=30&t=2&bgai=BSVjncd8DYoXsFZW2x_APsLe44AIAAAAAOAHgBAI&bg=!wMOlw4fNAAa4sGsQuLA7ACkAdvg8Ws0c0ELPd4NWwAumN4u_VNsjEZlbOBlib2aY9uiH5q83rs9N0gIAAAFRUgAAAAJoAQcKALubwzKFdidkeERjTBTvWPusGQIbg7pbV8jSYJZLeAbq0MKpIt6yiGYCc8RgAXCZMt-FRjqvtQDPC6ISFdTlW6NAt1-XYQlC8IPcvzV0HHqNIRPLCty1VkjqdKVLG0X2Du4KSzSgBj4TrOSQpSuOdVzLmqN3upKIEB9a5w0QmRTa4aYObIoHbkChe6snpz4o6ClLj2RWEUrJmn44c70b5MfCVhQBOyYeDiOB7XZkeMnMqVJIbVmxexBzPbrNmQKljwowJXTyDnijjkOlz7tB_ChoS5DBt0rSzW7IFLtDvkReQPmU0w863lCUPbNquaPdN6inFqJ1LAb2ySDNbCXqfqPxVv-Iy5leqgEdS0Ic9BhyHwFGTgK3pO7aiNVVcATrMCyluSos_YbO_m6ztSpouQ1b4QHHEOOcPQb_Vey9y6pdMaDscWYcR1N3CCtXD3s3wSFRASKl1iFbrOpEq6886E1nabkTW8pI_9u7wZ80cPnkqGdZiX3ELdZ7gz8WCpg3aYDKrgt0C0K3TXg1G4Gx8CyvKupba6jzRUcIY-lIigCkf5oab4QCsxYHPlLKPVN5u73L-JBkQHkrqbTqSOaTZtWX-JIbgaY1ULO1qGhp2wLLl3Jxyls8_aDYuC_F265MHDTdCTjOHzPO-jYlYyXbpRJFDAKsJXFJ0rPgRxsQkrwFvtnvZZ9otrrtbOKX6C_WL9szCuu9ciWiIR7VbD2flz0-QxbTvOBMFyegQvyI7P2d4u6D7hfU0E3Pt-b_KXPiuZaFkC7GtkVZSrkDaT1Pdnc0PIFKh8yXCHoY3ukuuqswyWLO32mleDtk6xZ8w3LxdhWoDCfAAPXg9Bt9LT5M8eUVWNaIt8_WpEDoIwQ_fmp4EWyEptJ5kMP893PFD4XnA8Z1rEbXvoDue5zU1HJikQsKYccQkzsiXfxBcBQ117nFYeOj_9SPxyaCMie1t5W1lQhtEgZLKsMsdX8SmZXjWRIwAAxpC0mZ9rOIekDxFfc8umYuxVTV6OabsY8TAuGT428ZKlrdVkagc9ngBijbpMpTkG3-rUBeU_MvjDEiYboCJwvKAzfJRhsA6Y1Zf4dM-DaEb6--PzXX0mveGio3fG7J5y71p85SGVCIQvzfFGaNWSivLpoF-2kmcI8wpE9pcwOpRiI
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:18 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
gen_204
pagead2.googlesyndication.com/pagead/ Frame F191
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar&v=30&t=2&bgai=B7H3xcd8DYoTsFZW2x_APsLe44AIAAAAAOAHgBAI&bg=!kpGlkdXNAAa4sGsQuLA7ACkAdvg8Wpkzkpsnk4DZ_LELfTRDSWJeERB4hY2ZDGFPMsJaLSUKlIRvaQIAAAFnUgAAAAFoAQcKANk4HIxfwN3hD5U-pcsMCa2tRLHsdf7lrSR3JVdBdzlIDgCeKSM9NqFqvttdPAYOcZH2i-oU3sX8HJb6UDVHiO8t3Y8dBU3T8HdrOUgFGznYppy1qlXLzXopa1Ib1fIO9BJhZn2Dt4sBMMFwacrJtR1nfFaSLac-2-cL8ovBoYZ5AD1pY1IiidOguz-NniyM0DdSirNP561tVy1-nocGKOXMxL6ULLVDCcs6ES2YD39i0q5HwbM4qryumDytHEMQzHj3VWVfySr6i5XWdufiI1WYOD3mIOe4UBF5mQKv0Is45rFuTg42PY2fUtBmMJrqfIzy1QiLwuoNPhCLNiGhaO2VoQoHSmDA3g93Ov9cYBMjR3jk7Zz0ZVrnu9uSY74NjRfpr3XvmAK16Xe31C8vKPRkH4Xc3XLdVUdRqJtXTgks2VZo4v_2yJAp6XSnhqAAtdqBNbXvl8o0AGLS4uK21VFwgEv1FSt_kWgWOMx7B6ViWCoNj_AJhDvnrE7Ot2As57upluYhYs-HRolKuLL3kuclgN2jGNAsTATkTVooJLIH9qch-u0vD4jS5e7Yq33LmNepm_gN8YQ4cUAQgwOtbmg3WWpAOTw12utxGa2FymdDDlmGxVHDlM5DufGpnDlVE8gdP8LOQaAYK4T0PVlRgwvJ4dPBu5VJZAGBu8pt0KQ6Jz7HbnP5AMiLE_h979Vy5HXWousTs3AD3Nvz0gpsMyvDLYwSN13PvMAvBlZj997kX9dLGUSTuxve-IS_MjwTccDS2jEOVL05zbyKqKG881908xEM2TiQNAf9uPmWEYyDBFdzzRR0BvVGf7Y-H0NLuq-HAZdvGTUixdyKV8L_a6VvlVURvM0eu06sEEWn0odwPwlKYul0DiVjr4GmRDTPHWgXCW_44c3R_aov9beVXuFHS6p2qBtKBFHhVRAC401S2AM1XXPEvkaM9zYaMGbv6fliBj4SdBAXqZuK3pUn_CXAhIT3D4B8QVg_q8wo2ZRuzP-75RUyuuZqbwY3gpy3zBeJ0fdcIRpVaGnxV1FKTqrYaUDpMNjXGLZ873R992D9SxRlZMd-NGIpH95Cr5jxcLkGqj92EMBkijWY-nNqCkfRDWhCZVgcVtUCKgj2rvjFZm8rjtisvveF6kVcM_SutYSzuWDWvYvN1TsvlMfLXWR_YKcZ-6WPHR6s7uovrK2lBvrkKDkxuyGKRcEe
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:18 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
gen_204
pagead2.googlesyndication.com/pagead/ Frame 58AF
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar&v=30&t=2&bgai=BL50acd8DYoLsFZW2x_APsLe44AIAAAAAOAHgBAI&bg=!Z2SlZCDNAAa4sGsQuLA7ACkAdvg8Wq1RX-yono8Ab-76BJL07ez8HSnUJQJTapkyj8n1nPO1JQEa_QIAAAFdUgAAAAFoAQeZAqCtZ2i3In2bWHJZ4R-7lLUC9Ec_Ucs-alBpFZVvHzIJvOxicgPa_Tw6irOK1Y7k9Ho5FYIB5I8VbthliqVVksP1gEKYvvHWaVQ81C4RL6R1xEu-DubMlTfUxR8WpVkGfbuChzYGbi33qqtL444IkpBhnKKCNY8OjU-mISJFGw0oBAvzgOCm9_48Ml9sF7cMWkVlyAgf3oWjS7vw4-D0kGALLZnZfxuIM5Vjr4p_1nGPo1eaUxvHa6qxqCIUdoL9BR8Q0i6I5XrN9jiyjqSa6X8NHOCBrNjRO_UGC8bBrb7iPmkowCOoD8yMZwS-JqkBbf0J1nbFwEKhDm72ZNvY9UeegswqtcOhTLAqMRF8BsUEMG3hvF7hE2KJWNcuzskQdd0fNEy3wTatESJ9N8lMIyG7OMTVEMsd-Fx0VAlyUXTO8EisChCYQcIHEotRgizF5BUqumHKpyvkADXaqtIhP62M5vv6XXwBAduIRR1OdmEtndAuPyPtyabwys-l3LYy-CJPpjJ2UI1dw85mITr-NLJ-UGjErzujzY0eUntFOgwJ9r2hp8GgTnzLzZj4HB54mawAVzNB4jYvURP84oeUoY8aYOh4HDrRiK961t5TqGtEpKIH15gq4zGAS0eLxrl6F3xadAvD2xOhNIPeSFIL8Yg4H-lxE9-A7O2xDuWuh_7JlouU2C5wyJjoj1e0ls8NvqnZzdbzlsWglXNJRDzUqp6x2x4RastLtm7oR33WamNk77chWUetz1G6lZ_WDTa0vLb0LBL2MT23CJx4j2HaHv09uf-ISJ6U8qpm9Gg3mfXBYamOyubvQz1MizfsgtViWgGboHSy3zI6h0PDMBzsMX96lRcfccgI6_Vd5IUQLBgC6EKBCYD-_liIrhJfrBP2x0E
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:18 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
gen_204
pagead2.googlesyndication.com/pagead/ Frame 03B7
0
20 B
Image
General
Full URL
https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar&v=30&t=2&bgai=BAOMxcd8DYoPsFZW2x_APsLe44AIAAAAAOAHgBAI&bg=!zM-lz4vNAAa4sGsQuLA7ACkAdvg8Wo2Hz-9KtHb9joL7rVPtGjzD6ItjnujM7Uw4owwWgclZQ5FwYwIAAAGWUgAAAAVoAQeZAqlXXWKI9Moau5iIMlOurfOeoogypjLq7nfQHsTYFLmsfUr2l5tAsDbX2DOAhPfMHV_ofBqdfz-4ePzAhoDF8xA5Yre5y2Ax6SAI31mkWG-v-PprxYz471Lpy2LUPmI4CnlUAb3LszzYifXj-Xs6BzLvYdVuQfvljdXg0MocofVBeFuXDjRK1Kk0pR85qrwRlh4gUf9DS5gci2W_yauEGZ5CDLYo8u2jSXNuE7FpW9ajJVrd8g18Hrk5NlScDHuesgl_rdUoiE-xUhicFXkZ78cF6YYiDxA2G3sFdRIBxL0wRKqNQ2Pb0-1KJp-XtEu5chJHHJuhulcxVMPQaikiEqEOF2hcsgDBup-8-rJlXh8MwB9IJV8MH9I3oKRX2OnteWKcx1dbYQivHoH90l6AmzdrmiquW3_hXLLtdXoDs_o219BFGBQSDRXMApsQjw_HYGT_vy7O7Chtjtcp8CGUSME48ACoTwjVEA6Op-dvVxEegiuE84yFWaOPsw5ru1Tws32hFLT4vf7hEuhvfqc2MZtohv4xzKCGq2_awlALTErGMmeA4_cWjC-xrVmn66bkgA88ON85hU56BURMFwZsj9d28QBcUIwTPgZ_cb0jhkxl61dtdyJEHvyV3Yw--DR4QUpbL1wbTjM198cP0V2zUx6Rw_OAr59LExf0jJucHhzrS1CdzdgkHyqK0bGR3xSiBYDB7MkKg8ATMgt1uB-FMNMWHGUFV2SiZ2tdrLcuKklSyly6hfb8XqHScuzsVnhsersFR8iP5jc6nrm7L3Ru64tjqt3LFo5J0e5O7HHUCNd-TGnHAJ7YTAjp76wt42ndmPjEwCp0VHsnLMVHi6LeIHFOvRHRoaQC8p_xBk8Zyx4MDyTwg1NKGzUtV-jHcbdDO6kCmhUEb5PN1FY
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://tpc.googlesyndication.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:18 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
0
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
multitracking
ghb.hbmp.mediafuse.com/adunit/
0
211 B
XHR
General
Full URL
https://ghb.hbmp.mediafuse.com/adunit/multitracking
Requested by
Host: player.hbmp.mediafuse.com
URL: https://player.hbmp.mediafuse.com/prebidlink/456783/hbw_master_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a06:8640:799:0:ec4:7aff:fe6e:a48e Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Wed, 09 Feb 2022 15:36:17 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
p
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://sample.dragonforms.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Wed, 09 Feb 2022 15:36:17 GMT
Server
Apache
p
olytics.omeda.com/olytics/segments/ Frame 4E7F
0
197 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/p
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://sample.dragonforms.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
application/json

Response headers

Access-Control-Allow-Origin
*
Date
Wed, 09 Feb 2022 15:36:17 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-XSS-Protection
1; mode=block
X-Frame-Options
SAMEORIGIN
cswitch
olytics.omeda.com/olytics/segments/ Frame 4E7F
94 B
387 B
XHR
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Requested by
Host: olytics.omeda.com
URL: https://olytics.omeda.com/olytics/js/v3/p/olytics.min.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash
680e1442c007ce398c61aa402c79c92d347eea5ff2826db202d6025b687377d3
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://sample.dragonforms.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
application/json

Response headers

Date
Wed, 09 Feb 2022 15:36:17 GMT
X-Content-Type-Options
nosniff
Server
Apache
X-Frame-Options
SAMEORIGIN
Content-Type
application/json
Access-Control-Allow-Origin
*
Cache-Control
no-cache
Transfer-Encoding
chunked
X-XSS-Protection
1; mode=block
cswitch
olytics.omeda.com/olytics/segments/ Frame
0
0
Preflight
General
Full URL
https://olytics.omeda.com/olytics/segments/cswitch
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_256_GCM
Server
204.180.130.159 , United States, ASN53866 (QTS-AS, US),
Reverse DNS
my.omedastaging.com
Software
Apache /
Resource Hash

Request headers

Accept
*/*
Access-Control-Request-Method
POST
Access-Control-Request-Headers
content-type
Origin
https://sample.dragonforms.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

Access-Control-Allow-Origin
*
vary
Access-Control-Request-Headers,Access-Control-Request-Headers,access-control-request-method
Access-Control-Max-Age
1800
Access-Control-Allow-Methods
HEAD,DELETE,POST,GET,OPTIONS,PUT
Access-Control-Allow-Headers
access-control-max-age,accept-language,origin,x-requested-with,access-control-request-headers,host,content-type,access-control-request-method,accept-encoding,accept,user-agent
Content-Length
0
Date
Wed, 09 Feb 2022 15:36:17 GMT
Server
Apache
/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977643%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977650%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977643%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977651%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json581
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.112.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-112-18.fra56.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977660%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977669%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977660%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977671%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json582
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.112.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-112-18.fra56.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

/
c405.fiercepharma.com/DG/DEFAULT/rest/rpc/
0
0
Script
General
Full URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977679%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977690%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977679%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977691%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json583
Requested by
Host: cdn.blueconic.net
URL: https://cdn.blueconic.net/questex.js
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
18.66.112.18 , United States, ASN16509 (AMAZON-02, US),
Reverse DNS
server-18-66-112-18.fra56.r.cloudfront.net
Software
/
Resource Hash

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

mut
ghb.adtelligent.com/adunit/ Frame D0E0
0
204 B
XHR
General
Full URL
https://ghb.adtelligent.com/adunit/mut
Requested by
Host: p.annocdn.com
URL: https://p.annocdn.com/prebidlink/19032/pbm_307825_11594.js
Protocol
HTTP/1.1
Security
TLS 1.3, , AES_128_GCM
Server
2a06:8640:799:0:ec4:7aff:fe6e:a48e Piscataway, United States, ASN55081 (24SHELLS, US),
Reverse DNS
Software
VertaMedia 1.0 /
Resource Hash
e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer
https://p.annocdn.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

Access-Control-Allow-Origin
https://p.annocdn.com
Date
Wed, 09 Feb 2022 15:36:17 GMT
Access-Control-Allow-Credentials
true
Server
VertaMedia 1.0
Connection
Keep-Alive
activeview
pagead2.googlesyndication.com/pcs/ Frame D450
42 B
64 B
Fetch
General
Full URL
https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjstgtrDDnaFgLJiusW6q9nd6qeiks0-dExjg7UhKjUneY_jMbi8bUe8UN7Z4FOgQRhoCICi7R2zsDJn6DBviy72M46WY5aSmn2NwkehLR5Un4wb2tCMX05kdMQ9OyJwkbDWoslDgh4NT7Af97CRREjv9UNMXPmCXOB6nq_Evgm5ksqH2ICl9j94h&sig=Cg0ArKJSzFFnDy8hj8wWEAE&id=lidar2&mcvt=1000&p=988,315,1078,1285&mtos=1000,1000,1000,1000,1000&tos=1000,0,0,0,0&v=20220207&bin=7&avms=nio&bs=1600,1200&mc=1&app=0&itpl=19&adk=313090359&rs=4&la=0&cr=0&uach=WyIiLCIiLCIiLCIiLCIiLFtdLG51bGwsbnVsbCwiIixbXV0%3D&vs=4&r=v&rst=1644420977450&rpt=611&isd=0&lsd=0&met=ie&wmsd=0
Requested by
Host: www.googletagservices.com
URL: https://www.googletagservices.com/activeview/js/current/rx_lidar.js?cache=r20110914
Protocol
H3
Security
QUIC, , AES_128_GCM
Server
2a00:1450:4001:829::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software
cafe /
Resource Hash
ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629
Security Headers
Name Value
X-Content-Type-Options nosniff
X-Xss-Protection 0

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:19 GMT
x-content-type-options
nosniff
server
cafe
timing-allow-origin
*
p3p
policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin
*
cache-control
no-cache, must-revalidate
cross-origin-resource-policy
cross-origin
content-type
image/gif
alt-svc
h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length
42
x-xss-protection
0
expires
Fri, 01 Jan 1990 00:00:00 GMT
report
creative.spotible.com/creative/f4mq/
43 B
98 B
Image
General
Full URL
https://creative.spotible.com/creative/f4mq/report?,1644420976,444003;IN_VIEW_TIME!0,4,0!18,3,0!55,4,0!69,4,0!113,3,0!120,4,0&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.215.243.168 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-215-243-168.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:20 GMT
cache-control
no-store
content-length
43
content-type
image/gif
json
gum.criteo.com/sid/ Frame
0
0
Preflight
General
Full URL
https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
2a02:2638::1c , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept
*/*
Access-Control-Request-Method
GET
Access-Control-Request-Headers
content-type
Origin
https://www.fiercepharma.com
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
content-type
application/json; charset=utf-8
expires
0
access-control-allow-origin
https://www.fiercepharma.com
access-control-allow-headers
content-type
access-control-allow-credentials
true
access-control-allow-methods
GET
server-processing-duration-in-ticks
1588
date
Wed, 09 Feb 2022 15:36:19 GMT
strict-transport-security
max-age=31536000; preload;
content-encoding
gzip
vary
Accept-Encoding
sid
mug.criteo.com/
Redirect Chain
  • https://gum.criteo.com/sid/json?origin=prebid&topUrl=https%3A%2F%2Fwww.fiercepharma.com%2F&domain=www.fiercepharma.com&cw=1&pbt=1&lsw=1
  • https://mug.criteo.com/sid?cpp=zk4gtXx0WTJhVHhHSGh1Q0x1b3VLV0g2S05XM1JjRkZGUmlpMlRXUlQ0SmdJczBxOHhCK2cySnM0SHAyc2I0bzhBZWNtZS9DSzlmRS9CSlNjQi9qMmYvNUxlY21SeE9CM3JoSnZwd0xsZ3gxN3dNcERqVHh2YUVpb1dCb0...
350 B
619 B
XHR
General
Full URL
https://mug.criteo.com/sid?cpp=zk4gtXx0WTJhVHhHSGh1Q0x1b3VLV0g2S05XM1JjRkZGUmlpMlRXUlQ0SmdJczBxOHhCK2cySnM0SHAyc2I0bzhBZWNtZS9DSzlmRS9CSlNjQi9qMmYvNUxlY21SeE9CM3JoSnZwd0xsZ3gxN3dNcERqVHh2YUVpb1dCb0pQUHcrSDVWTU9LU29PNVJuMmRwdUV4UHlRV1NIQUZBcndEMytGdUpjaFJxTU9sZUdtN0FoYnpBU3pEWFltR0RIWW9DcFd2ZUV2NVBhZGRmTXBEVHJZVFZKblRzbUV1L0tqM3JMalppK2RPbk5OUUJEQkJPOVJPT2dDT04yeTYxMXByUUlxWkU0fA&cppv=2
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Server
178.250.2.146 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
39a02aba60adfb61bc7941f96731a9b09f5ad686c282e31953585368fde18826
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:19 GMT
content-encoding
gzip
vary
Accept-Encoding
access-control-allow-methods
GET
content-type
application/json; charset=utf-8
access-control-allow-origin
null
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
2977
strict-transport-security
max-age=31536000; preload;
expires
0

Redirect headers

pragma
no-cache
date
Wed, 09 Feb 2022 15:36:19 GMT
location
https://mug.criteo.com/sid?cpp=zk4gtXx0WTJhVHhHSGh1Q0x1b3VLV0g2S05XM1JjRkZGUmlpMlRXUlQ0SmdJczBxOHhCK2cySnM0SHAyc2I0bzhBZWNtZS9DSzlmRS9CSlNjQi9qMmYvNUxlY21SeE9CM3JoSnZwd0xsZ3gxN3dNcERqVHh2YUVpb1dCb0pQUHcrSDVWTU9LU29PNVJuMmRwdUV4UHlRV1NIQUZBcndEMytGdUpjaFJxTU9sZUdtN0FoYnpBU3pEWFltR0RIWW9DcFd2ZUV2NVBhZGRmTXBEVHJZVFZKblRzbUV1L0tqM3JMalppK2RPbk5OUUJEQkJPOVJPT2dDT04yeTYxMXByUUlxWkU0fA&cppv=2
strict-transport-security
max-age=31536000; preload;
access-control-allow-methods
GET
content-type
text/html; charset=utf-8
access-control-allow-origin
https://www.fiercepharma.com
cache-control
no-cache, no-store, must-revalidate
access-control-allow-credentials
true
server-processing-duration-in-ticks
1925
content-length
509
expires
0
692.json
id5-sync.com/g/v2/
213 B
538 B
XHR
General
Full URL
https://id5-sync.com/g/v2/692.json
Requested by
Host: player.mediafuse.com
URL: https://player.mediafuse.com/prebidlink/456783/hb_302826_6936.js
Protocol
HTTP/1.1
Security
TLS 1.2, ECDHE_RSA, AES_128_GCM
Server
54.36.109.166 , France, ASN16276 (OVH, FR),
Reverse DNS
p10.id5-sync.com
Software
/
Resource Hash
3c74e26a6bbfae2e15045641952ba02844f9b94d1144ea5c59e827d47c19df86
Security Headers
Name Value
Strict-Transport-Security max-age=63072000; includeSubDomains; preload

Request headers

Referer
https://www.fiercepharma.com/
Accept-Language
de-DE,de;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Content-Type
text/plain

Response headers

Access-Control-Allow-Origin
https://www.fiercepharma.com
Date
Wed, 09 Feb 2022 15:36:20 GMT
Access-Control-Allow-Credentials
true
Vary
Origin
Transfer-Encoding
chunked
Strict-Transport-Security
max-age=63072000; includeSubDomains; preload
Content-Type
application/json;charset=UTF-8
sid
mug.criteo.com/ Frame
0
0
Preflight
General
Full URL
https://mug.criteo.com/sid?cpp=zk4gtXx0WTJhVHhHSGh1Q0x1b3VLV0g2S05XM1JjRkZGUmlpMlRXUlQ0SmdJczBxOHhCK2cySnM0SHAyc2I0bzhBZWNtZS9DSzlmRS9CSlNjQi9qMmYvNUxlY21SeE9CM3JoSnZwd0xsZ3gxN3dNcERqVHh2YUVpb1dCb0pQUHcrSDVWTU9LU29PNVJuMmRwdUV4UHlRV1NIQUZBcndEMytGdUpjaFJxTU9sZUdtN0FoYnpBU3pEWFltR0RIWW9DcFd2ZUV2NVBhZGRmTXBEVHJZVFZKblRzbUV1L0tqM3JMalppK2RPbk5OUUJEQkJPOVJPT2dDT04yeTYxMXByUUlxWkU0fA&cppv=2
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
178.250.2.146 , France, ASN44788 (ASN-CRITEO-EUROPE, FR),
Reverse DNS
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000; preload;

Request headers

Accept
*/*
Access-Control-Request-Method
GET
Access-Control-Request-Headers
content-type
Origin
null
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36
Sec-Fetch-Mode
cors

Response headers

cache-control
no-cache, no-store, must-revalidate
pragma
no-cache
content-type
application/json; charset=utf-8
expires
0
access-control-allow-origin
null
access-control-allow-headers
content-type
access-control-allow-credentials
true
access-control-allow-methods
GET
server-processing-duration-in-ticks
1151
date
Wed, 09 Feb 2022 15:36:19 GMT
strict-transport-security
max-age=31536000; preload;
content-encoding
gzip
vary
Accept-Encoding
report
creative.spotible.com/creative/f4mq/
43 B
98 B
Image
General
Full URL
https://creative.spotible.com/creative/f4mq/report?,1644420976,444004;IN_VIEW_TIME!0,3,0!18,4,0!55,3,0!69,3,0!113,4,0!120,3,0&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.215.243.168 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-215-243-168.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:23 GMT
cache-control
no-store
content-length
43
content-type
image/gif
report
creative.spotible.com/creative/f4mq/
43 B
98 B
Image
General
Full URL
https://creative.spotible.com/creative/f4mq/report?,1644420976,444005;IN_VIEW_TIME!0,3,0!18,3,0!55,3,0!69,3,0!113,3,0!120,3,0&referrer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten
Requested by
Host: www.fiercepharma.com
URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Protocol
H2
Security
TLS 1.3, , AES_128_GCM
Server
3.215.243.168 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS
ec2-3-215-243-168.compute-1.amazonaws.com
Software
/
Resource Hash
b1442e85b03bdcaf66dc58c7abb98745dd2687d86350be9a298a1d9382ac849b

Request headers

Accept-Language
de-DE,de;q=0.9
Referer
https://www.fiercepharma.com/
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/98.0.4758.80 Safari/537.36

Response headers

date
Wed, 09 Feb 2022 15:36:26 GMT
cache-control
no-store
content-length
43
content-type
image/gif

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A14%2B00%3A00&ts=1644420974570
Domain
rtb.adxpremium.services
URL
https://rtb.adxpremium.services/openrtb2/auction
Domain
rtb.adxpremium.services
URL
https://rtb.adxpremium.services/openrtb2/auction
Domain
rtb.adxpremium.services
URL
https://rtb.adxpremium.services/openrtb2/auction
Domain
rtb.adxpremium.services
URL
https://rtb.adxpremium.services/openrtb2/auction
Domain
rtb.adxpremium.services
URL
https://rtb.adxpremium.services/openrtb2/auction
Domain
ads.spotible.com
URL
https://ads.spotible.com/tag/universal-tag.js
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977624
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977644
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977666
Domain
c405.fiercepharma.com
URL
https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977680

Verdicts & Comments Add Verdict or Comment

116 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| 0 object| 1 object| 2 object| 3 object| 4 object| 5 object| 6 object| 7 object| 8 object| 9 object| 10 object| 11 object| event function| structuredClone object| NREUM object| newrelic function| __nr_require function| mobileCheck object| dataLayerValues object| dataLayer object| googletag object| vmpbjs object| vpb object| a2a_config object| Modernizr object| blueConicPreListeners function| BCClass object| blueConicClient function| bc_json573 string| ssaUrl undefined| $ function| jQuery object| drupalSettings object| Drupal object| picturefillCFG function| picturefill function| _toConsumableArray function| disablePurgingButton object| WebFont object| ggeac object| google_js_reporting_queue object| google_tag_manager string| GoogleAnalyticsObject function| ga object| google_tag_data string| method string| bid string| oid object| olytics object| a string| qtxSection object| a2a function| a2a_show_dropdown function| a2a_miniLeaveDelay function| a2a_init number| a2apage_init undefined| google_measure_js_timing object| PARSELY object| gaplugins object| gaGlobal object| gaData function| Dpxl object| dpmPixels object| jQuery111102601779594524847 function| mktoMunchkinFunction object| Munchkin function| mktoMunchkin function| vmpbjsChunk object| _pbjsGlobals object| mnet string| nobidVersion object| nobid object| MktoForms2 function| mktoFormSubmitCallback function| _typeof object| _ml function| readCookie function| profileIdExecute string| queryString boolean| disableBcMarketoIntegration boolean| CE_USER_SCRIPT object| CE2 string| CE_USER_DATA_URL object| MunchkinTracker string| CE_USER_COMMON_SCRIPT_URL string| CE_USER_THIRDPARTY_SCRIPT_URL object| CE2BH function| CE_URL_FINGERPRINT function| bc_json574 object| Criteo object| googleToken object| googleIMState function| processGoogleToken number| google_unique_id function| setImmediate function| clearImmediate function| normalize function| bc_json575 function| __$PP object| spotible object| auvars object| w7eDOMEvents function| docReady object| au object| autag object| criteo_pubtag object| criteo_pubtag_prebid_117 object| Criteo_prebid_117 function| bc_json576 function| bc_json577 function| bc_json578 function| bc_json579 function| bc_json580 function| bc_json581 function| bc_json582 function| bc_json583

78 Cookies

Domain/Path Name / Value
www.fiercepharma.com/special-report Name: hasLiveRampMatch
Value: true
www.fiercepharma.com/ Name: last_visit_bc
Value: 1644420974055
.fiercepharma.com/ Name: _ga
Value: GA1.2.1143913336.1644420975
.fiercepharma.com/ Name: _gid
Value: GA1.2.1561711950.1644420975
.fiercepharma.com/ Name: _gat_UA-336524-28
Value: 1
.app-sj10.marketo.com/ Name: __cf_bm
Value: 0sjzW4fXMsH9JNfJ9b3qR3VSAN.IGKRTt7rogckPZyY-1644420974-0-AUDa69xtjks0DpwXPuLriA4j/0Uepx7Gr3+2j3BcpqhMUK8Y7kj89ss73XYPZy91C3rSooRfJsClDw44g/ogL3U=
www.fiercepharma.com/ Name: dpm_url_count
Value: 1
.adnxs.com/ Name: uuid2
Value: 1521003946560112395
.fiercepharma.com/ Name: _parsely_session
Value: {%22sid%22:1%2C%22surl%22:%22https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten%22%2C%22sref%22:%22%22%2C%22sts%22:1644420974641%2C%22slts%22:0}
.fiercepharma.com/ Name: _parsely_visitor
Value: {%22id%22:%22pid=ec1936911eda5a9ebc764a19a2b3d83e%22%2C%22session_count%22:1%2C%22last_session_ts%22:1644420974641}
.fiercepharma.com/ Name: _mkto_trk
Value: id:294-MQF-056&token:_mch-fiercepharma.com-1644420974676-46333
.ws.zoominfo.com/ Name: visitorId
Value: 9251230ef13f0c181aeac657483f2367fae8478f6122525ff93b07187528696e
sample.dragonforms.com/ Name: JSESSIONID
Value: 7A96E48C4BC732B16292C5D4DE636B21
.hbmp.mediafuse.com/ Name: vmuid
Value: e1fe37d60e9ba04b
.adtelligent.com/ Name: vmuid
Value: f4b0d7c034dd141c
www.fiercepharma.com/ Name: _pbjs_userid_consent_data
Value: 3524755945110770
.fiercepharma.com/ Name: _pubcid
Value: 27248500-09db-46fe-83fe-d89b65c9ccbf
.dpmsrv.com/ Name: dpm_pxl
Value: 79863853af97082a7d3787205eba663b9429fc74
.dpmsrv.com/ Name: dpm_pxl_aid
Value: 1521003946560112395
.admixer.net/ Name: am-uid
Value: 560247090b3c42ffaf789405e5348a26
.lijit.com/ Name: ljtrtb
Value: eJyrrgUAAXUA%2BQ%3D%3D
.go.sonobi.com/ Name: __uih
Value: 1
.go.sonobi.com/ Name: HAPLB5A
Value: s569|YgPfc
.fiercepharma.com/ Name: oly_enc_id
Value: null
.fiercepharma.com/ Name: oly_anon_id
Value: %222c0d619f-d327-450e-834b-d392a2544ee7%22
.doubleclick.net/ Name: IDE
Value: AHWqTUneUoq6ILLwQobVd8ce88gdSSAkcXyuecAwISfSsLmUv_A-DZp24ffzYYsDxMg
.betweendigital.com/ Name: dc
Value: was1
.betweendigital.com/ Name: tuuid
Value: ec03dc19-58c6-5328-8e62-44acec619bc3
.betweendigital.com/ Name: ut
Value: YgPfbwAJVqCFC8_WfFynDiJM5ceXOcblLF8ERg==
.betweendigital.com/ Name: ss
Value: 1
.betweendigital.com/ Name: unm
Value: 1
.rubiconproject.com/ Name: khaos
Value: KZFPSHAS-D-6WD
.rubiconproject.com/ Name: audit
Value: 1|hLZGFuTafB3/p3ulrz9LnP+oE/PhLWQEKtLvkckcz9t2wHsFnqwQFH1e8LJd5Si62Viil87TsQADU4L+VXaOPcBQn6AvuCLF61D5O5FC39QCLOF+SfmOaw==
.contextweb.com/ Name: V
Value: GlshiBi1LVCC
prebid.a-mo.net/ Name: __amc
Value: 1_1644420975_1644420975
.ad.gt/ Name: au_id
Value: d8c30461-bd3e-4abf-9ed6-3e6c3f35ef49
.ad.gt/ Name: au_idmatch
Value: {"apn": "2022-02-09", "ttd": "2022-02-09", "pub": "2022-02-09", "adx": "2022-02-09", "halo": "2022-02-09", "goo": "2022-02-09", "ado": "2022-02-09", "smart": "2022-02-09", "impr": "2022-02-09"}
.adnxs.com/ Name: icu
Value: ChgIk419EAoYASABKAEw8L6PkAY4AUABSAEQ8L6PkAYYAA..
.adsrvr.org/ Name: TDID
Value: c11d1b10-ea13-4e77-a2d1-20ec64332d28
.demdex.net/ Name: demdex
Value: 62058959424908984673071064968801906464
.adsrvr.org/ Name: TDCPM
Value: CAEYBSABKAIyCwj02tPDlPu1OhAFOAE.
.dpm.demdex.net/ Name: dpm
Value: 62058959424908984673071064968801906464
.360yield.com/ Name: tuuid
Value: c9317cb7-bf2e-465e-b7ee-531af9130fae
.360yield.com/ Name: tuuid_lu
Value: 1644420976
.pubmatic.com/ Name: KTPCACOOKIE
Value: true
.ad.gt/ Name: last_seeng_hosted
Value: 1644420976519
.ad.gt/ Name: g_hosted
Value:
.ad.gt/ Name: last_seenadnxs
Value: 1644420976530
.ad.gt/ Name: adnxs_id
Value: 1521003946560112395
.ad.gt/ Name: first_seenadnxs
Value: 1644420976530
.ad.gt/ Name: last_seenadb
Value: 1644420976533
.ad.gt/ Name: adb
Value: 62058959424908984673071064968801906464
.ad.gt/ Name: last_seenadx
Value: 1644420976533
.ad.gt/ Name: google_gid
Value: CAESEPpBdfmxhS_Ja7mAPsrE_W8
.ad.gt/ Name: first_seenadx
Value: 1644420976533
.pubmatic.com/ Name: KADUSERCOOKIE
Value: 5FBA7F2A-C28D-4634-958B-689A4440E22D
.ad.gt/ Name: last_seentd
Value: 1644420976533
.ad.gt/ Name: tdid
Value: c11d1b10-ea13-4e77-a2d1-20ec64332d28
.ad.gt/ Name: first_seentd
Value: 1644420976533
.ad.gt/ Name: last_seenimprove
Value: 1644420976536
.ad.gt/ Name: impr_uid
Value: c9317cb7-bf2e-465e-b7ee-531af9130fae
.ad.gt/ Name: last_seenpbm
Value: 1644420976744
.ad.gt/ Name: pbm
Value: 5FBA7F2A-C28D-4634-958B-689A4440E22D
.ad.gt/ Name: first_seenpbm
Value: 1644420976744
.adnxs.com/ Name: anj
Value: dTM7k!M4/8CxrEQF']wIg2In1s'<ki!]tbP6j2F-XstGt!@Dmn$q]k*
.dpmsrv.com/ Name: xdpm_segsid_913
Value: 16013439%2C16671093%2C29315652%2C29315642%2C29430809%2C29028703
.dpmsrv.com/ Name: xdpm_segs_913
Value:
.ad.gt/ Name: last_seenhaloid
Value: 1644420976863
.ad.gt/ Name: halo_id
Value: 0200j2q9gt07jv2yg08xizqr0bwpa1w0evvljv1k7cm961o8b5po0ntek210qskvk40trr7270wqxik90zq3u2c12pa5j31k0gxf118nmsj90fzd0bt1elzfjf1hl5r1i1kkc2jl
.ad.gt/ Name: first_seenhaloid
Value: 1644420976863
.dragonforms.com/ Name: oly_enc_id
Value: null
.fiercepharma.com/ Name: __gads
Value: ID=383af4d7f074109a:T=1644420975:S=ALNI_MZnAnt9RqmMir6HNwXoWsSoTARqbA
.dragonforms.com/ Name: oly_anon_id
Value: %22bba97cad-68a6-4113-80bc-357cc3f077cc%22
c405.fiercepharma.com/ Name: AWSALB
Value: b/IKB5M9cD9oTx5w+K8NrDb7pWHU40DUOhaTHaLKtv17SLQoALF00WXYC7Qi6HMMlfi6TPR1L49EYgirShe/1vv/JLS+BvKsV+okhKZ0go+PBfk4wiYkvvYRqXPn
c405.fiercepharma.com/ Name: AWSALBCORS
Value: b/IKB5M9cD9oTx5w+K8NrDb7pWHU40DUOhaTHaLKtv17SLQoALF00WXYC7Qi6HMMlfi6TPR1L49EYgirShe/1vv/JLS+BvKsV+okhKZ0go+PBfk4wiYkvvYRqXPn
.fiercepharma.com/ Name: cto_bundle
Value: 5bzfsF9SYVVOWUhtMThqUFJpTng0TWhTcU9JNERLamgzTUdPYjVCY2c2V1l4Q0d5Tjdwd0dMSnpVZ3RGeE9WMDZ0JTJGWVBJcSUyRmFuV3VJJTJCUktGYks1eCUyRkdaamxRUGpFSlFDSTFBOXFWMU5Bbkc2U1I1c3NhMjVuZ1QwcGcxN08lMkJHRDhaJTJCZA
.fiercepharma.com/ Name: cto_bidid
Value: P023-V9WNDFSSW5MbXNNQU93dHM3VGp1a28wdG9ZSnVEUUdGZUVKSDlZM202bGxsV21mMUE1WWxvNTA4WnBSOFNvJTJCbG1RVmM5TmhKbklsSzlZSDZQM1hiOWd3JTNEJTNE
www.fiercepharma.com/ Name: dpm_time_site
Value: 7.011

23 Console Messages

Source Level URL
Text
network error URL: https://questex.blueconic.net/DG/DEFAULT/cs?&callback=bc_json573
Message:
Failed to load resource: the server responded with a status of 404 ()
javascript error URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A14%2B00%3A00&ts=1644420974570' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A14%2B00%3A00&ts=1644420974570
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://prebid.adnxs.com/pbs/v1/openrtb2/auction
Message:
Failed to load resource: the server responded with a status of 400 (Bad Request)
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644420974057%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420974060%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420974061%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644420974062%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A15%2B00%3A00&callback=bc_json574
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://idsync.rlcdn.com/423396.gif?partner_uid=1521003946560112395
Message:
Failed to load resource: the server responded with a status of 451 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22getProfile%22%2C%22params%22%3A%22null%22%2C%22id%22%3A%221644420974057%22%7D%2C%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22language%5C%22%3A%5B%5C%22en%5C%22%5D%2C%5C%22currentscreenwidth%5C%22%3A%5B1600%5D%2C%5C%22currentscreenheight%5C%22%3A%5B1200%5D%2C%5C%22currentresolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%2C%5C%22entrypage%5C%22%3A%5B%5C%22https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten%5C%22%5D%2C%5C%22new_visit_bc%5C%22%3A%5B%5C%22true%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22language%5C%22%2C%5C%22currentscreenwidth%5C%22%2C%5C%22currentscreenheight%5C%22%2C%5C%22currentresolution%5C%22%2C%5C%22entrypage%5C%22%5D%2C%5C%22newvisitlistener%5C%22%3A%5B%5C%22new_visit_bc%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420974060%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22resolution%5C%22%3A%5B%5C%221600x1200%5C%22%5D%7D%2C%5C%22sources%5C%22%3A%7B%5C%22listenerinteractiontype%5C%22%3A%5B%5C%22resolution%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420974061%22%7D%2C%7B%22method%22%3A%22createEvent%22%2C%22params%22%3A%22%7B%5C%22type%5C%22%3A%5B%5C%22PAGEVIEW%5C%22%5D%2C%5C%22referrer%5C%22%3A%5B%5C%22%5C%22%5D%2C%5C%22profile%5C%22%3A%5B%5D%7D%22%2C%22id%22%3A%221644420974062%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A15%2B00%3A00&callback=bc_json575
Message:
Failed to load resource: the server responded with a status of 404 ()
javascript error URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977624' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977624
Message:
Failed to load resource: net::ERR_FAILED
javascript error URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977644' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977644
Message:
Failed to load resource: net::ERR_FAILED
javascript error URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977666' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977666
Message:
Failed to load resource: net::ERR_FAILED
javascript error URL: https://www.fiercepharma.com/special-report/10-most-anticipated-drug-launches-2022-8-mavacamten
Message:
Access to XMLHttpRequest at 'https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977680' from origin 'https://www.fiercepharma.com' has been blocked by CORS policy: No 'Access-Control-Allow-Origin' header is present on the requested resource.
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/572?referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A17%2B00%3A00&ts=1644420977680
Message:
Failed to load resource: net::ERR_FAILED
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977623%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977628%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977623%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_all_%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_all_%5C%22%3A%5B%5C%222898354882%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977629%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json576
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977643%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977650%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977643%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977651%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json577
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977660%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977669%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977660%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977671%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json578
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977679%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977690%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977679%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977691%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json579
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977643%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977650%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977643%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977651%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json581
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977623%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977628%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977623%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_all_%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_all_%5C%22%3A%5B%5C%222898354882%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977629%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json580
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977679%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977690%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977679%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977691%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json583
Message:
Failed to load resource: the server responded with a status of 404 ()
network error URL: https://c405.fiercepharma.com/DG/DEFAULT/rest/rpc/?requests=%5B%7B%22method%22%3A%22setProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_mr%5C%22%3A%5B%5C%221644420977660%5C%22%5D%2C%5C%22ad_viewed_-_banner_id_mr%5C%22%3A%5B%5C%225773092226%5C%22%5D%2C%5C%22ad_viewed_-_order_id_most_recent_%5C%22%3A%5B%5C%222898354882%5C%22%5D%2C%5C%22ad_viewed_-_source_most_recent_%5C%22%3A%5B%5C%22wrapper%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977669%22%7D%2C%7B%22method%22%3A%22addProperties%22%2C%22params%22%3A%22%7B%5C%22properties%5C%22%3A%7B%5C%22ad_viewed_all_%5C%22%3A%5B%5C%221644420977660%5C%22%5D%7D%7D%22%2C%22id%22%3A%221644420977671%22%7D%5D&referer=https%3A%2F%2Fwww.fiercepharma.com%2Fspecial-report%2F10-most-anticipated-drug-launches-2022-8-mavacamten&bcsessionid=&bctempid=&overruleReferrer=&time=2022-02-09T15%3A36%3A18%2B00%3A00&callback=bc_json582
Message:
Failed to load resource: the server responded with a status of 404 ()

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

294-mqf-056.mktoresp.com
73a3e8657f23645a3dbd8f1241c4efa7.safeframe.googlesyndication.com
a.ad.gt
a.dpmsrv.com
acdn.adnxs.com
ad.360yield.com
ads.betweendigital.com
ads.servenobid.com
ads.spotible.com
ads.yieldmo.com
adservice.google.com
adservice.google.de
adtelligent-d.openx.net
ajax.googleapis.com
ap.lijit.com
apex.go.sonobi.com
api-54-245-167-10.b2c.com
api.fouanalytics.com
app-sj10.marketo.com
assets-tracking.crazyegg.com
aufp.io
bid.contextweb.com
bidder.criteo.com
c2shb.ssp.yahoo.com
c405.fiercepharma.com
cdn.blueconic.net
cdn.omeda.com
cdn.parsely.com
cdn.spotible.com
cm.g.doubleclick.net
code.jquery.com
colossusssp.com
creative.spotible.com
d1z2jf7jlzjs58.cloudfront.net
dm.hybrid.ai
dpm.demdex.net
fastlane.rubiconproject.com
fonts.googleapis.com
fonts.gstatic.com
ghb.adtelligent.com
ghb.hbmp.mediafuse.com
googleads4.g.doubleclick.net
gum.criteo.com
hbopenbid.pubmatic.com
hostedcontent.dragonforms.com
htlb.casalemedia.com
ib.adnxs.com
id5-sync.com
ids.ad.gt
idsync.rlcdn.com
image2.pubmatic.com
in.ml314.com
inv-nets.admixer.net
match.adsrvr.org
ml314.com
mug.criteo.com
munchkin.marketo.net
olytics.omeda.com
onetag-sys.com
oqs.omeda.com
p.ad.gt
p.annocdn.com
p1.parsely.com
pagead2.googlesyndication.com
pagestates-tracking.crazyegg.com
pbjs.e-planning.net
pixel-a.basis.net
pixel.sitescout.com
pixels.ad.gt
player.adtelligent.com
player.hbmp.mediafuse.com
player.mediafuse.com
prebid-eu.creativecdn.com
prebid-us.creativecdn.com
prebid.a-mo.net
prebid.adnxs.com
prebid.deepintent.com
prebid.media.net
qtxasset.com
questex.blueconic.net
rtb.adxpremium.services
s.dpmsrv.com
s0.2mdn.net
sample.dragonforms.com
script.crazyegg.com
secure.adnxs.com
securepubads.g.doubleclick.net
static.addtoany.com
static.criteo.net
stats.g.doubleclick.net
sync.adtelligent.com
sync.medidexs.com
sync.smartadserver.com
t.trafmag.com
tag.1rx.io
tpc.googlesyndication.com
tracking.crazyegg.com
u.openx.net
v4-api-54-245-167-10.b2c.com
ws.zoominfo.com
www.fiercepharma.com
www.google-analytics.com
www.googletagmanager.com
www.googletagservices.com
ads.spotible.com
c405.fiercepharma.com
rtb.adxpremium.services
104.111.234.67
104.16.92.80
104.16.93.165
104.18.15.141
108.128.129.221
13.224.194.178
13.224.228.100
13.32.99.71
142.250.181.226
142.250.184.226
142.250.185.130
146.0.227.110
147.75.61.140
169.197.150.8
178.162.133.150
178.250.0.165
178.250.2.146
18.156.195.47
18.66.100.58
18.66.112.18
18.66.122.57
18.66.139.105
184.31.84.150
185.184.10.30
185.184.8.65
185.33.220.241
185.33.221.53
185.64.189.112
185.86.137.133
192.28.147.68
193.200.65.5
198.148.27.134
2.21.141.148
2001:4de0:ac18::1:a:3a
204.180.130.159
204.180.130.165
204.180.130.190
204.237.133.120
205.162.42.5
213.19.147.43
2602:803:c004:200::140
2606:4700:10::6816:46c5
2606:4700:20::681a:623
2606:4700:3036::ac43:c834
2606:4700::6810:a852
2606:4700::6813:9308
2a00:1450:4001:800::200a
2a00:1450:4001:808::2001
2a00:1450:4001:808::200e
2a00:1450:4001:811::2002
2a00:1450:4001:811::200a
2a00:1450:4001:828::2001
2a00:1450:4001:828::2002
2a00:1450:4001:828::2006
2a00:1450:4001:829::2002
2a00:1450:4001:82a::2002
2a00:1450:4001:82f::2003
2a00:1450:4001:831::2008
2a00:1450:400c:c06::9b
2a02:2638:1::3
2a02:2638::1c
2a06:8640:799:0:ec4:7aff:fe6e:a48e
3.215.243.168
3.226.203.17
34.107.148.139
34.200.182.42
34.240.134.29
34.246.73.139
34.249.212.247
34.98.64.218
35.244.174.68
37.18.16.23
37.252.161.190
44.236.205.19
44.237.47.166
44.238.59.174
45.133.44.4
5.178.65.246
51.89.9.254
52.208.138.90
52.222.236.10
52.223.40.198
52.35.70.100
52.43.149.174
54.144.144.142
54.245.167.10
54.246.208.198
54.36.109.166
54.72.7.92
62.149.0.72
66.155.71.150
72.251.249.14
8.2.111.126
96.46.186.59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